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Chapter I 
 
1. TRP channels: a remarkable family of ion channels 
Ion channels are pore-forming integral membrane proteins that allow ions to cross the 
biological membrane barrier upon channel activation. Once activated, channels utilize an 
electrochemical gradient across cellular membranes generated by pumps and co-transporters. 
This gradient determines the so-called membrane potential and enables the entering of ions 
with rates up to millions of ions per second until inactivation of the channel complex that can 
be independent of the chemical equilibrium. Based upon their structure, function and 
biophysical properties several ion channel families can be distinguished. Transient Receptor 
Potential (TRP) channels constitute a large and functionally versatile superfamily of cation 
channel proteins that are expressed in many cell types from yeast to mammals (1). Here these 
channels fulfill critical functions in processes ranging from sensory physiology, male fertility, 
vasorelaxation and epithelial ion transport. Based on structure homology mammalian TRP 
channels are comprised of six related subfamilies defined as Classical or Canonical (TRPC); 
Vanilloid receptor related (TRPV); Melastin related (TRPM); Polycystins (TRPP); 
Mucolipins (TRPML) and ANKTM1 related (TRPA) (Fig. 1) (2). A seventh family, NOMPC 
related (TRPN), has so far only been detected in worm, fly, frog and zebra fish and is 
proposed to form a mechanosensing channel (3-6). All TRP channels are postulated to share a 
topology of six transmembrane domains (TM), with a cytoplasmic amino- and carboxyl-
terminus and a cation-permeable pore between TM5 and TM6 that come together in 
functional (hetero) tetramers. Most TRP channels are nonselective cation channels with the 
exception of the monovalent-selective TRPM4 and TRPM5, and the Ca2+-selective TRPV5 
and TRPV6.  
 
2. TRPV5 and TRPV6 as key players in Ca2+ homeostasis 
Ion homeostasis in our body is tightly maintained and disturbances in its balance may lead to 
pathogenesis. The kidney plays a vital role in this process by harmonizing the dietary ion 
intake by the intestine with ion reabsorption from the pro-urine. One of these ions is Ca2+ that 
plays a key role in many physiological processes like hormone secretion, muscle contraction, 
bone formation, nerve conduction, exocytosis and (in)activation of enzymes. The body, 
therefore, carefully regulates the plasma concentration of Ca2+ within a narrow range by the 
concerted action of intestinal Ca2+ absorption, exchange of Ca2+ from bone and renal Ca2+ 
reabsorption. In kidney, Ca2+ can re-enter the blood from the prourine by paracellular 
(passive) as well as transcellular (active) Ca2+ reabsorption. The latter is the main target for 
the calciotropic hormones that are released upon a demand for Ca2+ and subsequently increase 
the renal Ca2+ reabsorption. 
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Fig. 1. Mammalian TRP channel phylogeny  
The mammalian TRP families consist of six related subfamilies defined as Classical or Canonical 
(TRPC); Vanilloid receptor related (TRPV); Melastin related (TRPM); Polycystins (TRPP); 
Mucolipins (TRPML) and ANKTM1 related (TRPA). The evolutionary distance between 
individual TRP family members is indicated by the total branch lengths in point accepted 
mutations (PAM) units, which resembles the mean number of amino acid substitutions per 100 
residues (from Clapham (1)).  
 
Paracellular Ca2+ transport is localized in the proximal part of the nephron, whereas   active 
Ca2+ reabsorption comprises a sequence of processes restricted to the distal convoluted tubule 
(DCT) and the connecting tubule (CNT). At the cellular level, Ca2+ enters the renal epithelial 
cell via the highly Ca2+-selective channel TRPV5 due to the steep inward electrochemical 
gradient across the apical membrane (7). In the cell, Ca2+ is bound to calbindin-D28K that 
ferries Ca2+ from the apical to the basolateral side where the high affinity / low capacity 
plasma membrane ATPase (PMCA1b) and the low affinity / high capacity Na+/Ca2+-
exchanger (NCX1) extrude Ca2+ into the blood compartment (Fig. 2). In kidney, TRPV5 is 
abundantly expressed compared to other tissues, whereas TRPV6 localization and regulation 
has been largely confined to the small intestine. In the intestine a similar mechanism for 
transcellular Ca2+ absorption occurs with TRPV6 as the gatekeeper, calbindin-D9K for 
intracellular Ca2+ handling and PMCA1b as the extrusion mechanism. In addition, 
immunohistochemistry revealed that TRPV6 localizes at the apical domain of the DCT and 
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CNT in kidney were it might contribute to Ca2+ reabsorption. However, TRPV6 was also 
found at the apical domain of principal and intercalated cells in cortical and medullar 
collecting ducts (CCD, MCD), which are not generally implicated in active Ca2+ reabsorption 
(8).   
Fig. 2. Transcellular 
Ca2+ transport  
Integrated model of 
active transcellular 
Ca2+ transport in 
kidney consisting of 
TRPV5 as the apical 
entry gate for Ca2+, 
calbindin-D28K as an 
intracellular ferry 
protein for Ca2+ and, 
NCX1 and 
PMCA1b as Ca2+ 
extrusion systems 
across the basolateral membrane to the blood compartment. These proteins are under the control of 
the calciotropic hormones that are released upon a demand for Ca2+. PTH stimulates renal Ca2+ 
handling by regulating active Ca2+ reabsorption on both the genomic and non-genomic level. The 
active form of vitamin D, 1,25(OH)2D3 contributes to the overall Ca2+ balance by enhancing the 
expression of the Ca2+ transport machinery. Estrogens harbor calciotropic hormone characteristics 
positively regulating the expression of TRPV5, independently of 1,25(OH)2D3. The magnitude of 
Ca2+ entry via TRPV5 controls the expression of the other Ca2+ transport proteins. 
 
Bone is the major Ca2+ store of the body in which osteoblasts deposit Ca2+ from blood into 
bone during bone formation and osteoclasts resorb Ca2+ from bone during bone 
mineralization. In both osteoblasts and osteoclasts transcellular Ca2+ transport is crucial 
during bone formation and absorption. In osteoclasts TRPV5, calbindin-D28K, NCX1 and 
PMCA1b are present (9). Moreover, the predominant localization of TRPV5 to the ruffled 
border membranes facing bone and the finding that bone resorption in osteoclast cultures 
from mice that lack TRPV5 (TRPV5-/-) is impaired led to the conclusion that TRPV5-
mediated transcellular Ca2+ transport in osteoclastic bone resorption is comparable to that of 
the kidney (9). Importantly, osteoclastic ruffled border membranes are strongly acidified by 
an active mechanism which is mediated by a specialized H+ pump (V-ATPase) located on the 
plasma membrane (10). This V-ATPase mediates H+ transport into the resorption pits where a 
low pH is essential for dissolution of bone crystals. At acidified extracellular conditions 
TRPV5 is not active which will result in the absence of ruffled border membrane Ca2+ influx 
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(11-13) (see below). In total, the results until now demonstrate that TRPV5 is present in bone 
and that osteoclastic bone resorption in TRPV5-/- mice is impaired. However, if TRPV5 
constitutes the ruffled border membrane Ca2+ gate essential for the maintenance of a normal 
Ca2+ balance remains to be elucidated.  
     
3. Expression of TRPV5 and TRPV6 in other tissues  
3.1 Stomach 
Although TRPV5 and TRPV6 are mainly expressed in Ca2+-transporting organs, including 
kidney, intestine, and bone, both channels are detected in several other tissues. Along the 
gastro-intestinal tract, the stomach is generally not considered to play a major role in Ca2+ 
absorption, however, functional measurements demonstrated a luminal to blood transport of 
Ca2+ (14). Interestingly, TRPV6 and, to a lesser extent, TRPV5 have been detected in the 
stomach (15, 16). At least for TRPV6 it was suggested that in mucus-secreting cells this 
channel plays an important role in maintaining [Ca2+]i by refilling the depleted Ca2+ stores 
after hormone-controlled mucus secretion (17). Thus, in these latter cells TRPV6 potentially 
acts as a kind of store-operated Ca2+ channel. However, functional characterization of mucus-
secreting cells from stomach isolated from TRPV5-/- and TRPV6-/- mice is needed to 
completely understand the role of these Ca2+ channels in the stomach. 
 
3.2 Placenta 
During pregnancy, Ca2+ absorption in the placenta is solely responsible for the Ca2+ supply to 
the developing fetus. In line with this function, transcellular Ca2+ transport takes place in 
placental syncytiotrophoblasts that separate maternal and fetal circulation (18). Similar as in 
the intestine and kidney, the Ca2+ transport machinery in these cells is suggested to comprise 
of apical influx followed by subsequent intracellular transport by calbindin-D9K and -D28K and 
basolateral extrusion by Ca2+-ATPases and Na+/Ca2+ exchangers (19). Among the candidates 
for apical Ca2+ influx channels are TRPV5 and TRPV6 which both are expressed in the 
placenta, although the expression of TRPV6 appears to be dominating (20, 21). Moreover, the 
expression level of TRPV5 and TRPV6 correlates with the differences in Ca2+ uptake during 
the differentiation of cultured human trophoblasts isolated from placenta providing 
circumstantial evidence for a role of these channels in Ca2+ uptake by the syncytiotrophoblast 
(21). 
3.3 Exocrine tissues 
In exocrine tissues such as pancreas, testis, prostate, mammary-, sweat- and salivary-gland 
epithelial Ca2+ channels are expressed (22). Although the function of TRPV5 and TRPV6 in 
these tissues remains elusive several studies indicated that they are essential components of 
Ca2+ handling in these tissues. TRPV5 and TRPV6 possibly fulfill an critical role in the 
9
Chapter I 
 
pancreas were they are part of the signaling complex leading to excretion of insulin from β-
cells (23). In prostate, TRPV6 is correlated with the progression of prostate carcinoma and 
here TRPV6 is involved in Ca2+ signaling (24, 25). In conclusion, the differences in the 
localization of these channels throughout the organism may reflect diverse physiological 
functions. 
 
4. TRPV5 and TRPV6; biophysically unique channels  
TRPV channels are Ca2+ permeable, however TRPV5 and TRPV6 discriminate much higher 
between divalent and monovalent cations. They are, however, permeable for monovalents in 
the absence of divalents (e.g. the relative selectivity for Ca2+ over Na+ Pca/PNa = 1-10 
(TRPV1-TRPV4) and Pca/PNa >100 (TRPV5 and TRPV6)) (26-29). For both TRPV5 and 
TRPV6 a divalent cation permeation sequence of Ca2+ > Ba2+ > Sr2+ > Mn2+ has been reported 
(30-32). In the physiological context, this selectivity makes TRPV5 and TRPV6 particularly 
suited for Ca2+ transport in the presence of other cations, fitting the basic requisites for 
luminal Ca2+ influx channels in Ca2+-transporting epithelia. Differences in selectivity and 
permeation within the TRPV subfamily are explained by structural variations residing in the 
selectivity filter (a stretch of negatively charged residues in the pore structure that selectively 
enables the entering of cations). For TRPV5 and TRPV6 the high Ca2+ selectivity is 
pinpointed to a single aspartate residue within the selectivity filter (TRPV5-D542 and 
TRPV6-D541) and mutation of this residue completely abolished Ca2+ permeability without 
affecting Na+ permeability (33, 34) (Table 1). In addition, apartate-542 within the selectivity 
filter of TRPV5 is essential for its Mg2+ sensitivity since mutation of this residue (D542A) 
abolished the Mg2+-induced inhibition (35). Single channel measurements of Na+ currents for 
TRPV5 and TRPV6 indicated a similar conductance of 40-70 pS and corresponding current-
voltage relationships show inward rectification. Whereas other TRP channels are activated 
upon a rise in [Ca2+]i, TRPV5 and TRPV6 display a negative feedback regulation of channel 
activity by Ca2+, even in the presence of high affinity Ca2+ buffers and a negative membrane 
potential (36) (Fig. 3). It could be envisaged that such channel regulation is of physiological 
importance in Ca2+-transporting cells to reduce the entering of Ca2+ when [Ca2+]i becomes 
detrimental. The subsequent recovery after Ca2+-dependent inactivation of TRPV5 and 
TRPV6 is not directly linked to [Ca2+]i (e.g. unbinding of Ca2+ from the channel complex). 
This originated from the observations that the recovery from the Ca2+-induced inhibited state 
is much slower than the inhibition and does not correlate with the restoration of the basal Ca2+ 
level after Ca2+ influx (36). The complex kinetics of Ca2+ inhibition and subsequent recovery 
of channel activity thus suggest that processes other than rapid binding of Ca2+ to the channel 
and slow dissociation are involved in coupling the Ca2+ current and coherent [Ca2+]i to 
TRPV5 and TRPV6 activity.  
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Table 1. TRPV5 and 
TRPV6 topology and 
regulation 
Like all TRP channels 
TRPV5 and TRPV6 are 
comprised of six 
transmembrane domains 
with a predicted pore 
structure between TM5 
and TM6 and an 
intracellular amino- and 
carboxyl-terminus. 
TRPV5 and TRPV6 
contain 3-5 conserved 
ankyrin repeats in their 
amino-terminus involved 
in channel 
multimerization. Indicated 
are the suggested extra- 
and intracellular pH 
sensors E522 and K607 
determining the pH 
sensitivity of TRPV5. For 
TRPV5 and TRPV6 the 
high Ca2+ selectivity is 
pinpointed to a single 
aspartate residue within 
the selectivity filter 
(TRPV5-D542 and 
TRPV6-D541). A number 
of factors and associated 
proteins were previously 
identified to affect the 
activity of TRPV5 and 
TRPV6 (see text for 
details).   VATTV and 
MLERK are important 
residues for associated 
proteins.   
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Detailed electrophysiological analysis of TRPV5 and TRPV6 currents revealed that both 
channels display constitutive activity at physiological membrane potentials with similar 
characteristics. However, differences concern divalent cation permeability, pharmacology, the 
kinetics of Ca2+-dependent inactivation and recovery from inactivation (Fig. 3). In the 
absence of other cations TRPV5 is more permeable for Ba2+ than TRPV6 (37). Furthermore, 
the Ca2+-dependent inactivation kinetics of TRPV5 are initially, after hyperpolarization, less 
pronounced than for TRPV6 although total inactivation is not significantly different (37). 
Subsequent recovery of TRPV6 activity after Ca2+-dependent inactivation is twice as slow as 
for TRPV5. In addition, TRPV5 sensitivity for the potent Ca2+ channel blocker ruthenium red 
is 100-fold higher (IC50 ~ 121 ± 13 nM) than TRPV6 (IC50 ~ 9 ± 1 µM). In total these 
differences should allow dissection of individual TRPV5 and TRPV6 currents in tissues 
where both channels are expressed and operate independently from each other.  
 
 
Fig. 3. Negative feedback inhibition of TRPV5 and TRPV6 activity by intracellular Ca2+  
Currents through TRPV5 and TRPV6 during a voltage step from +70 to -100 mV. Charge carrier 
is either Ca2+ (30 mM) or Ba2+ (30 mM). All of the other cations are substituted by 150 mM 
NMDG+. Cells were loaded with 10 mM BAPTA. Insets show currents normalized to the peak 
current. Upon opening of these channels, as evident from the immediate rise in current after 
hyperpolarization, channel activity decreases as reflected by inactivation of the current.  
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Like the majority of the TRP channels, TRPV5 and TRPV6 form functional hetero tetramers 
that posses distinctive properties than that of either channel alone (38). TRP channel 
multimerization appears to be restricted to members within relatively narrow confines of 
phylogenetic subfamilies, although several TRP channels form functional multimers with 
other non-TRP ion channels underlying a direct coupling of TRP channels mediated signaling 
with other process (39-43). The tetrameric stoichiometry of TRP channels resembles that of 
KscA K+ channels where the four subunits cluster together to form a central pore such that the 
pore selectivity filters are central in determining ion permeation (Fig. 4). Within the TRPV6 
amino-terminus an ankyrin repeat at position 116 - 191 was identified as a stringent 
requirement for physical assembly of TRPV6 subunits. It was proposed that this repeat 
initiates a molecular zippering process that proceeds past the last ankyrin repeat, thereby 
creating an intracellular anchor essential for functional TRPV6 subunit assembly (44). The 
regions that determine TRPV5 subunit assembly reside within both the N- (64-77) and 
carboxyl-terminus (596-601) (45). Recently the crystal structure of the TRPV2 ankyrin 
repeats has been elucidated and detailed analyses revealed that, although TRPV2 form 
functional tetramers, the six ankyrin repeat domains do not associate during multimerization 
(46). Translating these results to the epithelial Ca2+ channels suggests that the ankyrin repeats 
in TRPV5 and TRPV6 are distantly related to those in TRPV2 and directly tertramerize to 
promote channel assembly. Another possibility is that the TRPV5 and TRPV6 ankyrin repeats 
promote channel assembly by interacting with associated proteins or other regions of these 
channels. Additional studies with the isolated TRPV5 and/or TRPV6 ankyrin repeat domains 
could discriminate between these hypotheses.       
 
5. TRP channel regulation  
Regulation of TRP channels has recently gained profound interest due to the diverse cellular 
functions they fulfill. The various mechanisms adapted by cells to control channel activity 
basically operate at four distinct levels. First, channel activity can be affected on the genomic 
level via (hormone-mediated) signaling of messengers to the nucleus to regulate gene 
transcription. Second, after synthesis and controlled assembly of (hetero)multimeric channel 
complexes in the ER/Golgi trafficking of these channels towards the cell surface is under the 
control of several systems. Trafficking of TRP channels is of special interest since many 
channels (including TRPV5 and TRPV6) are not clearly localized at the plasma membrane, 
but merely reside in intracellular vesicles. Third, channel activity at the cell surface can be 
affected by structural modifications of the channel complex and/or binding and release of 
intra- and extracellular compounds affecting channel (in)activation. Fourth, recycling and 
degradation of plasma membrane inserted channels via distinct pathways enables tight and 
spatiotemporal control of TRP channels. Regulation of TRPV5 and TRPV6 is a pivotal 
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process in the maintenance of a normal Ca2+ balance. In this way the organism is able to 
respond to fluctuations in the demand for Ca2+.  
 
Fig. 4. TRPV5 pore 
structure 
Model for the TRPV5 
pore region, based on 
the K+ channel KscA 
structure. Views of the 
structure are shown, 
looking down from 
the external solution 
to the complete 
homotertrameric 
channel (top) or 
looking sideways 
(below). Blue residues 
correspond to the 
residues in TM5 and 
TM6. Amino acids 
that were subjected to 
SCAM analysis to 
determine their position to the extracellular compartment (47), are colored in green, yellow, red or 
gray. Intra- and extracellular protons determine the position of the TRPV5 pore helix position 
leading to opening and closing of the TRPV5 pore such that protons cause the pore helix to rotate 
in the clockwise direction, leading to closing (narrowing) of the pore, whereas in the absence of 
protons (alkalinization) the pore opens. The model is partly adapted from Voets et al  (48).     
 
5.1 Hormonal regulation of TRPV5- and TRPV6-mediated transcellular Ca2+ transport 
An intrinsic physiological mechanism is sensing the Ca2+ demand by a specialized Ca2+-
sensing receptor (CaSR) that couples the blood Ca2+ levels to the secretion and production of 
the Calciotropic hormones including 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), parathyroid 
hormone (PTH) and calcitonin. At a blood ionized [Ca2+] below 1.25 mM the parathyroid 
CaSR is inactivated, which enables a cascade of signaling pathways to increase the secretion 
of PTH. PTH in turn stimulates the production of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) 
and calcitonin that increase Ca2+ uptake in the intestine, Ca2+ reabsorption in kidney and Ca2+ 
uptake from bone. Upon a subsequent rise in blood ionized [Ca2+] the CaSR is activated 
which suppresses the release of PTH and thus maintains plasma Ca2+ levels within a narrow 
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physiologic range by efficiently regulating Ca2+ transport processes in kidney, intestine and 
bone (Fig. 2). 
 
5.1.1 Transcellular Ca2+ transport and PTH 
Primary hyperparathyroidism is characterized by PTH levels that are inappropriate to the level 
of plasma Ca2+ and is one of the endocrine disorders that underline the importance of PTH in 
maintaining the overall Ca2+ balance. In addition, mutations in the CaSR, which couples 
plasma Ca2+ levels to the production and secretion of PTH from the thyroid glands, were 
identified in patients with familial hypocalciuric hypercalcemia, neonatal severe 
hyperparathyroidism (inactivating mutations) (49) and autosomal-dominant hypocalcemia 
(activating mutations) (50). From the clinical symptoms of these PTH-related disorders, 
including hypo- or hypercalciuria and renal stone formation, it is evident that also renal Ca2+ 
handling is affected. PTH receptors have been detected throughout the nephron including 
DCT and CNT, thus enabling the body to directly control active Ca2+ reabsorption in kidney 
via PTH (22). In addition, genetic ablation of CaSR resulted in hyperparathyroidism and 
hypercalcemia, accompanied by an up-regulation of TRPV5 and TRPV6 in kidney and 
intestine, respectively (51). To understand the molecular regulation of the Ca2+ transport 
proteins by PTH, parathyroidectomy was performed in rats (52). The effectiveness of this 
treatment was evident from the marked reduction of PTH levels and hyperphosphatemia, a 
well-known symptom of hypoparathyroidism. Moreover, parathyroidectomy reduced the 
expression of TRPV5, calbindin-D28K and NCX1 in kidney. This decline in expression of the 
renal Ca2+ transport proteins was accompanied by reduced active Ca2+ reabsorption and the 
development of hypocalcemia. PTH supplementation in these parathyroidectomized rats 
normalized the renal Ca2+ transport protein expression levels and increased the plasma Ca2+ 
concentration (52). In addition, the regulation by PTH was investigated in primary cultures of 
rabbit CNT and cortical collecting duct (CCD) cells (52). Long-term stimulation of PTH 
resulted in an elevated expression of the Ca2+ transport proteins TRPV5, calbindin-D28K, 
NCX1 and PMCA1b in these renal cell cultures. Taken together, these studies indicated that 
PTH stimulates renal Ca2+ handling by co-regulating the expression of the Ca2+ transport 
proteins. 
Regulation of expression of the Ca2+ transport proteins, however, is a relatively slow process, 
while a fast non-genomic response operates on a time scale that is sufficient for an immediate 
increase of Ca2+ reabsorption. An established pathway for short-term PTH-stimulated active 
Ca2+ reabsorption in kidney is activation of adenylyl cyclase, accumulation of cAMP and 
subsequent activation of protein kinase A (PKA). Addition of PTH to perfused rabbit CNT or 
primary cultures of rabbit CNT and CCD resulted in a rise of cytosolic cAMP levels 
accompanied by an increase in transcellular Ca2+ transport (53, 54). Moreover, PKA inhibitors 
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reduced this PTH stimulation, which suggests that cAMP-dependent phosphorylation is an 
essential step in short-term PTH stimulation. In addition to cAMP, a prominent role for 
protein kinase C (PKC) was demonstrated in the short-term PTH response (55). However, it 
remains to be established if this short-term PTH stimulation of transcellular Ca2+ transport is 
mediated by direct activation of TRPV5. Thus, besides a genomic effect, PTH can stimulate 
Ca2+ reabsorption directly via a short-term mechanism involving PKA and PKC.  
Taken together, these studies revealed that PTH-dependent stimulation of transcellular Ca2+ 
reabsorption in kidney occurs via both genomic and non-genomic pathways.  
 
5.1.2 Transcellular Ca2+ transport and estrogens 
The increased risk for osteoporosis in postmenopausal women is associated with estrogen 
deficiency. Furthermore, estrogen deficiency is associated with renal Ca2+ wasting and 
intestinal Ca2+ malabsorption that can be restored by estrogen replacement therapy (56). From 
these findings the physiological relevance of estrogens in maintaining the Ca2+ balance is 
feasible. In addition, this suggests that estrogens can comply with the action of the 
calciotropic hormones, regulating the expression of the renal Ca2+ transport proteins. Estrogen 
receptors have been detected in DCT and CNT, thus enabling the body to directly regulate 
active Ca2+ reabsorption in kidney by estrogen (22). Estrogen replacement therapy in 
ovariectomized rats revealed an increase in the renal expression of TRPV5, calbindin-D28K, 
NCX1 and PMCA1b suggesting an important role for this hormone in regulating Ca2+ 
reabsorption (22). In addition, genetic ablation of the estrogen receptor-α in mice decreased 
the expression of the aforementioned renal Ca2+ transport proteins. In principle these effects 
could be explained by estrogen-dependent vitamin D activation. This possibility was 
investigated in vitamin D-deficient animal models. Estrogen supplementation in 25-
hydroxyvitamin D3-1α-hydroxylase (1α-OHase) knockout mice increased the expression of 
TRPV5 in kidney, while the expression of the other Ca2+ proteins remained unaltered (22). In 
the intestine estrogens regulate the expression of TRPV6 in a vitamin D-independent manner 
that became clear from estrogen supplementation in vitamin D receptor (VDR) and 1α-OHase 
knockout mice. This resulted in an up-regulation of duodenal TRPV6, whereas the expression 
of calbindin-D9K and PMCA1b was not altered (22). Thus, estrogens harbor calciotropic 
hormone characteristics regulating the expression of TRPV5 and TRPV6 in kidney and 
intestine, respectively.     
 
5.1.3 Transcellular Ca2+ transport and vitamin D 
The active form of vitamin D, 1,25(OH)2D3, is an important steroid hormone in the body Ca2+ 
homeostasis. This is reflected by several vitamin D-related disorders with symptoms like 
rickets and hypercalciuria. Inactivating mutations in 1α-OHase are associated with vitamin D-
16
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deficiency rickets type 1 (57) and mutations in the VDR are associated with hypocalcemic 
rickets (58).  Active Ca2+ (re)absorption is a main target for 1,25(OH)2D3, as illustrated by 
1,25(OH)2D3-stimulated Ca2+ transport in primary cultures of rabbit CNT and CCD cells and 
human intestinal Caco-2 cells (53, 59). Strikingly, microarray analysis of 1,25(OH)2D3-
stimulated carcinoma cells revealed TRPV6 as one of the most highly vitamin D-responsive 
genes underlining the ability of vitamin D to regulate TRPV6 expression (60).  
Evidence for 1,25(OH)2D3-controlled expression of the renal Ca2+ transport proteins came 
from rats that were raised on a vitamin D-deficient diet. This diet decreased the renal 
expression of TRPV5, which was accompanied by a marked drop in plasma Ca2+ levels. In 
addition, genetic ablation of 1α-OHase in mice resulted in severe hypocalcemia, 
hyperparathyroidism, bone abnormalities and retarded growth (61). In line with the 
development of hypocalcemia is the diminished Ca2+ reabsorption in kidney, presumably as a 
result of the down-regulated expression of the Ca2+ transport proteins TRPV5, calbindin-D28K 
and NCX1 (22). Supplementation of 1,25(OH)2D3 restored the expression of the renal Ca2+ 
transport proteins and normalized the hypocalcemia (22). Thus, vitamin D is of fundamental 
importance for the regulation of renal Ca2+ transport proteins and the maintenance of a normal 
Ca2+ balance. 
Mice lacking TRPV5 display robust renal Ca2+ wasting due to impaired Ca2+ reabsorption in 
DCT and CNT (62). In addition, elevated 1,25(OH)2D3 plasma levels, intestinal Ca2+ 
hyperabsorption and reduced bone thickness were demonstrated. Besides the decreased 
storage of Ca2+ in bone, compensatory hyperabsorption of Ca2+ in the intestine prevented the 
development of hypocalcemia in these knockout mice. The underlying mechanism of this 
compensatory hyperabsorption is hypervitaminosis D which increases the expression of the 
intestinal Ca2+ transport proteins TRPV6, calbindin-D9K and PMCA1b (62). This finding 
indicates that a renal Ca2+ leak due to the absence of TRPV5 triggers a rescue mechanism 
resulting in an increased production of vitamin D-stimulated intestinal Ca2+ absorption. The 
absence of hypervitaminosis D in the recently developed 1α-OHase and TRPV5 double 
knockout (1α-OHase-/-/TRPV5-/-) mice, resulted in hypocalcemia and thus suggests that the 
elevated levels of 1,25(OH)2D3 in TRPV5-/- mice are responsible for the up-regulation of 
intestinal Ca2+ transport proteins and the coherent Ca2+ hyperabsorption (63). The absence of 
hyperabsorption in 1α-OHase-/-/TRPV5-/- mice resulted in a more aggravated phenotype 
compared to TRPV5 ablation. Thus, 1,25(OH)2D3 is crucial to compensate for the renal Ca2+ 
leak and to maintain normal plasma Ca2+ levels in TRPV5-/- mice. Importantly, PTH levels in 
these knockout models are comparable to wild-type littermates, indicating that the observed 
regulation is not due to altered PTH levels.  
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5.2 Regulation of TRPV5 and TRPV6 activity by associated protein complexes 
Non-genomic regulation of TRPV5 and TRPV6 activity is under the control of associated 
protein partners that affect channel trafficking and, activity or stability at the cell surface 
(Table 1). The Ca2+-dependent activity of TRPV5 and TRPV6 is under special interest since 
the biophysical properties of these channels cannot explain this phenomenon and sequences 
analysis revealed that both TRPV5 and TRPV6 do not contain known sequences involved in 
Ca2+-sensing. Both channels are, however, highly regulated by Ca2+ suggesting the 
involvement of Ca2+-binding proteins that translate the local Ca2+ concentration to TRPV5 
and TRPV6 activity.  
 
5.2.1 Cell surface expression of TRPV5 and TRPV6: role of S100A10-annexin 2 and 
Rab11 
Using yeast two-hybrid, GST pull-down analyses and co-immunoprecipitations the Ca2+-
binding protein S100A10 was identified as an associated protein of TRPV5. S100A10 forms a 
well-defined heterotetrameric complex with annexin 2 and specifically binds the conserved 
sequence VATTV in the carboxyl-terminus of TRPV5 and TRPV6 (64). Importantly, both 
S100A10 and annexin 2 co-localize with TRPV5 in kidney and with TRPV6 in the intestine. 
Disruption of the first threonine of the VATTV motif in the carboxyl-terminus (TRPV5 
T599A and TRPV6 T600A) resulted in a diminished S100A10 binding, localization of 
TRPV5 to a sub-plasma membrane area in Xenopus leavis oocytes and disruption of channel 
activity. In addition, downregulation of annexin 2 using annexin 2-specific small interference 
RNA inhibited TRPV5 and TRPV6 activity as assessed by electrophysiological recordings in 
HEK293 cells. In total, these findings revealed that the S100A10-annexin 2 complex is 
essential for TRPV5 and TRPV6 trafficking towards the cell surface. S100A10 is a member 
of the Ca2+-binding proteins and annexin 2 is a phosphoinositide binding protein (65). Since 
both Ca2+ and phosphoinositides affect the activity of TRPV5 and TRPV6 (7, 35, 66, 67) (see 
below), it could be envisaged that the S100A10-annexin 2 complex is involved in Ca2+- 
and/or phosphoinositide-dependent channel activity. The binding of S100A10 to TRPV5 and 
TRPV6 is, however, independent of Ca2+ as reflected by the lack of Ca2+ dependence in GST 
pull-down experiments suggesting that the S100A10-annexin 2 dependent regulation does not 
involve Ca2+-sensing. It remains, however, to be elucidated if S100A10 is involved in 
phosphoinositide-dependent activity of TRPV5 and TRPV6.      
The family of Rab GTPases consists of important factors in vesicular cargo delivery (68). The 
ability to cycle between GTP- and GDP-bound states enables Rab proteins to act as molecular 
switches determining protein delivery to their targets. Rab11a was found to directly associate 
with TRPV5 and TRPV6 (69). Detailed analysis of this association revealed that the 
interaction was specific for GDP-bound Rab11a. Co-expression of a GDP-locked Rab11a 
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mutant resulted in an inhibition of TRPV5-mediated Ca2+ uptake in oocytes and transcellular 
Ca2+ transport in primary rabbit CNT/CCD cultures. This inhibition is caused by a diminished 
cell surface expression of TRPV5 that substantiated the conclusion that Rab11a is an essential 
factor in TRPV5 trafficking. In intracellular vesicles Rab11a-GDP and TRPV5 and/or TRPV6 
directly associate and upon exchange of GDP for GTP, the channel is delivered to the plasma 
membrane. Subsequent GTP hydrolyzes will result in an internalization of the complex and 
inhibition of transcellular Ca2+ transport.        
 
5.2.2 Activity of TRPV5 and TRPV6 at the cell surface: 80K-H and BSPRY  
The widely expressed PKC substrate 80K-H was found to be concomitantly regulated with 
TRPV5 by 1,25(OH)2D3 and dietary Ca2+ (70). Both proteins co-localize in kidney and 
directly associate independently of Ca2+ (71). 80K-H binds Ca2+ and inactivation of its Ca2+-
binding EF-hand structures eliminated Ca2+ binding. Co-expression of a Ca2+-insensitive 80K-
H mutant in TRPV5-expressing cells reduced TRPV5 currents which led to the conclusion 
that 80K-H acts as a Ca2+-sensor controlling TRPV5 activity. 
The biological function of BSPRY (B-box and SPRY-domain containing protein) remains to 
be established, however, yeast two-hybrid, GST pull-downs and co-immunoprecipitation 
experiments revealed that BSPRY associates with TRPV5 independently of Ca2+ (72). Both 
proteins co-localize in kidney and co-expression of BSPRY resulted in a significant reduction 
of TRPV5-mediated Ca2+ influx in confluent monolayers of Madine Darby Canine Kidney 
cells. BSPRY affects TRPV5 activity at the cell surface, which is evident from the 
biotinylation experiments showing that the BSPRY-mediated TRPV5 inhibition independent 
from altered plasma membrane expression. Together these findings demonstrated a role of 
BSPRY in the regulation of TRPV5-mediated epithelial Ca2+ transport and revealed the first 
physiological function of this novel protein.  
 
5.2.3 TRPV5 and TRPV6 stability at the plasma membrane: NHERF and klotho   
Molecular and cellular studies over the past decade showed that NHERF members (Na+/H+ 
Exchanger Regulating Factors) regulate the targeting and stability of ion transporters and 
other membrane proteins, and transduce (patho)physiological signals that determine ion 
homeostasis in mammals (73). NHERF2 specifically interacts with the TRPV5 carboxyl-
terminus, whereas NHERF4 associates with both TRPV5 and TRPV6 (74, 75). Interestingly, 
in a large-scale proteomic analysis to unravel the TRPV5 interactome NHERF1 was found to 
associate with TRPV5 (Lambers et al., unpublished results). Although NHERF4 binds to both 
TRPV5 and TRPV6, these proteins only co-localize in the intestine where NHERF4 could act 
as putative plasma membrane scaffolding protein. Upon co-expression of NHERF2 and serum 
and glucocorticoid inducible kinases (SGK1 and SGK3) the activity of TRPV5 was 
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upregulated (75). Similarly, co-expression of SGK1 with NHERF2 stimulates the activity of 
the K+ channel ROMK1 as a result from stabilization of channels at the plasma membrane 
(76). To address whether TRPV5 stimulation by NHERF2, SGK1 and SGK3 is mediated by 
stabilization of the channel at the plasma membrane remains to be elucidated. In conclusion, 
NHERF proteins appear to be essential factors involved in controlling TRPV5 and TRPV6 
activity. 
The β-glucuronidase klotho is associated with human aging, however, the molecular function 
and the downstream targets of this enzyme are largely unknown (77). Detailed analysis 
revealed that the klotho gene also expresses a secreted form, lacking transmembrane and 
intracellular domains, due to alternative RNA splicing. Therefore, klotho could also act as a 
humoral factor (78). The expression of klotho in kidney was found to be downregulated in 
mice lacking TRPV5 (79). Moreover, the expression of klotho is tightly regulated by vitamin 
D, suggesting a functional link between TRPV5 and klotho in the maintenance of the Ca2+ 
balance. Furthermore, mice lacking klotho (klotho-/-) displayed renal Ca2+ loss (77). In line 
with the detection of klotho in urine it was found that klotho regulates the activity of TRPV5 
from the extracellular side via its glucuronidase activity. Further analysis revealed that klotho 
hydrolyzes the extracellular N-glycosylation of TRPV5 resulting in entrapment of TRPV5 at 
the plasma membrane. This study demonstrated the first molecular target of klotho providing 
insight in TRPV5-mediated Ca2+ reabsorption, Ca2+ deficits in klotho-/- mice and aging-related 
Ca2+ disorders.  
 
5.3. Other factors that control TRPV5 and TRPV6 activity 
Besides hormones and associated proteins several other physiological factors are involved in 
TRPV5 and TRPV6 regulation, thereby indirectly determining the overall Ca2+ balance 
(Table 1).  
 
5.3.1 Dietary Ca2+ 
Hereditary hypocalcemic vitamin D-resistant rickets, which are caused by a genetic defect in 
the VDR gene, are treated with high dietary Ca2+ supplementation (80). This suggests that 
dietary Ca2+ can act as an additional regulatory mechanism of Ca2+ handling independent of 
vitamin D. From a molecular point of view, dietary Ca2+ affects the Ca2+ balance by 
regulation the expression of the renal and intestinal Ca2+ transport proteins. This is evident 
from high dietary Ca2+ supplementation in mice which, among others, resulted in a decreased 
TRPV5 and TRPV6 expression (22). This decline in expression is likely mediated by the 
accompanied decrease in 1,25(OH)2D3 levels. In contrast, in 1α-Ohase-/- a high dietary Ca2+ 
load normalized the plasma Ca2+ concentration as well as the expression of TRPV5, 
calbindin-D28K, NCX1 and PMCA1b (22). Likewise, in mice that lack VDR an increased 
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dietary Ca2+ intake upregulated the expression of TRPV5 in kidney and TRPV6 in the 
intestine (80). Taken together, dietary Ca2+ regulates the expression of the Ca2+ transport 
proteins, both independent and dependent of 1,25(OH)2D3 .  
 
5.3.2 Phosphoinositides 
Phosphoinositides are ubiquitously employed interconverting signaling molecules in 
eukaryotic cells that can affect a wide range of cellular process among others the activity of 
ion channels. Phosphatidylinositol 4,5-biphosphate (PIP2) influences the activity of a diverse 
range of ion channels like, inward-rectifier and voltage-gated K+ channels, the two-P domain 
K+ channels, voltage-gated Ca2+ channels, cyclic nucleotide-gated channels, intracellular Ca2+ 
release channels and the epithelial Na+ and Cl- channels (81). How phosphoinositides alter 
channel function is an area of intense research interests. It has been shown for many ion 
channels that direct interaction with PIP2 stabilizes channels in a particular conformation (81). 
By stabilization in one conformation, PIP2 modulates the response of ion channels to 
regulators, such as GTP-binding proteins, intracellular pH, Na+, ATP, etc. Likewise, several 
TRP channels have been shown to be affected by PIP2 and recently a mechanism was 
proposed for PIP2-mediated TRPM8 channel regulation via a carboxyl-terminal stretch of 
amino acids that is conserved in most TRP members (termed TRP domain). TRPV5 and 
TRPV6 do not contain a conserved TRP domain, however, TRPV5 is demonstrated to be 
regulated by PIP2 (35). In this study PIP2 was identified to stimulate TRPV5 activity by 
decreasing the sensitivity of the channel to extracellular Mg2+-induced inhibition. 
 
5.3.3 Extracellular pH 
Acid-base homeostasis is known to affect the Ca2+ balance as evident from changes in renal 
Ca2+ handling during chronic metabolic acidosis or alkalosis (82, 83). Likely, renal Ca2+ loss 
during chronic acidosis is a result of downregulation of the Ca2+ transport proteins TRPV5, 
CaBP28K and NCX1, while renal Ca2+ sparing during chronic alkalosis is a result of an 
increased expression of the Ca2+ transport machinery (83). Besides genomic regulation, pH 
(both intra- and extracellular) was found to directly affect the activity of TRPV5 such that 
acidification inhibited TRPV5 activity and alkalinization increased channel activity (11-13). 
The intracellular lysine (K607) and the extracellular glutamic acid (E522) residues of TRPV5 
have been postulated as pH sensors determining TRPV5 activity, although K607N and E522Q 
mutants still displayed pH-sensitivity (11, 13) (Table 1). The activity of a diverse range of ion 
channels is regulated by extracellular factors and often structural rearrangements within the 
pore underlie biophysical changes that determine channel activity (84-86). Likewise, cellular 
pH was found to determine the position of the TRPV5 pore helix such that intra- and 
extracellular protons cause the pore helix to rotate in the clockwise direction, leading to 
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closing (narrowing) of the pore, whereas in the absence of protons the pore opens (Fig. 4) 
(13).    
 
6. Scope of this thesis 
The molecular regulation of TRPV5 and TRPV6 activity in kidney and intestine, respectively, 
is of fundamental importance to understand the Ca2+ homeostasis. Since the discovery of these 
channels, TRPV5 and TRPV6 regulation also gained interest from clinicians given the 
numerous symptoms involving malfunctioning of the Ca2+ balance. Although we can now 
pinpoint the effect of the calciotropic hormones to changes in the expression of the Ca2+ 
transport machinery including TRPV5 and TRPV6 as the luminal entry gates, the molecular 
regulation of these channels at the plasma membrane and their trafficking to the cell surface 
still remains elusive. As indicated, channel-associated protein complexes generally fulfill an 
important role in these processes. To date, a number of associated proteins are implicated in 
TRPV5 trafficking to the plasma membrane. However, physiological factors that initiate 
(rapid) recruitment of TRPV5 towards the cell surface and the precise mechanisms these 
factors employ to transport channels to the cell surface remain to be identified. To this end, 
several processes known to affect the activity of TRPV5 and TRPV6 have been studied for 
their ability to initiate TRPV5 trafficking.  
The general aim of this thesis was to gain insight into the molecular regulation of TRPV5 and 
TRPV6 in Ca2+-transporting epithelia. In chapter 2 the influence of extracellular pH on the 
rapid insertion of TRPV5 is described. This study demonstrated that TRPV5 plasma 
membrane expression is under tight control of extracellular pH. TRPV5 accesses the 
extracellular compartment via transient openings of rapidly recruited vesicles, providing 
evidence that rapid activation of constitutive active ion channels in response to physiological 
stimuli relies on vesicular “kiss and linger” interactions with the plasma membrane. Chapter 
3, 4 and 5 focus on the intrinsic mechanism of Ca2+-dependent regulation of TRPV5 and 
TRPV6, a mode of channel regulation still not understood. In chapter 3 the regulation of 
TRPV5 and TRPV6 by the Ca2+-sensor calmodulin is presented. Although both TRPV5 and 
TRPV6 interact with calmodulin, TRPV6 is specifically regulated by calmodulin. Calmodulin 
is constitutively bound to TRPV6 were it acts as a Ca2+-sensor regulating TRPV6 channel 
activity. To identify novel TRPV5 and/or TRPV6 interacting protein partners that might 
affect channel activity, a large-scale proteomic approach has been performed. This resulted in 
the identification of calbinidin-D28K as a TRPV5-interacting protein. In Chapter 4, the 
association and functional regulation of calbindin-D28K is described. This study demonstrated 
that upon a decrease in [Ca2+]i calbindin-D28K translocates towards the plasma membrane 
where it associates with TRPV5 to regulate [Ca2+] in close proximity of the TRPV5 pore. To 
further implicate our experimental data on transcellular Ca2+ transport a mathematical model 
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of transcellular Ca2+ transport was established as given in chapter 5. In addition, Nipsnap1 
was identified as novel TRPV5-interacting protein. Chapter 6 highlighted that Nipsnap1 is a 
novel protein of which the physiological function is unknown. However, our study 
demonstrated the first function for this protein as regulator of the TRPV5 activity at the 
plasma membrane.  
In the past years TRPV5 research has focused on the unraveling of its function and regulation 
in kidney, while its function in other tissues remains elusive. The results given in chapter 7 
provide evidence for localization of TRPV5 in the inner ear and elucidate a new physiological 
function of TRPV5 in sound perception. Finally, a general discussion and summary of the 
thesis work is presented in chapter 8.  
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Abstract  
Extracellular pH has long been known to affect the rate and magnitude of ion transport 
processes among others via regulation of ion channel activity. The Ca2+-selective Transient 
Receptor Potential Vanilloid 5 (TRPV5) channel constitutes the apical entry gate in Ca2+-
transporting cells contributing significantly to the overall Ca2+ balance. Here, we demonstrate 
that extracellular pH determines the cell surface expression of TRPV5 via a unique 
mechanism. By a comprehensive approach using total internal reflection fluorescence 
microscopy, cell surface protein labeling, electrophysiology, 45Ca2+ uptake assays and 
functional channel recovery after chemobleaching this study shows that upon extracellular 
alkalinization a pool of TRPV5-containing vesicles is rapidly recruited to the cell surface 
without completely fusing with the plasma membrane. These vesicles contain functional 
TRPV5 channels since extracellular alkalinization is accompanied by an increased TRPV5 
activity. Conversely, upon subsequent extracellular acidification vesicles are retrieved from 
the plasma membrane, simultaneously resulting in decreased TRPV5 activity. Thus, TRPV5 
accesses the extracellular compartment via transient openings of vesicles suggesting that rapid 
responses of constitutive active TRP channels to physiological stimuli rely on vesicular “kiss 
and linger” interactions with the plasma membrane. 
 
Introduction 
The superfamily of transient receptor potential (TRP) channels is involved in diverse 
physiological processes ranging from sensory activity to fertility and epithelial ion transport 
(1). The highly Ca2+-selective TRPV5 channel constitutes the apical entry gate in Ca2+-
transporting cells and facilitates renal Ca2+ influx from the pro-urine (2). Several lines of 
evidence indicate that TRPV5 activity is sensitive to pH. First, acid-base homeostasis is 
known to affect renal Ca2+ handling as reflected by altered Ca2+ excretion in kidneys during 
chronic acidosis or alkalosis, which is mediated at least in part by changes in TRPV5 gene 
expression (3). Second, in vitro studies indicated that intra- and extracellular pH directly 
regulate the activity of TRPV5. Acidification inhibited, whereas alkalinization stimulated 
TRPV5 activity, likely mediated by conformational changes of the channel pore helix (4-6).  
 
An intrinsic physiological effect of extracellular pH is the regulation of trafficking processes 
like endo- and exocytosis and lysosomal trafficking (7-9). Since several TRP channels display 
constitutive activity, controlled recruitment of these channels towards the plasma membrane 
is important to translate physiological stimuli into an increased ion permeability of the plasma 
membrane. For instance, an essential process during insulin-like growth factor-I stimulation 
of cell growth is TRPV2 recruitment facilitating Ca2+ entry during progression through the 
cell cycle (10). In Drosophila photoreceptors, TRPL is shuttled between the plasma 
membrane and an intracellular compartment by a light-regulated mechanism to fine-tune 
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visual responses (11). Furthermore, rapid insertion of TRPC5 channels into the plasma 
membrane was recently identified as a mechanism underlying epidermal growth factor 
(EGF)-hormone-induced neurite extension in cultured hippocampal neurons (12). However, 
rapid plasma membrane recruitment of TRPV5 by extracellular physiological stimuli to 
control its activity in Ca2+-transporting epithelia has not been studied. 
 
The aim of the present study was to investigate the effect of extracellular pH on TRPV5 
plasma membrane recruitment as a mechanism underlying pH-dependent channel activity. By 
using Total Internal Reflection Fluorescence (TIRF) microscopy, cell surface protein labeling, 
electrophysiology, 45Ca2+ uptake assays and Functional Recovery After Chemobleaching 
(FRAC), this study revealed that plasma membrane expression of TRPV5 is under the control 
of extracellular pH and relies on TRPV5-containing vesicles that remain intact during 
recruitment and subsequent retrieval. Our results contribute to the concept of “kiss and linger” 
delivery of constitutive active TRP channels in response to physiological stimuli.   
 
Materials and Methods  
 
Molecular biology and cell culture 
pCINEO/IRES-GFP-HA-TRPV5, pCINEO/IRES-GFP, EGFP-TRPV5 and EGFP-TRPM7 
were constructed and transiently transfected in HEK293T cells as described previously (13, 
14). MDCK cells were stably transfected with EGFP-TRPV5 as described (14). 
45Ca2+ uptake assay and electrophysiology  
45Ca2+ uptake was determined using EGFP, EGFP-TRPM7 and EGFP-TRPV5 transfected 
HEK293T cells and confluent layers of MDCK cells stably expressing EGFP-TRPV5. After 
10 min incubation in KHB buffer (for TRPV5: 110 mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 
0.1 mM CaCl2, 10 mM Na-acetate, 2 mM NaH2PO4, 20 mM HEPES pH 6.0, 7.4 or 8.5 with 
HCl / NaOH; for TRPM7: 110 mM NaCl, 5 mM KCl, 10 mM Na-acetate, 20 mM HEPES pH 
6.0, 7.4 or 8.5 with HCl / NaOH), cells were incubated for 6-10 min with 45CaCl2 (1 µCi/ml) 
in KHB buffer with 4 mM L-lactate, 10 mM D-glucose, 1 mM L-alanine and voltage-gated 
Ca2+ channel inhibitors (10 µM felodipine, 10 μM verapamil). Cells were incubated with 10 
μM ruthenium red to block TRPV5-mediated 45Ca2+ uptake. After washing with ice-cold stop 
buffer (110 mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 10 mM Na-acetate, 20 mM HEPES, 0.5 
mM CaCl2, 1.5 mM LaCl3 pH 6.0, 7.4 or 8.5) 45Ca2+ uptake was measured. Whole cell 
currents of HEK293 cells, transiently transfected with pCINEO/IRES-GFP-HA-TRPV5, were 
measured using ramp protocols and standard extracellular divalent free solutions (adjusted to 
pH 6.0 and 8.5 with HCl and NaOH, respectively) as described previously (15). On line 
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alterations in extracellular pH were achieved by perfusion of the extracellular solution 
surrounding the clamped cell.   
 
Functional recovery after chemobleaching 
MDCK-EGFP-TRPV5 cells were incubated for 10 min with 5 mM MTSET in KHB pH 7.4 to 
nullify all TRPV5 channels on the cell surface. Cells were washed three times with KHB pH 
7.4 before pre-incubation for 10 min in KHB pH 6.0, pH 7.4 or pH 8.5 and subsequent 45Ca2+ 
uptake to investigate the recovery of TRPV5 channels on the functional level. Total block was 
investigated by adding 5 mM MTSET to all buffers and 10 μM ruthenium red was added to 
investigate ruthenium red sensitivity of the functional recovery. 
 
Confocal microscopy, TIRF microscopy and image analysis 
Live cell confocal images were taken on A Zeiss LSM510meta (Carl Zeiss GmbH, Jena, 
Germany) with a PlanApochromatic 63x 1.4 oil immersion DIC lens (Carl Zeiss GmbH) at 
room temperature. A custom-built objective-based TIRF microscope, as described in detail 
previously (12), was used to image EGFP-labeled proteins in close proximity to the cell 
surface. Cells grown on glass cover slips were placed in a custom made chamber with 
standard external solution (135 mM NaCl, 5 mM KCl, 1.5 mM MgCl2, 1.5 mM CaCl2, 20 
mM HEPES 10 mM D-glucose, pH 6.0 or pH 8.5 with HCl / NaOH) and imaged at room 
temperature. Cells were analyzed for 100 s (1 frame/s) at pH 6.0 to establish a baseline in 
whole-cell TIRF measurements before switching to pH 8.5 by whole bath perfusion. After 
150 s extracellular pH was reduced to pH 6.0 and images were taken for 150 s. To quantify 
changes in TIRF, intensities of the regions of interests (ROIs) of several (n = 5-6) cells, with 
areas between 5-10% of the footprint of the cell, were averaged and normalized according to 
the following equation: Relative change = I(t) – I(0). Where I(0) is the intensity at the 
beginning of the time series and I(t) is the intensity at time point t. Changes in the mean 
square displacement (MSD) and diffusion constant (D) were calculated as described (16). 
 
Biotinylation 
HEK293T cells were transfected with pCINEO/IRES-GFP-HA-TRPV5 or pCINEO/IRES-
GFP. Cells were incubated at 37ºC with standard external solution pH 6.0 or pH 8.5 for 10 
min before cells were placed on ice to inhibit endo- and exocytosis. Subsequent biotinylation 
was performed on ice as described previously (17). Thus, at the point of biotin incubation the 
pH of the solutions was equal in all conditions, thereby preventing differences in cell surface 
labeling due to pH sensitivity of biotinylation. The purified biotinylated surface proteins were 
probed for the presence of TRPV5 by immunoblotting using anti-TRPV5. 
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Statistical analysis 
In all experiments, data are expressed as mean ± SEM. Overall statistical significance was 
determined by analysis of variance (ANOVA) followed by Bonferroni contrast analysis to 
investigate individual significance using Instat 3 software for Macintosh (San Diego, CA, 
USA). P values below 0.05 were considered significant. 
 
Results 
   
Extracellular pH determines TRPV5-mediated Ca2+ influx  
In kidney, TRPV5 is exposed to pro-urine pH values ranging from 6 to 7 (2). Using 
electrophysiological recordings TRPV5 has been reported to be regulated by both intra- and 
extracellular pH (4, 5). To further assess the role of extracellular pH on TRPV5 activity 45Ca2+ 
uptake in transiently transfected Human Embryonic Kidney (HEK293T) cells was 
investigated at different extracellular pH values. At pH 6.0, 45Ca2+ uptake of TRPV5-
expressing cells was not significantly different from mock (EGFP) transfected cells indicating 
a lack of functional TRPV5 channels at the cell surface. At pH 7.4, however, 45Ca2+ uptake of 
TRPV5-expressing cells was significantly higher compared to mock transfected cells and 
extracellular alkalinization (pH 8.5) further increased 45Ca2+ uptake of TRPV5-expressing 
cells (Fig. 1A). Interestingly, extracellular pH had no significant effect on TRPM7-mediated 
45Ca2+ uptake in this pH range, showing the specificity of the pH effect on TRPV5 activity 
(Fig. 1B). Furthermore, electrophysiological recordings of HEK293 cells transiently 
expressing TRPV5 were used to investigate the pH dependence of channel activity. 
Extracellular alkalinization from pH 6.0 to 8.5 resulted in a rapid increase in TRPV5 activity 
while extracellular acidification from pH 8.5 to pH 6.0 revealed a rapid decrease in TRPV5 
activity (Fig. 1C). 
 
The intracellular lysine (K607) and the extracellular glutamic acid (E522) residues of TRPV5 
have been postulated as pH sensors regulating TRPV5 activity, although K607N and E522Q 
mutants still displayed pH-sensitivity (4, 5). To further assess the pH dependence of these 
mutants 45Ca2+ uptake measurements were performed with HEK293T cells transiently 
expressing these mutated channels (Fig. 1D). Cells expressing EGFP-TRPV5 E522Q or 
EGFP-TRPV5 K607N exhibited pH-dependent 45Ca2+ uptake activity that was not 
significantly different from wild-type EGFP-TRPV5. Importantly, expression levels of these 
mutants were equal to wild-type EGFP-TRPV5 (Fig. 1E). 
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Fig. 1. Alkaline 
pH stimulates 
the activity of 
TRPV5  
45Ca2+ uptake at 
different 
extracellular pH 
values of 
HEK293T cells 
expressing 
EGFP-TRPV5 
(n=6) (A), or 
EGFP-TRPM7 
(n=6) (B) 
compared to 
45Ca2+ uptake of 
mock (EGFP) 
transfected cells 
(n=6). Black 
bars represent 
45Ca2+ uptake at 
pH 6.0, open 
bars at pH 7.4 
and dashed at 
pH 8.5. (C) 
Whole cell 
current voltage relation measured from 400 ms voltage ramps (interval = 10 s) in nominally DVF 
solution in HEK293 cells transiently expressing TRPV5 (n = 10). Extracellular pH was switched at 
indicated time points. Open symbols represent traces of mock transfected HEK293 cells. (D) 
Comparison of alkaline pH-stimulated 45Ca2+ uptake in HEK293T cells transfected with EGFP, 
EGFP-TRPV5 or EGFP-TRPV5 E522Q or EGFP-TRPV5 K607N. Black bars represent 45Ca2+ 
uptake at pH 6.0, open bars at pH 7.4 and dashed at pH 8.5. (E) Expression of EGFP-TRPV5 and 
EGFP-TRPV5 mutants as analyzed by immunoblotting using the anti-GFP antibody. Significant 
differences in pH-dependent 45Ca2+ uptake compared to mock transfected cells are indicated by an 
asterisk (p<0.05).   
 
Extracellular alkalinization stimulates insertion of TRPV5 at the plasma membrane  
pH-dependent 45Ca2+ uptake in TRPV5-expressing cells can be explained by altered activity 
of TRPV5 present at the cell surface or changes in the number of functional TRPV5 channels 
at the plasma membrane. Because cellular trafficking processes, like endo- and exocytosis, 
are regulated by extracellular pH (7-9), the trafficking of TRPV5 was assessed by TIRF 
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microscopy. Detailed analysis of EGFP-labeled TRPV5 in transiently transfected HEK293T 
cells with live cell confocal and TIRF microscopy revealed a highly motile punctuate 
distribution pattern with no clear plasma membrane localization (Fig. 2A, Movies IA and 
IB).  Immunocytochemistry in fixed cells expressing TRPV5 showed no co-localization of the 
channel with markers for endosomes (EEA1), lipid rafts (Caveolin1), endoplasmic reticulum 
(58K) and lysosomes (LAMP1) (data not shown). TIRF microscopy indicated that these 
EGFP-TRPV5-containing vesicles move in an undirected manner (Movie IB). To investigate 
the influence of extracellular pH on these EGFP-TRPV5-containing vesicles, TIRF 
microscopy was applied to monitor the number and proximity of vesicles to the plasma 
membrane in response to changes in extracellular pH (Fig. 2B/C, movie IIA). Alkalinization 
resulted in a rapid elevation of the overall EGFP-TRPV5 TIRF signal to a peak plateau level 
suggesting rapid recruitment and subsequent delivery of EGFP-TRPV5 to the plasma 
membrane (Fig. 2C/D). Subsequent acidification decreased the overall EGFP-TRPV5 TIRF 
signal, even below the initial unstimulated level of fluorescence, suggesting retrieval of 
TRPV5 from the plasma membrane to a cytosolic compartment. Importantly, no significant 
changes in TIRF signal were observed in EGFP-TRPM7 or EGFP transfected HEK293T cells 
when switching the pH from 6.0 to 8.5 or from 8.5 to 6.0 (Fig. 2C/D, Movies IIB/C). This 
indicates that recruitment of TRPM7 is independent of extracellular pH and fluorescent 
changes were not due to a pH sensitivity of EGFP. TIRF microscopy is a valuable method to 
study protein movements within the periplasmic space, but does not define plasma membrane 
expression. Therefore, cell surface biotinylation was applied to investigate the localization of 
TRPV5 in the plasma membrane at different extracellular pH values (Fig. 2E). Importantly, at 
the point of incubation with biotin the pH of the solutions was equal in all conditions to 
prevent differences in cell surface labeling due to pH sensitivity of biotinylation (see methods 
for details). In line with the results obtained with TIRF microscopy, cell surface expression of 
TRPV5 was significantly increased (2.35 ± 0.75 fold) at pH 8.5 compared to pH 6.0.  
 
Functional recovery after chemobleaching of TRPV5 activity is regulated by 
extracellular pH  
Madin-Darby Canine Kidney type-I epithelial (MDCK) cells stably expressing TRPV5 were 
used to assess the pH dependence of TRPV5 trafficking by Functional Recovery After 
Chemobleaching (FRAC) (18). MDCK cells are convenient for imaging of EGFP-TRPV5- 
containing vesicles in contrast to transfected HEK293T cells that display a high density of 
EGFP-TRPV5-containing vesicles. In agreement with the observations in HEK293T cells, 
extracellular alkalinization of TRPV5-expressing MDCK cells resulted in rapid recruitment of 
EGFP-TRPV5 towards the plasma membrane, while subsequent acidification reduced cell 
surface EGFP-TRPV5 expression (Supplemental data Fig. SI, Movie IIIA). 2-
(trimethylammonium)ethyl methanethiosulfonate bromide (MTSET) irreversibly binds to an 
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accessible cysteine in the channel pore of wild-type rabbit TRPV5 (19). This enabled us to 
study FRAC without introducing cysteine residues in the TRPV5 pore, which could 
potentially alter channel activity. Addition of MTSET to stably EGFP-TRPV5-expressing 
MDCK cells completely silenced 45Ca2+ uptake at pH 6.0, 7.4 and 8.5 (Fig. 3), confirming the 
accessibility of the cysteine in the TRPV5 pore and the blockade by MTSET. Cells only pre-
incubated for 10 min with MTSET, showed a subsequent functional recovery of 45Ca2+ uptake 
at pH 7.4 and 8.5, whereas no recovery was observed at pH 6.0. At pH 8.5 the recovery of 
45Ca2+ uptake was significantly increased compared to the recovery at pH 7.4 demonstrating 
that extracellular alkalinization amplified the insertion of active TRPV5 channels. 
Furthermore, incubation with the TRPV5 channel antagonist ruthenium red (10 µM) during 
the 45Ca2+ uptake completely inhibited functional recovery after MTSET treatment, indicating 
that the recovery is mediated by TRPV5.  
 
“Kiss and linger” plasma membrane delivery of TRPV5-containing vesicles  
In MDCK cells stably expressing EGFP-TRPV5 TIRF single vesicle fluorescence rapidly 
increased after switching from pH 6.0 to 8.5 and reached a peak plateau level within 10-20 s, 
whereas subsequent extracellular acidification decreased the vesicle fluorescence (Fig. 4A/B, 
Movie IIIB). These findings indicate that recruitment to and subsequent retrieval of single 
TRPV5-containing vesicles from the plasma membrane is affected by extracellular pH. 
Moreover, TRPV5-containing vesicles appeared to remain intact at the plasma membrane 
interface since the fluorescence intensity did not disperse after reaching the peak plateau 
level. In addition, the number of vesicles within the TIRF field did not increase, suggesting 
that the rise in fluorescence reflects rapid recruitment of TRPV5-containing vesicles just 
underneath the plasma membrane. 
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Fig. 2. Alkaline pH stimulates plasma membrane insertion of TRPV5 channels in HEK293T 
cells 
Confocal (left) and TIRF (right) image of a single HEK293T cell expressing EGFP-TRPV5 (A) 
(supplemental Movies IA/B). Scale bar = 5 µm. TIRF images of single HEK293T cells 
expressing EGFP-TRPV5, EGFP-TRPM7 or EGFP (B/C) (supplemental Movies IIA/B/C). Scale 
bar = 10 µm. Cells were imaged as indicated in the figure and extracellular pH was switched at the 
indicated time points. Gradient filters were applied such that saturating levels turn red. Time 
course of the overall EGFP fluorescence signal in EGFP-TRPV5- (♦, n=5), EGFP-TRPM7- (□, 
n=5) or EGFP- (▲, n=5) expressing HEK293T cells (D). Cell surface expression of TRPV5 at 
different extracellular pH values as measured by cell surface biotinylation of HA-TRPV5-
expressing HEK293T cells (E). Analysis of total TRPV5 expression revealed a non-glycosylated 
form (lower band) and a complex glycosylated form (upper) that is the band accessible to 
extracellular biotin. A representative blot of three independent experiments is shown. 
 
To determine the vesicle motility upon consecutively extracellular alkalinization and 
acidification we calculated the Mean Square Displacement (MSD) (Fig. 4C). Upon 
extracellular alkalinization TRPV5-containing vesicles were rapidly converted in lateral 
motility from a high to a more restricted velocity. The decrease in MSD occurred as the 
vesicle fluorescence increased, suggesting capture of TRPV5-containing vesicles at the 
plasma membrane as soon as they approach the cell surface. During subsequent decrease of 
vesicle fluorescence due to extracellular acidification, TRPV5-containing vesicles are rapidly 
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converted to a high lateral motility, suggesting retrieval from the plasma membrane to a 
cytosolic compartment. Note that the average diffusion constant as calculated from changes in 
MSD (16) of several vesicles from different cells before recruitment and after retrieval was 
identical (Fig. 4D). Because the diffusion constant is determined by the radius of the vesicle 
as reflected by the Stokes and Einstein equation (20) these findings further support that 
TRPV5-containing vesicles remain intact during the delivery of TRPV5 to the cell surface. 
 
Fig. 3. Functional recovery of TRPV5 
activity after chemobleaching is 
elevated at alkaline pH.  
45Ca2+ uptake at different extracellular 
pH values of MDCK cells stably 
expressing EGFP-TRPV5 (n=6). To 
inhibit TRPV5-mediated 45Ca2+ uptake 
10 μM of ruthenium red was added. The 
irreversible blocker 2-(trimethylammonium)ethyl methanethiosulfonate bromide (MTSET) (5 
mM) was applied to study the functional recovery of TRPV5 after MTSET treatment. Open bars 
represent 45Ca2+ uptake under normal conditions, gray bars with continues presence of MTSET, 
black bars recovery after MTSET treatment and dashed bars recovery in the presence of ruthenium 
red. Significant differences in pH-dependent 45Ca2+ uptake compared to MTSET or ruthenium red 
treated cells are indicated by an asterisk (p<0.05). Significant increases in 45Ca2+ uptake as 
compared to 45Ca2+ uptake at pH 7.4 are indicated by a hash (p<0.05).   
 
Discussion 
The present study identifies extracellular pH as a dynamic switch controlling TRPV5 cell 
surface expression and, thereby, TRPV5 activity. This conclusion is based on the following 
experimental observations. First, extracellular alkalinization increases, whereas acidification 
decreases TRPV5 channel activity. Second, extracellular alkalinization induces rapid 
recruitment of EGFP-TRPV5 containing vesicles that remain intact at the plasma membrane 
interface, whereas subsequent acidification results in retrieval of TRPV5-containing vesicles. 
Third, extracellular alkalinization augments the number of TRPV5 channels at the plasma 
membrane as analyzed by cell surface protein biotinylation. Fourth, functional recovery of 
TRPV5 activity after chemobleaching is dependent on extracellular pH. Fifth, TRPV5 
vesicles undergo a rapid conversion in lateral motility from high to restricted as they approach 
the membrane and visa versa during manipulation of the extracellular pH.  
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Here, we showed that the activity of TRPV5 is directly controlled by the extracellular pH as 
measured by electrophysiological recordings and 45Ca2+ uptake analysis. This is in line with 
our previous studies demonstrating that the current density of TRPV5-expressing HEK293 
cells is significantly smaller at pH 6.0 compared to pH 7.4. At pH 8.5 they were slightly 
larger (4-6). Subsequently, Huang and coworkers further substantiated our findings by 
showing that both extracellular and intracellular acidification reduces TRPV5 channel activity 
(4-6). In addition, two pH-sensing residues were identified in TRPV5. Compared to wild-type 
TRPV5, mutation of these amino acids (K607N and E522Q) revealed a significantly 
diminished electrophysiological response to intra- and extracellular pH, although the overall 
pH sensitivity persisted. Our 45Ca2+ uptake experiments indicated that mutation of these 
residues does not change the activity of TRPV5 in the pH range 6.0-8.5, suggesting that the 
role of these amino acids as pH sensors is less pronounced as previously assumed. Despite 
this controversy, all observations share an important physiological role of the extracellular pH 
in determining TRPV5 activity. Indeed, the pH of the pro-urine in the TRPV5-expressing 
tubule segments normally varies between 6 and 7, a range by which TRPV5 activity is 
significantly altered. Furthermore, early observations showed that urinary Ca2+ excretion 
increases during metabolic and respiratory acidosis (21, 22), which is in line with the 
observed pH-sensitivity of TRPV5. 
 
To determine the molecular mechanism by which extracellular protons inhibit TRPV5 
channel activity a comprehensive set of experiments was performed. TIRF analysis, 
biotinylation assays and functional recovery of TRPV5 activity after chemobleaching together 
demonstrated that extracellular pH determines the cell surface localization of TRPV5. 
Importantly, the increase in single vesicle recruitment upon alkalinization was accompanied 
by a rise in TRPV5 activity, suggesting capture of functional channels at the plasma 
membrane. Subsequent acidification decreased the TRPV5 activity that was accompanied by 
retrieval of TRPV5-containing vesicles from the plasma membrane to the cytosol. Previous 
data describing that conformational changes within the channel pore are coupled to inhibition 
of TRPV5 by protons (4), together with our results suggest that the extracellular pH affects 
the activity of TRPV5 via multiple mechanisms. Both TRPV5 trafficking to and activity at the 
cell surface are inhibited by extracellular protons indicating an efficient regulation of TRPV5 
channel activity during changes in extracellular pH. 
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Fig. 4. Alkaline pH stimulates plasma membrane recruitment of TRPV5-containing vesicles 
in MDCK cells 
TIRF images of a single vesicle in MDCK cells stably expressing EGFP-TRPV5 directly after 
extracellular alkalinization (upper panel) and subsequent acidification (lower panel) (A) 
(supplemental Movie IIIB). Time interval between images is 3 s and scale bar = 2 µm. Average 
time course of single vesicle fluorescence in EGFP-TRPV5-expressing MDCK cells (n=5) (B). 
The mean square displacement (plotted accumulative in time) of the vesicle shown in (A) reveals a 
rapid conversion from cytosolic diffusion at pH 6.0 (solid line) to a more restricted lateral motion 
at pH 8.5 (dashed line) and back to free cytosolic diffusion at pH 6.0 (dotted line) (C). Averaged 
vesicle diffusion constant (D) (n=10 vesicles) during the protocol (pH 6.0 at time points 0-100 s, 
pH 8.5 at 125-250 s and subsequent pH 6.0 at 275-400 s). Significant difference in the diffusion 
constant compared with cells exposed to pH 6.0 is indicated by an asterisk (p<0.05). 
 
TIRF analysis revealed that upon stimulation by extracellular alkalinization the EGFP-TRPV5 
fluorescence of single vesicles rapidly reaches a peak plateau level. Importantly, this 
fluorescence signal did subsequently not disperse while the pH was maintained at 8.5, 
suggesting that the TRPV5-containing vesicles are not completely fused with the plasma 
membrane, but rather remain intact at the membrane interface. This finding is different from 
that observed with TIRF recordings of GLUT4-containing vesicles or synaptic vesicles (23, 
24). Upon stimulation GLUT4-containing vesicles were recruited towards the cell surface 
where they completely fused with the membrane and GLUT4 diffused into the plasma 
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membrane as reflected by dispersion of the vesicle fluorescence. On the other hand, synaptic 
vesicles translocated towards the plasma membrane after stimulation where a transient 
opening with the plasma membrane is formed. Upon exocytosis of its cargo, these vesicles 
immediately relocated to the cytosol as measured by the sudden loss in fluorescence of intact 
vesicles (termed “kiss and run”) (25). TRPV5 recruitment during extracellular alkalinization 
is, however, comparable with plasma membrane recruitment of TRPC5-containing vesicles by 
EGF stimulation (12). After initiation of plasma membrane recruitment both TRPV5- and 
TRPC5-containing vesicles did not clearly fuse with the membrane as reflected by the lack of 
fluorescence diffusion and disappearance of single vesicles after reaching the cell surface. 
These channels might access the extracellular solution from inside the vesicle membrane 
(referred to as “kiss and linger”), as supported by the accompanied increase in activity, 
enhanced accessibility to biotin and, for TRPV5, increased FRAC. Because several TRP 
channels, including TRPV5 and TRPC5, display constitutive activity, the suggested “kiss and 
linger” mechanism of channel delivery to the plasma membrane is attractive since this novel 
concept integrates a direct response to physiological stimuli by TRP channel insertion. The 
experiments with TRPC5 could not distinguish between actual vesicle fusion and subsequent 
diffusion of the channel into the plasma membrane or transient interaction of the vesicles with 
the plasma membrane (12). The performed experiments, however, enabled us to control 
TRPV5 plasma membrane expression by consecutive alkalinization and acidification of the 
extracellular solution. Our results indicate that single vesicles, located just underneath the 
plasma membrane, are rapidly recruited towards the plasma membrane upon extracellular 
alkalinization, linger at the plasma membrane without fusing, and are subsequently retrieved 
to the cytosol upon removal of the stimulus (i.e. extracellular acidification). Together with the 
increase in TRPV5 activity, enhanced accessibility to biotin and functional recovery of 
TRPV5 activity after chemobleaching, this suggests that upon extracellular alkalinization 
recruited TRPV5 accesses the extracellular environment via transient openings because the 
same vesicles are intact relocated upon extracellular acidification. Comparable with secretory 
vesicles in synapses, vesicles are recaptured largely intact after exocytosis (25, 26). Thus, 
recapturing non-fused vesicles from the plasma membrane might occur via uniform 
mechanisms.  
In summary, these findings demonstrate recruitment of TRPV5 to the cell surface as a novel 
mechanism underlying pH-sensitive TRPV5-mediated Ca2+ transport. Thereby contributing to 
the concept that activation of constitutive active ion channels relies on “kiss and lingering” 
vesicles which remain intact during the process of plasma membrane recruitment and 
subsequent retrieval.   
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Summary  
TRPV5 and TRPV6 are members of the superfamily of transient receptor potential (TRP) 
channels and facilitate Ca2+ influx in a variety of epithelial cells. The activity of these Ca2+ 
channels is tightly controlled by the intracellular Ca2+ concentration in close vicinity to the 
channel mouth. The molecular mechanism underlying the Ca2+-dependent activity of 
TRPV5/TRPV6 is, however, still unknown. Here, the putative role of calmodulin (CaM) as 
the Ca2+-sensor mediating the regulation of channel activity was investigated. Overexpression 
of Ca2+-insensitive CaM mutants (CaM1234 and CaM34) significantly reduced the Ca2+ as well 
as Na+ current of TRPV6, but not of TRPV5, expressing HEK293 cells. By combining pull-
down assays and co-immunoprecipitations we demonstrated that CaM binds to both TRPV5 
and TRPV6 in a Ca2+-dependent fashion. The binding of CaM to TRPV6 was localized to the 
transmembrane domain (TRPV6327-577) and consensus CaM-binding motifs located in the N- 
(1-5-10 motif, TRPV688-97) and C-terminus (1-8-14 motif, TRPV6643-656) suggesting a 
mechanism of regulation involving multiple interaction sites. Subsequently, chimeric 
TRPV6/TRPV5 proteins, in which the N- and/or C- termini of TRPV6 were substituted by 
that of TRPV5, were co-expressed with CaM34 in HEK293 cells. Exchanging, the N- and/or 
C-terminus of TRPV6 by that of TRPV5 did not effect the CaM34-induced reduction of the 
Ca2+ and Na+ current. In conclusion, these results suggest that CaM positively affects TRPV6 
activity upon Ca2+ binding to EF-hand 3 and 4 located in the high Ca2+ affinity CaM C-
terminus, which involves the N- and C-terminus and the transmembrane domain of TRPV6.  
 
Introduction  
The superfamily of transient receptor potential (TRP) channels is involved in diverse 
processes ranging from sensory activity to fertility and epithelial Ca2+ transport (1). The 
submembers TRPV5 (formerly named ECaC1) and TRPV6 (formerly named CaT1) are 
postulated as gatekeepers facilitating epithelial Ca2+ influx in kidney and small intestine (2,3). 
Initial electrophysiological characterization of these channels revealed that TRPV5 and 
TRPV6 are homologous channels that display a Ca2+-dependent feedback regulation of 
channel activity. Differences between these channels concern their divalent cation 
permeability, the kinetics of Ca2+-dependent inactivation and subsequent recovery (4). 
Furthermore, it was shown that TRPV5 and TRPV6 form functional homo- and 
heterotetrameric channels displaying intermediate phenotypes (5). At present, the molecular 
mechanism underlying these differences in Ca2+-dependent activity is unknown. 
 Ca2+-regulated channel activity is not restricted to TRPV5 and TRPV6 since a diverse range 
of voltage and non-voltage-dependent ion channels are regulated by the intracellular Ca2+ 
concentration. Ca2+-dependent regulation of the L- and P/Q-type voltage-gated Ca2+ channels 
(Cav) is mediated by the ubiquitously expressed Ca2+-sensor calmodulin (CaM) (6,7). CaM 
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consists of four Ca2+-binding EF-hand structures, which are localized in the N- and C-
terminus. Ca2+ binding to CaM is highly cooperative with Ca2+ binding first to the C-terminal 
EF-hands, which have the highest affinity for Ca2+, followed by Ca2+ binding to lower affinity 
sites located in the N-terminus (8). The CaM termini can differentially regulate ion channel 
activity as shown by electrophysiological analysis of Ca2+-dependent regulation of P/Q- and 
L-type Cav channels (6,7). Ca2+ binding to the high Ca2+-affinity C-terminus of CaM 
selectively induces P/Q-type Cav channel facilitation, whereas Ca2+-sensing by the low Ca2+-
affinity N-terminus induces channel inactivation. Thus, CaM acts as a Ca2+-sensor translating 
the local Ca2+ signals that modulate these channels (7).  
Consensus CaM binding motifs have been identified in associated proteins (9). CaM binding 
to Cav is localized to an IQ-like motif in the α1C- (L-type Cav) and α1A C-terminus (P/Q- 
type Cav). Although, TRPV5 and TRPV6 lack an IQ-related motif a previous study indicated 
that CaM binds to the TRPV6 C-terminus in a Ca2+-dependent manner (4,10). The described 
mechanism of competitive regulation of TRPV6 by protein kinase C (PKC) and CaM is, 
however, restricted to human TRPV6 since this PKC site in the CaM–binding motif is not 
conserved between different species (10). Recently, the corresponding region in mouse 
TRPV6 was shown to bind CaM. Detailed analysis of this region predicted a caseine kinase 
motif, but no significant phosphorylation could be detected in this particular domain (11). 
Also other members of the TRP family are possibly regulated by CaM. CaM binding to 
TRPV1 was restricted to a 35 amino-acid segment in the C-terminus and deletion of this CaM 
binding segment prevented TRPV1 desensitization (12). Members of the TRPC family have 
been shown to bind CaM (13). Another study using CaM inhibitors described that TRPC6 can 
be regulated by CaM (14). Furthermore, CaM acts as a Ca2+-sensor in the Ca2+-dependent 
feedback inhibition of TRPC1 as demonstrated using Ca2+-insensitive CaM mutants (15). 
The aim of the present study was to investigate the potential role of CaM in Ca2+-dependent 
regulation of TRPV5 and TRPV6 activity. To this end, we combined pull-down assays and 
co-immunoprecipitations with electrophysiological analysis of HEK293 cells heterologously 
expressing TRPV5, TRPV6 or TRPV5/6 chimeras in combination with Ca2+-insensitive CaM 
mutants.  
 
Experimental procedures 
 
Construction of mammalian expression vectors 
CaM, CaM1234, CaM12, and CaM34 were mutated (D --> A) in the EF-hand structures present 
in the N- and C-terminus resulting in (partial) Ca2+ insensitive mutants (16). CaM, CaM1234, 
CaM12, and CaM34  (kindly provided by Dr. Adelman) (16)  used in the patch-clamp analysis 
were cloned by polymerase chain reaction (PCR) into the pCINeo/IRES-BFP vector (17) 
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using the sense primer (5’ GGGACTAGTATGGCTGACCAACTGACTGAA 3’) and the 
antisense primer (5’ GGGCTGGAGTCACTTCGCTGTCATCATTTG 3’).  CaM34 was 
cloned by PCR into pGEX6p-2 (Amhersham Pharmacia Biotech, Roosendaal, Netherlands) 
using the sense primer (5’ CGCGGATCCATGGCTGACCAACTGACTGAA 3’) and the 
antisense primer (5’ GGGGTCGACTCACTTCGCTGTCATCATTTG 3’). Mouse TRPV5-, 
rabbit TRPV6- and TRPV5/6 chimeras-pCINeo/IRES-GFP were constructed as described 
previously (18). In short, TRPV5 and TRPV6 N-termini were exchanged in pCINeo/IRES-
GFP constructs via an introduced unique BspEI site at amino acid position Ser221-Tyr222 and 
C-termini were exchanged via an introduced unique BsiWI site at amino acid position Arg615-
Ser616. The fragment IQ-α1C (α1C1589-1708) containing the IQ-like motif from the L-type Ca2+-
channel α-subunit C-terminus (kindly provided by Dr. Birnbaumer) (19), the TRPV5 N- and 
C-terminus and truncated forms of the TRPV6 C-terminus were cloned into the oocyte-pT7Ts 
expression vector using PCR. Sense primers contained an EcoRV restriction site, a Kozak 
sequence, and ATG at the 5’ end with ATG in frame with the triplet encoding the first amino 
acid. Antisense primers contained a SpeI restriction site at the 3’ end with a stop codon in 
frame after the last amino acid. Truncated forms of the TRPV6 N-terminus were cloned into 
the pT7Ts expression vector (using a sense primer as described above). The antisense primer 
contained a BstEII restriction site at the 3’ end with a stop codon in frame after the last amino 
acid. All pCINeo/IRES-BFP, pGEX6p-2 and pT7Ts constructs were verified by sequence 
analysis.  
 
Cell culture and transfection 
Human Embryonic Kidney (HEK293) cells were grown in DMEM (Bio Whittaker Europe, 
Vervier, Belgium) containing 10% (v/v) fetal calf serum (PAA, Linz, Austria), 13 mM 
NaHCO3, 2 mM L-glutamine, 2 U/ml penicillin and 2 mg/ml streptomycin at 37 °C in a 
humidity controlled incubator with 5% CO2. The cells were transiently transfected with the 
pCINeo/IRES-GFP and pCINeo/IRES-BFP vectors using lipofectamine 2000 (Invitrogen-Life 
Technologies, Breda, Netherlands) as described previously (17). The GFP-containing vector 
was used for TRPV5, TRPV6 and TRPV5/6 chimeras, while the BFP-containing vector was 
used for CaM constructs. Transfected cells were identified visually by their green and/or blue 
appearance as described previously (17). GFP/BFP-negative cells from the same batch of 
cells were used as controls. 
 
Electrophysiology 
Electrophysiological methods have been described previously in detail (17,20). Whole cells 
currents were measured using an EPC-9 amplifier (HEKA, Lambrecht, Germany) using 
ruptured patches. Electrode resistances were 3-6 MΩ, and capacitance and access resistance 
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was monitored continuously. A ramp protocol, consisting of linear voltage-ramps from -100 
to +100 mV within 450 ms, was applied every 2 s from a holding potential of +20 mV. Ca2+-
dependent inactivation was studied using a 3 second voltage step to –100 mV from a holding 
potential of +70 mV. Current densities, expressed per unit of membrane capacitance, were 
calculated from the current at –80 mV during the ramp protocols (21). 
 
Solutions and experimental procedures 
The standard extracellular solution (“Krebs”) contained 150 mM NaCl, 6 mM CsCl, 1 mM 
MgCl2, 10 mM HEPES/NaOH pH 7.4 and 10 mM Glucose. The concentration of Ca2+ was 
varied between 1 and 10 mM. Divalent free solutions did not contain added divalent cations, 
while trace amounts of divalent cations were removed with 100 μM EDTA. To inhibit 
monovalent cation currents, 150 mM NaCl was replaced with an equimolar amount of N-
methyl-D-glucamine-Cl. The standard internal (pipette) solution contained 20 mM CsCl, 100 
mM Cs-aspartate, 1 mM MgCl2, 4 mM Na2ATP, 10 mM BAPTA, 10 mM HEPES/CsOH pH 
7.2. Cells were kept in nominal Ca2+-free medium to prevent Ca2+ overload and exposed for 
maximal 5 min to a Krebs solution containing 1.5 mM Ca2+ before sealing the patch pipette to 
the cell. All experiments were performed at room temperature (RT). 
 
CaM binding assays  
pT7Ts constructs were linearized and cRNA was synthesized in vitro using T7-RNA 
polymerase as described previously (21). [35S]Methionine labeled TRPV5 and TRPV6 
proteins were prepared in vitro using a reticulocyte lysate system in the presence of canine 
microsomal membranes (Promega Madison, WI, USA). To investigate potential interactions 
[35S]methionine labeled proteins were incubated for 2 h at RT either with CaM-coupled 
agarose beads or non-coupled agarose beads (Sigma-Aldrich, St. Louis MO, USA)  in Tris 
buffered saline (TBS) pH 7.4 containing 1% (v/v) Triton X-100 and either 1 mM CaCl2 or 5 
mM EDTA.  For pull-down experiments with CaM34 shown in Fig. 4B, GST-CaM34 and GST 
were expressed in and purified from transformed Escherichia coli BL21 according to the 
manufacturer’s protocol (Amersham Pharmacia Biotech, Roosendaal, Netherlands). For pull-
down experiments shown in Fig. 7 the indicated amount of free Ca2+ was buffered with EGTA 
as calculated with SLIDERS version 2.10 (www.stanford.edu/~cpatton/maxc.html). After 
extensive washing, bound proteins were subjected to SDS-polyacrylamide gel electrophoresis 
and binding was established by autoradiography.  
Xenopus laevis oocytes were isolated as described previously (22) and subsequently co-
injected with 5 ng Flag-tagged TRPV6 cRNA (23) and 15 ng CaM cRNA. For each immuno-
precipitation 20 oocytes were lysed by incubation for 30 min on ice in buffer containing 150 
mM NaCl, 20 mM Tris-HCl pH 7.5, 2 mM CaCl2, 10% (v/v) glycerol, 1% (v/v) NP-40, 0.5% 
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(w/v) sodium desoxycholate and protease inhibitors leupeptine (0.01 mg/ml), pepstatine (0.05 
mg/ml) and PMSF (1 mM). The lysates were centrifuged for 30 min at 16000 g and 
supernatants were incubated with protein A beads (Kem-En-Tec A/S, Kopenhagen, 
Denmark), coated o/n at 4 °C with either rabbit anti-TRPV6 antiserum (23) (1:3000) or 
monoclonal anti-CaM (Campro-scientific, Veenendaal, Netherlands) (1:2000). After 
extensive washing with lysis buffer, bound proteins were subjected to SDS-polyacrylamide 
gel electrophoresis. After immuno blotting co-immuno precipitation was investigated by 
incubating either with anti-CaM or peroxidase coupled anti-Flag (Sigma-Aldrich, St. Louis 
MO, USA).      
    
Statistical analysis. 
Data are expressed as mean ± SEM. Overall statistical significance was determined by 
analysis of variance. In case of significance (p < 0.05), individual groups were compared 
using Student t-test. 
Figure 1. Effect of Ca2+ insensitive CaM (CaM1234) on TRPV5 and TRPV6 Ca2+ current 
kinetics. Mean currents through TRPV5 (A) or TRPV6 (B) expressing HEK293 cells in response 
to a voltage step to –100 mV (VH = +70mV) in the presence of 10 mM [Ca2+]e. Other cations were 
substituted by 150 mM NMDG+. Cells were loaded with 10 mM BAPTA. Control traces are 
shown as solid lines, while CaM1234 traces are depicted as dotted lines. Zero current concentration 
is presented by a small bar at the left of each figure. n > 11 cells. 
 
Results 
 
Effect of CaM on TRPV5 and TRPV6 activity 
To study the potential role of CaM in modulating TRPV5 and TRPV6, the activity of these 
channels was determined by whole-cell patch-clamp analysis in HEK293 cells transiently co-
transfected with Ca2+-insensitive CaM mutants and TRPV5 or TRPV6. The CaM mutant 
(CaM1234) in which all four EF-hand structures were mutated, significantly reduced the inward 
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Ca2+ current in response to a hyperpolarizing voltage step in TRPV6 expressing HEK293 cells 
(Fig. 1B) (ppeak < 0.05, n > 11 cells), but had no significant effect on TRPV5 expressing 
HEK293 cells (Fig. 1A) (ppeak > 0.0.5, n > 11 cells). Likewise, the Na+ current measured with 
a ramp protocol was reduced in TRPV6 and CaM1234 expressing cells, whereas in TRPV5 
expressing cells no effect was observed (Fig 2). Subsequently, partial Ca2+-insensitive CaM 
mutants were co-transfected with TRPV5 or TRPV6 in HEK293 cells (Fig. 2). CaM 
constructs were mutated (D --> A) in either the low Ca2+ affinity site present in the N- 
(CaM12) or the high Ca2+ affinity site present in the C-terminus (CaM34). Overexpression of 
CaM1234 or CaM34 significantly reduced the Ca2+ as well as the Na+ current density in TRPV6 
expressing HEK293 cells, but did not affect the currents of TRPV5 expressing cells.  In 
contrast, the expression of CaM12 did not significantly affect the Ca2+ or Na+ currents of 
TRPV5 or TRPV6 expressing HEK293 cells. Thus, the high affinity EF-hand Ca2+ binding 
sites contribute primarily to the observed CaM effect on TRPV6 activity. 
 
Figure 2. Effect of CaM mutants on TRPV5 and TRPV6 activity.  Data obtained from linear 
ramps from +100 to –100 mV, holding potential was +20 mV. Currents were normalized to the 
density at –80 mV of controls. HEK293 cells heterologously expressing either TRPV5 or TRPV6 
and CaM mutated in EF-hands in the N-terminus (CaM12) or C-terminus (CaM34) or both 
(CaM1234) as indicated on the X-axis. (A) Effect of CaM and CaM mutants on Na+ current densities 
(100 μM EDTA in bath) (B). Effect of CaMWT and CaM mutants on Ca2+ current densities in 10 
mM [Ca2+]e (Open bars, TRPV5; solid bars, TRPV6). Significant differences from controls are 
indicated by an asterisk (p < 0.05, n = 7-23 cells). 
 
CaM binding to TRPV5 and TRPV6 
Subsequently, CaM binding to TRPV5 and TRPV6 was investigated. Binding was determined 
using CaM coupled agarose beads and in vitro translated full-length TRPV5 or TRPV6. In the 
presence of Ca2+ (1 mM CaCl2), CaM bound to TRPV6, whereas in the absence of Ca2+ (5 
mM EDTA) binding was virtually abolished (Fig. 3A). Likewise, TRPV5 bound CaM as 
determined for TRPV6, although CaM mutants do not affect currents in TRPV5-expressing 
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HEK293 cells. Binding experiments of in vitro translated full-length TRPV5 and TRPV6 to 
non-coupled and CaM-coupled agarose beads in the presence of Ca2+ indicated both TRPV5 
and TRPV6 specifically bind CaM (Fig. 3B). Subsequently, we tested the association of 
TRPV6 and CaM by co-immunoprecipitation studies. To this end, CaM and Flag-TRPV6 
were co-expressed in Xenopus laevis oocytes and immunoprecipitated with the CaM or 
TRPV6 antibodies. Immunoblots containing the precipitated complexes were probed with a 
peroxidase-coupled Flag antibody or the CaM antibody, respectively. CaM (17 KDa) co-
immunoprecipitated with the Flag-TRPV6 and vice versa, confirming the association of CaM 
and TRPV6 (Fig. 3C-D). 
 
Figure 3. CaM binding to TRPV5 and TRPV6. [35S]Methionine labeled, in vitro translated full-
length TRPV5 or TRPV6 was incubated with CaM-coupled agarose beads either in the presence (1 
mM CaCl2) or absence (5 mM EDTA) of Ca2+ (A). [35S]Methionine labeled, in vitro translated full-
length TRPV5 or TRPV6 was incubated with either CaM-coupled (+) or non-coupled (-) agarose 
beads in the presence (1 mM CaCl2) of Ca2+ (B).  Input control is 10% of the pull-down input. 
Xenopus laevis oocytes were co-injected with 15 ng CaMWT cRNA and 5 ng flag-tagged TRPV6 
cRNA. Oocyte lysates were loaded to protein A beads coated either with anti-TRPV6 (C) or 
monoclonal anti-CaM (D). Blots were incubated with monoclonal anti-CaM (C) or peroxidase-
coupled monoclonal anti-flag  
 
To further identify the CaM binding site in TRPV5 and TRPV6 the N-termini (TRPV51-327, 
TRPV61-326) and C-termini (TRPV5578-730, TRPV6577-727) were in vitro translated and 
subsequently CaM binding was determined (Fig. 4A). The described IQ-like CaM-binding 
motif in the C-terminus of α1C (24) was used as a positive control, whereas TRPV5 
transmembrane region TRPV5421-512 was used as a negative control. Besides the positive 
control, the N- and C-terminus of both TRPV5 and TRPV6 bound CaM in the presence of 
Ca2+, whereas no binding was observed with the negative control. In addition, it was 
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demonstrated that both TRPV5 and TRPV6 bind to GST-CaM34 in a Ca2+-independent manner 
(Fig. 4B). Furthermore, the TRPV6 transmembrane domain (TRPV6327-577) was in vitro 
translated and subsequently CaM binding was determined (Fig. 4C). The TRPV6 
transmembrane domain bound CaM only in the presence of Ca2+ although binding seems 
weaker than CaM binding to both TRPV6 tails. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Localization of CaM interaction domains in TRPV5 and 
TRPV6.  [35S]Methionine labeled in vitro translated TRPV5 and 
TRPV6  N-termini (TRPV51-327, TRPV61-326), C-termini (TRPV5578-
730, TRPV6577-727), positive (IQ-α1C) and negative (TRPV5421–512) 
controls were  incubated  with  CaM-coupled  agarose  beads   in   the  
presence of 5 mM EDTA or 1 mM CaCl2 (A). [35S]Methionine labeled in vitro translated TRPV5 
and TRPV6 were incubated with GST and GST-CaM34 in the presence of 5 mM EDTA or 1 mM 
CaCl2 (B). [35S]Methionine labeled in vitro translated TRPV6 transmembrane domain (TRPV6327-
577) was incubated with CaM-coupled agrose beads in the presence of 5 mM EDTA or 1 mM CaCl2 
(C). Input control is 10% of the pull-down input. 
 
Functional effect of CaM-binding domains in TRPV6 
Subsequently, TRPV5/6 chimeras were used in order to identify the critical domains in 
TRPV6 for the inhibition by CaM34. To this end, the effect of CaM34 on the Ca2+ and Na+ 
current density was examined in HEK293 cells expressing the TRPV5/6 chimera, in which 
the N- and/or C-termini were exchanged (Fig. 5). Co-transfection of CaM34 and TRPV6-C5, 
the chimera in which the TRPV6 C-terminus was substituted by that of TRPV5, revealed a 
reduction of both the Ca2+ and Na+ current as observed with co-transfection of CaM34 and 
wild-type TRPV6. Co-transfection of CaM34 with TRPV6-N5, the chimera in which the N-
terminus of TRPV6 was substituted by that of TRPV5, resulted in a reduction of the Ca2+ and 
Na+ current as compared to currents in TRPV6-N5 expressing cells. Co-transfection of CaM34 
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and TRPV6-N5C5 , the chimera in which both termini of TRPV6 were substituted by that of 
TRPV5, resulted in a reduction of the Ca2+ and Na+ current as compared to currents measured 
in TRPV6-N5C5 expressing cells.  
 
Figure 5. Effect of the N-, C-terminus and transmembrane domain of TRPV6 on the 
inhibitory effect of CaM34. Effects of CaM34 on Na+ current density of TRPV6 expressing 
HEK293 cells with 100 μM EDTA in the bath solution. Data obtained from linear ramps from 
+100 to –100 mV, holding potential was +20 mV. Currents were normalized to the density at –80 
mV of controls. TRPV6 chimeras (TRPV6 N- and/or C-termini replaced by that of TRPV5) were 
used for the experiments. Open bars represent control currents; solid bars represent co-transfection 
with CaM34 (n > 12 cells). 
 
Elucidation of the CaM binding sites in TRPV6  
A series of TRPV6 N- and C-terminal deletion mutants were constructed as depicted in Fig. 
6. Truncated forms of TRPV6 were in vitro translated and binding was determined as 
described above. The interaction between TRPV6 N-terminus and CaM was abolished when 
the N-terminus was truncated at position 93, whereas truncations at positions 103 up to 266 
had no effect on the interaction with CaM (Fig. 6A). This indicates that CaM binds the 
TRPV6 N-terminus in a region at position 93 – 103. Detailed analysis revealed that this 
putative CaM binding region consists of an α-helix according to the structural prediction 
program GORIV (www.expasy.org). A 1-5-10 motif with consensus sequence 
(FILVW)xxx(FAILVW)xxxx(FILVW) is present in this particular binding region (Fig. 6B). 
The interaction between TRPV6 C-terminus and CaM was partially abolished when the C-
terminus was truncated at position 655, whereas truncations at position 649 and 642 
completely abolished CaM binding (Fig. 6C). Truncation at position 667 up to 695 had no 
effect on the interaction with CaM. These findings suggest that CaM binds the TRPV6 C-
terminus at position 649 – 667. This putative binding region contains a 1-8-14 motif with 
consensus sequence (FILVW)xxxxxx(FAILVW)xxxxx(FILVW) and consists of an α-helix 
(Fig. 6D). 
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Fig. 6. Mapping of the CaM binding site in the N- and C-terminus of TRPV6. [35S]Methionine 
labeled in vitro translated N- (A) or C-termini (C) truncates were constructed and incubated with 
CaM-coupled agarose beads in the presence of 1 mM Ca2+. Input control is 10% of the pull-down 
input. (B,D) Alignment of N- or C-terminal CaM binding motif of different species with consensus 
CaM binding motifs (boxed). From top to bottom: Rat TRPV6 (AF160798); Mouse TRPV6 
(NM022413); Human TRPV6 (NM018646). The structure prediction program GORIV 
(www.expasy.org) was used to determine whether this region consists of an alpha helix. 
 
CaM binding to TRPV5 and TRPV6 at low Ca2+ concentrations 
The Ca2+-dependent binding of CaM to TRPV5 and TRPV6 was studied in detail using the 
TRPV5 and TRPV6 N-termini (TRPV51-327, TRPV61-326) and C-termini (TRPV5578-730, 
TRPV6577-727) in the absence or presence of increasing amounts of Ca2+ (Fig. 7). Both the 
TRPV5 N- and C-termini bound CaM at a Ca2+-concentration of 30 nM or higher, whereas 
binding is lost in the absence of Ca2+ (Fig. 7A). Similar observations were made for TRPV6 
(Fig. 7B), thus CaM is bound to both TRPV5 and TRPV6 at Ca2+-concentrations as low as 30 
nM. 
 
Discussion 
The present study identified CaM as a Ca2+-sensor specifically regulating TRPV6 activity. 
This is based on the following observations. First, electrophysiological measurements of 
HEK293 cells heterologously expressing TRPV5 or TRPV6 and CaM mutants revealed that 
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TRPV6, but not TRPV5, is regulated by CaM although both channels bind CaM in a Ca2+-
dependent fashion. Second, the effect of CaM is mediated by the high Ca2+ affinity EF-hand 
structures 3 and 4 present in the C-terminus of CaM. Third, binding studies indicated that 
CaM binds in a Ca2+-dependent fashion to both the TRPV5 and TRPV6 N-termini (TRPV51-
327, TRPV61-326) and C-termini (TRPV5578-730, TRPV6577-727) and to the TRPV6 
transmembrane domain (TRPV6327-577). Fourth, co-transfection of CaM34 and various 
TRPV5/6 chimeras revealed that the effect of CaM is mediated via the identified CaM-
binding domains in TRPV6.  
 
Fig. 7. CaM binding to TRPV5 and TRPV6 at low Ca2+ concentrations. [35S]Methionine 
labeled in vitro translated TRPV5 (A) and TRPV6 (B) N- and C-termini were incubated with CaM 
coupled agarose beads in the absence (5 mM EGTA) or presence of increasing concentrations of 
Ca2+ (30 or 100 nm). Input control is 10% of the pull-down input. The figure shown is a 
representative blot of 3 independent experiments.  
 
Previously, it has been shown that TRPV5 and TRPV6 activity is negatively regulated by the 
intracellular Ca2+ concentration and the ubiquitously expressed CaM could potentially play a 
regulatory role in this process (10,11,25). Interestingly, CaM is involved in Ca2+-dependent 
regulation of TRPV6 only, since CaM1234 significantly reduced the Ca2+ and Na+ current 
density in TRPV6 expressing HEK293 cells, whereas TRPV5-mediated currents were not 
significantly altered. This latter finding is remarkable given the high homology between both 
channels, similar Ca2+ dependent regulation of channel activity and binding of CaM to both 
channels. The effect of CaM1234 was localized to the high Ca2+ affinity EF-hand structures in 
the CaM C-terminus (EF hand 3 and 4). Overexpression of CaM34, the CaM mutant that lacks 
high affinity Ca2+-binding, reduced the TRPV6 current density to the same extent as CaM1234, 
whereas CaM12 did not effect TRPV6 currents. The effect of CaM34 on TRPV6 is not 
restricted to the Ca2+ current since also the Na+ current density was inhibited when CaM34 is 
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co-expressed. Together these results imply that CaM positively affects TRPV6 activity at 
basal Ca2+ concentrations via either structural changes in TRPV6 leading to an increased open 
probability, or via accumulation of active channels on the plasma membrane. However, to 
date several studies on voltage-operated Ca2+ channels indicated that CaM can regulate 
channel activity on the plasma membrane, whereas little evidence has been presented for 
effects on the routing of the channels (6,7,26-29).  
 
The association of CaM with TRPV5 was localized to the N-terminus (TRPV51-327) and C-
terminus (TRPV5578-730). The association of CaM with TRPV6 was localized to consensus 
CaM binding motifs in α-helical structures present in the N- and C-terminus and to the 
transmembrane part (TRPV6327-577) of TRPV6, where CaM binds in a Ca2+-dependent fashion. 
The N-terminal binding is localized to a consensus 1-5-10 motif (position 88-92-97) that is 
identical among different TRPV6 species. A 1-5-10 motif is a classical region for binding of 
Ca2+-CaM, which fits with the Ca2+-dependent binding of CaM to the TRPV6 N-terminus. 
The C-terminal binding is localized to a consensus 1-8-14 motif (position 643-650-656) that 
is identical between mouse and rat TRPV6. However, human TRPV6 does not contain a 1-8-
14 motif at this particular position, which might explain the previous observation that CaM 
binding to human TRPV6 is localized to a different region (10). When mouse TRPV6 is 
truncated at the position corresponding to the described human binding region (10) it still 
binds CaM, whereas truncations in the identified 1-8-14 motif virtually abolished CaM 
binding (this study). The mouse TRPV6 peptide, corresponding to the described human 
binding region, binds CaM (11), however these results are not in line with our results. Based 
on the fact that only the TRPV6 activity was inhibited by CaM34, despite binding of CaMWT 
and CaM34 to both TRPV5 and TRPV6, suggests that the regulatory effect of CaM is 
restricted to TRPV6.  
TRPV5 and TRPV6 chimeras were used in order to identify the essential domains of TRPV6 
for the CaM effect since CaM mutants had no effect on TRPV5 expressing HEK293 cells and 
TRPV5/6 chimeras give functional channels (18). The TRPV6 domains that bind CaM all 
contribute to the CaM34 effect because chimeras in which the N- and/or C-terminus of TRPV6 
were substituted by that of TRPV5, revealed a significant decrease in both the Ca2+ and Na+ 
current density when CaM34 was co-expressed. Comparison of current amplitudes of the 
different chimeras suggests that the TRPV6 N-terminus contributes predominantly to the 
inhibitory effect of CaM34, because the CaM34-induced decrease is maximally diminished 
when the TRPV6 N-terminus is substituted by that of TRPV5. 
The dominant negative effect of CaM mutants on TRPV6 activity suggests a constant 
tethering of CaM to the channel complex, since overexpression of Ca2+-insensitive CaM 
would otherwise not interfere appreciably with currents of TRPV6 expressing HEK293 cells 
53
Chapter III 
 
containing endogenous wild-type CaM. Like described for Cav channels (29) we suggest a 
tight and constitutive interaction between TRPV6 and CaM. The fact that CaM inhibitors do 
not affect TRPV6 activity (data not shown) supports the tight and constitutive interaction, as 
described previously for L-type Cav channels (29). The CaM binding to the TRPV6 N- and 
C- terminus at a Ca2+ concentration as low as 30 nM suggests that CaM is tethered to TRPV6 
at Ca2+-concentrations normally present in resting cells (60 – 100 nm). Thus, it is likely that 
CaM is constitutively tethered to the TRPV6 channel complex.  
In conclusion, our data demonstrate a regulatory role of CaM in TRPV6-mediated Ca2+ influx. 
The elucidated molecular mechanism possibly involves constitutively tethering of CaM to the 
TRPV6 channel complex. Upon Ca2+ sensing of the CaM C-terminus, TRPV6 activity is 
positively affected via combined actions at the N- and C-terminus and transmembrane domain 
of the channel.  
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Abstract  
In Ca2+-transporting epithelia, calbindin-D28K (CaBP28K) facilitates Ca2+ diffusion from the 
luminal Ca2+ entry side of the cell to the basolateral side, where Ca2+ is extruded into the 
extracellular compartment. Simultaneously, CaBP28K provides protection against toxic high 
Ca2+ levels by buffering the cytosolic Ca2+ concentration ([Ca2+]i) during high Ca2+ influx. 
CaBP28K consistently co-localizes with the epithelial Ca2+ channel TRPV5, which constitutes 
the apical entry step in renal Ca2+-transporting epithelial cells. Here, we demonstrate using 
protein-binding analysis, subcellular fractionation and evanescence-field microscopy that 
CaBP28K translocates towards the plasma membrane and directly associates with TRPV5 at a 
low [Ca2+]i. 45Ca2+ uptake measurements, electrophysiological recordings, and transcellular 
Ca2+ transport assays of lentivirus infected primary rabbit connecting tubule / distal convolute 
tubule cells revealed that associated CaBP28K tightly buffers the flux of Ca2+ entering the cell 
via TRPV5 facilitating high Ca2+ transport rates by preventing channel inactivation. In 
summary, CaBP28K acts in Ca2+-transporting epithelia as a dynamic Ca2+ buffer, regulating 
[Ca2+] in close vicinity to the TRPV5 pore by direct association with the channel. 
 
Introduction 
The vitamin D-dependent Ca2+-binding proteins, named calbindins (CaBPs), are expressed in 
cells that are challenged by a high Ca2+ influx such as in brain, bone, teeth, inner ear, placenta, 
mammary gland, kidney and intestine. In these tissues, CaBPs (i.e. CaBP9K and CaBP28K) are 
widely regarded as a key component in cellular Ca2+ handling. In Ca2+-transporting epithelial 
cells, CaBPs display the potential to facilitate multiple steps in the process of transcellular 
Ca2+ transport. First, Ca2+ influx in these cells is mediated by the epithelial Ca2+ channels 
TRPV5 and TRPV6, which are distinct members of the Transient Receptor Potential (TRP) 
family (1) acting as gatekeepers facilitating cellular Ca2+ entry due to a steep inward 
electrochemical gradient across the luminal membrane of epithelial cells (2). The activity of 
these highly Ca2+-selective channels is tightly regulated by the Ca2+ concentration in close 
vicinity to the channel mouth (3). Thus, adequate buffering of Ca2+ is essential for a 
continuous influx of Ca2+ through these channels. Second, during high rates of transcellular 
Ca2+ transport, strict regulation of the intracellular Ca2+ concentration ([Ca2+]i) is crucial in 
protecting the cell against the cytotoxic high levels of Ca2+ (4). Buffering of Ca2+ by 
specialized Ca2+-binding proteins is, therefore, required (5-7). Third, Ca2+ entering at the 
luminal side of the cell has to diffuse, without affecting other intracellular processes, to the 
basolateral side, where the Na+/Ca2+-exchanger (NCX1) and/or the plasma membrane ATPase 
(PMCA1b) extrude Ca2+ into the extracellular compartment. In transepithelial Ca2+ transport, 
CaBPs have been implicated in facilitated diffusion of Ca2+ from the luminal membrane to the 
basolateral surface by increasing the diffusional range of Ca2+ (8, 9). Moreover, the 
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importance of CaBPs in Ca2+-transporting epithelial cells is underlined by the consistent co-
expression with the Ca2+ transport proteins including TRPV5, TRPV6, NCX1 and PMCA1b 
(10). 
Negative feedback regulation of channel activity by an increased [Ca2+]i is not restricted to the 
epithelial Ca2+ channels. A broad range of both voltage and non-voltage-operated ion channels 
are regulated by [Ca2+]i (11, 12). Ion channels that are negatively regulated by Ca2+ inactivate 
upon a local rise in [Ca2+] in close proximity to the channel pore. Previous studies indicated 
that the Ca2+ sensor calmodulin is responsible for the Ca2+-dependent regulation of 
particularly voltage-operated Ca2+ channels (13, 14). However, how [Ca2+] near a channel 
pore is regulated is not well defined. Several studies implicate CaBPs in facilitated diffusion 
of Ca2+. However, other than mathematical models (15) and coordinated regulation of renal 
Ca2+ transport proteins (16), limited experimental data is available to substantiate these 
hypotheses.  
In addition, previous studies indicated that CaBP28K acts as a cytosolic Ca2+ buffer to protect 
neurons against large fluctuations in [Ca2+]i (6, 17, 18). Here, the buffer capacity of CaBP28K 
affects the shape of the postsynaptic Ca2+ signals and may underlie paired pulse facilitation of 
synapses (19-21). Recently, it was shown in cerebellar Purkinje neurons that CaBP28K directly 
interacts with membrane-targeted inositol-1,4,5-trisphosphate and acts as a Ca2+ sensor to 
regulate the degradation of inositol messengers in an activity-dependent manner (22). Thus, 
CaBP28K displays several properties that imply an important role in Ca2+-induced signal 
transmission and hence may function not only as a Ca2+ buffer, but also as a Ca2+ sensor 
affecting downstream processes in the cell.  
A key biochemical property specifying a Ca2+ sensor is the presence of EF-hand motifs that 
undergo a conformational change upon Ca2+ binding. CaBP28K is equipped with 6 EF-hand 
motifs that bind Ca2+ in a highly cooperative fashion. First, Ca2+ binds to the high affinity EF-
hand site 1, followed by EF-hands 4 and 5 and finally EF-hand 3 is loaded with Ca2+, in 
contrast to EF-hands 2 and 6 which do not bind Ca2+ (23). Although the crystal structure of 
CaBP28K has not been determined, structural analysis measured by nuclear magnetic 
resonance indicated that conformational changes occur in CaBP28K upon Ca2+ binding (24, 
25). 
The aim of the present study was to determine how CaBPs contribute to the regulation of 
TRPV5 channel activity, intracellular Ca2+ handling and transcellular Ca2+ transport in 
epithelial cells. By a comprehensive approach using protein-binding analysis, life cell 
imaging and functional assays, this study reveals a crucial role of CaBP28K in TRPV5-
mediated transepithelial Ca2+ transport in kidney. Here, we show that CaBP28K acts as a 
dynamic Ca2+ buffer regulating the local [Ca2+] in close vicinity to the TRPV5 pore by direct 
association with the channel. 
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Materials and methods 
 
Molecular biology 
TRPV4, 5, and 6 N- and C-termini were cloned into the pGEX6p-2 vector (Amersham 
Pharmacia Biotech, Roosendaal, The Netherlands). TRPV5 was cloned into the 
pCINeo/IRES-EGFP expression vector as described (26) and fused to the C-terminus of 
EGFP or ECFP by subcloning into pEGFP-C1 and pECFP (Clontech, Palo Alto, CA, USA). 
CaBP28K was cloned into the Xenopus laevis oocyte expression vector pT7Ts and pEBG (27), 
pGEX6p-2 and pCINeo/IRES-EGFP expression vectors using PCR. An EYFP-CaBP28K 
fusion construct was generated by cloning CaBP28K into pEYFP-C1 (Clontech, Palo Alto, CA, 
USA) and a Ca2+-insensitive CaBP28K mutant (CaBP28K∆EF) was constructed by mutating the 
EF-hand motifs (EF1: D24A, D26A; EF2: D69A, D70A; EF3: D111A, D113A, E119A, 
E121A, E122A; EF4: D155A, D159A, E163A, E166A EF5: D212A, D217A, E220A; EF6: 
D251A). All constructs were verified by sequence analysis and the integrity of the fusion 
constructs was investigated by western blot analysis using a rabbit anti-GFP antibody. 
 
Cell culture 
HEK293, HEK293T, HeLa and MDCK cells were grown and transfected as described (28). 
MDCK cells stably expressing both EGFP-TRPV5 and CaBP28K were constructed similar as 
previously described (29) and maintained in medium containing 800 µg/ml G418/700 µg/ml 
hygromycine (GIBCO Europe, Breda, The Netherlands). Expression was verified using mouse 
or rabbit anti-CaBP28K (Sigma-Aldrich, Zwijndrecht, The Netherlands) and rabbit anti-GFP 
antibodies, respectively. Five cell line clones were pooled to eliminate differences between 
independent clones. For flow cytometry analysis of EGFP-TRPV5 expression, relative 
fluorescence intensity was measured on a FACSCaliburTM (BD Biosciences, Amsterdam, The 
Netherlands). Primary cultures of rabbit CNT/CCD were isolated and transepithelial Ca2+ 
transport was measured as described previously (30). 
 
Protein-binding analysis 
GST pull down assays with [35S]Methionine-labeled proteins in TBS-HCl pH 7.4 containing 
0.5% (v/v) NP40 and 1 mM Ca2+ or 5 mM EDTA, were performed as described (28). For 
binding competition assays increasing amounts of non-radioactive in vitro translated 
CaBP28KΔEF were included during the pull down experiment of CaBP28K and TRPV5.  
HEK293 cells were transiently co-transfected with pEBG-CaBP28K and pCINeo-TRPV5- 
IRES-EGFP. Cells were loaded with or without 50 µM BAPTA-AM for 30 min at 37 ºC and 
lysed by incubation for 1 h on ice in TBS pH 7.4 containing 0.5% (v/v) NP40, 5 mM EDTA 
and the protease inhibitors leupeptin (0.01 mg/ml), pepstatin (0.05 mg/ml), 
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phenylmethylsulfonyl fluoride (1 mM) and aprotinine (5 mg/ml). The lysates were 
centrifuged for 30 min at 16,000 g and supernatants were incubated with glutathione 
sepharose beads (Amersham Bioscience, Piscataway, NJ, USA) for 16 h. After extensive 
washing in lysis buffer co-precipitation was performed by immunoblot analysis using guinea 
pig anti-TRPV5 (3).  
 
Cell fractionation assay  
Primary renal CNT/CCD cultures and transiently CaBP28K and TRPV5-transfected HeLa cells 
were homogenized in fractionation buffer (300 mM sucrose, 25 mM imidazole-HCl pH 7.4, 5 
mM EDTA and protease inhibitors leupeptin (0.01 mg/ml), pepstatin (0.05 mg/ml), 
phenylmethylsulfonyl fluoride (1 mM) and aprotinine (5 mg/ml)). After 5 min at 4,000 g 4 ºC 
to remove intact cells, nuclei and mitochondria the supernatant was centrifuged at 16,000 g 4 
ºC. The plasma membrane-enriched pellet fraction was subjected to SDS-PAGE and 
immunoblots were analyzed with rabbit anti-CaBP28K and rabbit anti-Na,K-ATPase (3) 
antibodies. The intensity of immuno-positive bands were measured and changes in the 
CaBP28K signal were expressed as a ratio of the internal control Na,K-ATPase. 
 
Confocal, total internal reflection fluorescence microscopy and image analysis 
For TRPV5 and CaBP28K co-localization, a Zeiss LSM510meta (Carl Zeiss GmbH, Jena, 
Germany) confocal laser scanning microscope was used. Images were taken with a 
PlanApochromatic 63x 1.4 oil immersion DIC lens (Carl Zeiss GmbH, Jena, Germany). The 
cytosolic localization of CaBP28K was quantified using Image J (NIH) software. Renal 
epithelial cells were divided in 5 regions (apical, apical-middle, middle, basolateral-middle, 
and basolateral) and the intensities of the individual regions in 30 renal cells of 6 different 
tubules were calculated according to the following equation: 
 
Relative intensity = Ix / (Iapical + Iapical middle + Imiddle + I basolateral middle + Ibasolateral)  
Where Ix is the intensity of domain X; Iapical is the apical intensity; Iapical middle is the apical 
middle intensity; Imiddle is the middle intensity; Ibasolateral middle is the basolateral middle intensity 
and Ibasolateral  is the basolateral intensity. 
 
To image EYFP-CaBP28K in EYFP-CaBP28K and ECFP-TRPV5-transfected HEK293T cells a 
custom-built objective-based TIRF microscope was used (31). Briefly, a 488 nm solid-state 
diode laser (Coherent, Santa Clara, CA, USA) was focused onto a single-mode optical fiber 
(Newport, Irvine, CA) with a 5-axis fiber-coupler (New Focus, San Jose, CA, USA) and 
guided through the rear illumination port of an Olympus IX70 fluorescence microscope. The 
laser light reflected from a specially coated dichroic mirror (Z488RDC; Chroma Technology, 
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Rockingham, VT, USA) passes through a high-numerical aperture objective (N.A. 1.45, X60, 
Olympus, Melville, NY, USA) and was totally internally reflected by the glass–water 
interface (n = 1.37). Fluorescence emitted from tagged-proteins passed through an HQ515-
30m (Chroma) filter for EGFP/EYFP before being collected by a cooled-CCD (ORCA ER II; 
Hamamatsu, Bridgewater, NJ). All imaging acquisition was performed with MetaMorph 
(Universal Imaging, West Chester, PA). Cells grown on glass cover slips were placed in a 
custom chamber with standard external solution (135 mM NaCl, 5 mM KCl, 1.5 mM MgCl2, 
1.5 mM CaCl2, 20 mM HEPES 10 mM D-glucose, pH 7.4 with HCl) and imaged at room 
temperature. Cells were screened for the expression of ECFP-TRPV5 and EYFP-CaBP28K 
using the normal light fluorescence setup before switching to TIRF for EYFP imaging. Cells 
were analyzed for 10 min (1 frame/5 s) to establish a baseline in whole-cell TIRF 
measurements before 50 µM BAPTA-AM was added. After 15 min, to allow BAPTA loading 
of the cells, cells were again followed for 10 min (1 frame/5 s). To quantify changes in TIRF, 
intensities of the regions of interests (ROIs) of several (n = 5-7) cells, with areas between 5-
10% of the visible 'footprint' of the cell, were averaged and normalized according to the 
following equation: 
 
Relative change = I(t) – I(0)  
 
Where I(0) is the intensity at the beginning of the time series and I(t) is the intensity at time 
point t. 
 
45Ca2+ binding and uptake assay  
GST-CaBP28K and GST were expressed and purified according to the manufacturers’ protocol 
(Amersham Biosciences, Piscataway, NJ, USA). Blots were washed in overlay-buffer (10 
mM imidazole-HCl pH 7.4, 60 mM KCl, 0.5 mM MgCl2) before incubation with 45CaCl2 (1 
µCi/ml) in overlay-buffer. After extensive washing in 50% (v/v) ethanol and drying of the 
blots, bound 45Ca2+ was determined by autoradiography. 45Ca2+ uptake was determined using 
confluent layers of MDCK cells as described (32). To block TRPV5-mediated 45Ca2+ uptake 
cells were incubated with 10 μM ruthenium red.  
 
 
Electrophysiology 
Whole-cell currents in HEK293 cells transiently transfected with TRPV5 and CaPB28K were 
measured using an EPC-9 patch-clamp amplifier and Pulse software (HEKA Elektronik, 
Lambrecht, Germany). Monovalent cation currents were measured in divalent-free 
extracellular solution (DVF) containing 150 mM NaCl, 10 mM EDTA and 10 mM HEPES-
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NaOH, pH 7.4. The internal (pipette) solution contained 120 mM NaCl, 1 mM CaCl2, 20 mM 
HEPES-NaOH and 1 mM Fura-2, supplemented with 5 mM 1-(4,5-metoxy-2-nitrophenyl)1,2-
aminoethane-N,N,N’,N’-tetraacetic acid (DMNP-EDTA). DMNP-EDTA is a Ca2+ chelator 
that exhibits a high affinity for Ca2+ ions with an increase in its Kd for Ca2+ upon photolysis 
(Kd rises from 5 nM to 3 mM). All experiments were performed at room temperature. 
Current-voltage relationships were measured from linear 400-ms voltage ramps, from -100 
mV to +100 mV. Ramps were applied every 5 s from a holding potential of +20 mV with a 
sampling interval of 0.8 ms. All current amplitudes in the dose-response curves were 
normalized to values of the inward current at -80 mV and a intracellular Ca2+ concentration 
([Ca2+]i) of 135 nM and subsequently fitted with a Hill function (Origin 7.0 software, 
OriginLab Corporation, Northampton, MA, USA). For photolytic release of Ca2+ and 
measurement of  [Ca2+]i during patch-clamp Fura-2 was excited with light alternated between 
350 and 380 nm using a monochromator (Polychrome IV, TILL Photonics, Planegg, 
Germany), and the resulting fluorescent signal was measured using a photodiode. The ratio of 
the fluorescent signal was converted into [Ca2+ ]i values according to the Grynkiewicz 
equation (33). Increases in [Ca2+]i were achieved by increasing the duration of 350/380 nm 
illumination from 15  to 150 ms each. 
 
Lentiviral infection of primary rabbit CNT/CCD cultures  
Third generation lentiviruses were produced by co-transfection of the packaging vectors 
pRSV-Rev, pMDL g/p RRE, and pMD2G from Tronolab (Lausanne, Switzerland), containing 
and the transfer vector into HEK293T cells as described (34). The virus titer was determined 
by p24 HIV ELISA (Murex Diagnostics, Dartford, UK). Primary rabbit CNT/CCD cultures 
were infected with lentiviruses containing EGFP or EGFP-CaBP28KΔEF immediately before 
plating, in the presence of polybrene (8 μg/ml) using 20 virus particles per cell (20 MOI). 
Virus was removed after 24 h and subsequently transepithelial Ca2+ transport was measured 6 
days post-infection in the presence of 10 μM forskolin as described previously (30).  
 
Statistical analysis 
In all experiments, the data are expressed as mean ± SEM. Overall statistical significance was 
determined by analysis of variance (ANOVA) followed by Bonferroni to investigate 
individual significance. P-values below 0.05 were considered significant. 
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Results 
Concomitant regulation of calbindin-D28K and TRPV5 in kidney 
In kidney CaBP28K and TRPV5 co-localized in the distal convoluted tubule (DCT) and the 
connecting tubule (CNT) (Fig. 1A). These cells transport Ca2+ transcellularly from the pro-
urine to the blood compartment (2). To investigate whether there is a correlation between the 
expression of TRPV5 and CaBP28K the abundance of these proteins was analyzed in different 
animal models that were treated with calciotropic hormones, exposed to various dietary Ca2+ 
levels or ablated for Ca2+ transporting encoding genes (Fig. 1B). Importantly, a highly 
significant correlation between the TRPV5 expression and CaBP28K abundance was 
consistently observed. CaBP28K is predominantly localized along the apical side of TRPV5-
expressing renal cells (Fig. 1A) Therefore, the apical localization of CaBP28K was investigated 
in kidneys of TRPV5-/- compared to wild-type mice. To this end, the immuno-positive 
staining of CaBP28K was semi-quantified in five subcellular regions of DCT and CNT cells 
(Fig. 1C). In TRPV5-/- kidney CaBP28K was equally distributed throughout the tubular cells 
with no apparent apical localization, whereas CaBP28K was significantly more abundant in the 
apical region in wild-type kidney cells. This finding further substantiates that the apical 
localization of CaBP28K is dependent on the presence of TRPV5. 
 
Calbindin-D28K interacts with TRPV5 in a Ca2+-dependent manner  
Ion channels in epithelial cells are frequently regulated by associated intracellular protein 
complexes. A potential interaction between CaBP28K and TRPV5 was investigated using GST 
pull-down assays. In addition, the interaction of CaBP28K with other TRPV members, 
including the highly homologous TRPV6 and closely related TRPV4 channels, was studied. 
CaBP28K bound to both the N- and C-termini of TRPV5 and TRPV6 in the absence of Ca2+ (5 
mM EDTA), whereas the binding was virtually abolished in the presence of Ca2+ (1 mM 
CaCl2) (Fig. 1D). However, binding between CaBP28K and TRPV4 could not be detected 
neither in the presence nor absence of Ca2+ (data not shown). Subsequently, the interaction of 
TRPV5 and CaBP28K was evaluated by co-precipitation from GST-CaBP28K and TRPV5-
expressing human embryonic kidney (HEK293) cells. The Ca2+ dependency of this 
association was investigated by incubation of the cells with BAPTA-AM to decrease [Ca2+]i. 
To this end, cell lysates were incubated with glutathione-coupled sepharose beads to 
precipitate GST-CaBP28K complexes and immunoblots containing the precipitated proteins 
were analyzed for the presence of TRPV5. TRPV5 co-precipitated with GST-CaBP28K in cells 
that were treated with BAPTA-AM, whereas the channel was not precipitated from non-
treated cells (Fig. 1E). In addition, co-precipitation of TRPV5 could not be detected in GST 
and TRPV5-expressing cells, demonstrating the specificity of the CaBP28K association.  
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Fig. 1. Coordinated 
expression and direct 
association of TRPV5 
and CaBP28K  
(A) Co-localization of 
TRPV5 (green) and 
CaBP28K (red) in the 
distal convoluted and 
connecting tubule. (B) 
Correlation in TRPV5 
and CaBP28K expression 
after treatment 
(1parathyroidectomized 
(16); 2tacrolimus (35); 
3acidose/alkalose (36); 
4thiazide (35, 37); 
5calcimemetics (16); 
6ovariectomized (16); 
7dexamethasone (37); 
8ovariectomized + 
vitamine D3 (38)). R2 = 
0.9068. (C) 
Localization of CaBP28K 
in kidney sections of 
TRPV5-/- and wild-type mice. The epithelial cells were divided in different regions including apical, 
apical-middle, middle, basolateral-middle and basolateral as indicated. The immuno-positive CaBP28K 
staining of these different cellular regions in 30 cells of 6 different tubules was calculated as described 
in the material and methods. Significant differences in CaBP28K intensities within the group were 
indicated by an asterisk. (D) [35S]Methionine labeled, in vitro translated CaBP28K was incubated, either 
in the presence (1 mM CaCl2) or absence (5 mM EDTA) of Ca2+, with GST or GST fused to the N- or 
C-terminus of TRPV5 and TRPV6 immobilized on glutathione-Sepharose 4B beads. Input control (IP) 
represents 10% of the total pull down input. The two TRPV5 immuno-positive bands correspond to the 
core (lower) and glycosylated forms of the protein. (E) Cells were co-transfected with pEBG-CaBP28K 
(GST-CaBP28K) and pCINeo-TRPV5-IRES-EGFP or pEBG (GST) and pCINeo-TRPV5-IRES-EGFP 
(control, C). To decrease the [Ca2+]i cells were treated with BAPTA-AM. Lysates were loaded on 
glutathione-Sepharose 4B beads and after extensive washing co-precipitation was investigated by 
immunoblotting using the guinea pig anti-TRPV5 antibody (IP = input). 
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CaBP28K translocates towards the plasma membrane in a Ca2+- and TRPV5-dependent 
manner 
The physiological characteristics of the interaction of CaBP28K with TRPV5 suggests that this 
Ca2+-binding protein translocates towards the plasma membrane at a low [Ca2+]i. This 
hypothesis was investigated by the isolation of plasma membrane-enriched fractions of 
TRPV5 and CaBP28K-transfected HeLa cells. As compared to the endogenously expressed 
Na,K-ATPase, CaBP28K was more abundant (260 ± 105 %, n = 3, p<0.05) in the plasma 
membrane-enriched fraction of cells that were treated with BAPTA-AM compared to non-
treated cells (Fig. 2A, left panel). Importantly, cells lacking TRPV5 did not reveal an 
elevated expression of CaBP28K in the plasma membrane-enriched fraction after BAPTA-AM 
treatment (Fig. 2A, right panel). Subsequently, CaBP28K expression in plasma membrane-
enriched fractions of primary rabbit CNT / cortical collecting duct (CNT/CCD) cultures 
endogenously expressing TRPV5 and CaBP28K (2) was evaluated. In line with the experiments 
using transfected cells, CaBP28K was more abundant (146 ± 6 %, n = 3, p<0.05) in plasma 
membrane-enriched fractions of BAPTA-AM-treated primary CNT/CCD cultures as 
compared to non-treated cultures (Fig. 2B). 
 
Fig. 2. Subcellular localization of 
CaBP28K at low intracellular Ca2+ 
concentrations 
(A) Cells were transfected with CaBP28K 
and TRPV5 (left panel) or CaBP28K and 
empty vector (right panel) and treated 
with or without BAPTA-AM. Plasma 
membrane-enriched fractions were 
probed for the presence of endogenously 
expressed Na,K-ATPase and 
exogenously expressed CaBP28K using 
anti-Na,K-ATPase and anti-CaBP28K 
antibodies, respectively. NT = non-
transfected. (B) Plasma membrane-
enriched fractions of primary CNT/CCD 
cultures, either treated with or without 
BAPTA-AM, were isolated and probed 
for the presence of endogenously 
expressed   CaBP28K   and  Na,K-ATPase.  
Representative  blots  of   3   independent  
experiments are shown. 
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Next, the Ca2+-dependent translocation of CaBP28K towards the plasma membrane in TRPV5-
expressing HEK293T cells was investigated by total internal reflection fluorescence (TIRF) 
or evanescent-field microscopy. TIRF microscopy illuminates fluorophores within 100-200 
nm of the plasma membrane-glass cover slip interface, with excitation intensity depending on 
the relative indices of refraction and the angle of incidence. Light intensity falls exponentially 
in the axial (z) direction, such that fluorescence output is inversely proportional to the 
distance from the plasma membrane. TIRF therefore enabled us to study the dynamic process 
of CaBP28K translocation towards the plasma membrane in a direction vertical to the plasma 
membrane, without interference of cytosolic CaBP28K fluorescence. The presence of EYFP-
CaBP28K in the TIRF signal of cells co-transfected with EYFP-CaBP28K and TRPV5-ECFP 
was followed in the presence and absence of BAPTA-AM, respectively. After BAPTA-AM 
treatment, the EYFP-CaBP28K TIRF signal increased in time as compared to non-treated cells 
(Fig. 3A and B). In line with the cell fractionation experiments, this increase of EYFP-
CaBP28K TIRF signal was not observed in cells lacking TRPV5 (Fig. 3C and D). 
Furthermore, the BAPTA-dependent changes in TIRF signal were not detected in cells 
expressing TRPV5-IRES-EGFP (bicistronic expression of TRPV5 and EGFP) (Fig. 3E and 
F) demonstrating that the observed alterations in EYFP-CaBP28K fluorescence represent a 
cellular redistribution of CaBP28K. 
 
Co-expression of CaBP28K elevates 45Ca2+ uptake in TRPV5-expressing MDCK cells   
In order to investigate the functional role of the Ca2+-binding EF-hand motifs in CaBP28K, a 
Ca2+-insensitive mutant (CaBP28KΔEF) was constructed and characterized by 45Ca2+ overlay 
and pull down experiments. As compared to the negative control (GST), disruption of the EF-
hand motifs in GST-CaBP28K resulted in a Ca2+-insensitive CaBP28K mutant whereas wild-type 
GST-CaBP28K displayed normal 45Ca2+ binding (Fig. 4A). In addition, pull down analysis 
demonstrated that CaBP28KΔEF binds in the absence (5 mM EDTA) as well as presence (1 
mM CaCl2) of Ca2+ to the N- and C-terminus of both TRPV5 and TRPV6 (Fig. 4B). To 
investigate whether CaBP28KΔEF competes with wild-type CaBP28K for TRPV5 binding 
increasing amounts of non-radioactive in vitro translated CaBP28KΔEF were added during the 
pull down assay. This resulted in a dose-dependent reduction of CaBP28K binding indicating 
that CaBP28KΔEF competed with wild-type CaBP28K for TRPV5 association (Fig. 4C). 
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Fig. 3. CaBP28K translocation at low intracellular Ca2+ concentrations 
(A) TIRF images of a single cell expressing EYFP-CaBP28K and TRPV5-ECFP that was treated 
with (lower panel) or without (upper panel) BAPTA-AM. Scale bar = 5 µm (B) Average time 
courses of the TIRF signal of EYFP-CaBP28K in EYFP-CaBP28K and TRPV5-ECFP expressing 
cells that were treated either with (□) or without (Δ) BAPTA-AM (n=7). Significant differences in 
total EYFP changes after BAPTA-AM treatment (inset) are indicated by an asterisk (p<0.05). (C) 
TIRF images of a single cell expressing EYFP-CaBP28K that was treated with (lower panel) or 
without (upper panel) BAPTA-AM. Scale bar = 5 µm (D) Average time courses of the TIRF signal 
of EYFP-CaBP28K-expressing cells that were treated either with (□) or without (Δ) BAPTA-AM 
(n=5). (E) TIRF images of single cells expressing TRPV5-IRES-EGFP treated with (lower panel) 
or without (upper panel) BAPTA-AM. Scale bar = 5 µm (F) Average time courses of the TIRF 
signal in TRPV5-IRES-EGFP-expressing cells that were treated either with (□) or without (Δ) 
BAPTA-AM (n=5). In all images a gradient filter was applied such that saturation of TIRF 
fluorescence turns red and the intensities were measured between 5–10% of the visible 'footprint' 
of the cell. 
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Fig. 4. Characterization of a Ca2+-
insensitive CaBP28K mutant 
(A) Wild-type CaBP28K and 
CaBP28KΔEF were fused to GST (left 
panel) and 45Ca2+-binding was 
determined (right panel). (B) 
[35S]Methionine labeled, in vitro 
translated CaBP28KΔEF was incubated, 
either in the presence (1 mM CaCl2) or 
absence (5 mM EDTA) of Ca2+, with 
GST or GST fused to the N- and C-
termini of TRPV5 and TRPV6 
immobilized on glutathione-Sepharose 
4B beads. Input control (IP) represents 
10% of the total pull down input. (C) 
[35S]Methionine-labeled in vitro 
translated CaBP28K was incubated in the 
presence of increasing amounts of non-
radioactive in vitro translated  
CaBP28KΔEF with GST or GST fused 
to C-termini of TRPV5 immobilized on 
glutathione-Sepharose 4B beads. This 
pull down experiment was performed 
in the absence of Ca2+ (5 mM EDTA). 
Input control (IP) represents 10% of the 
input. 
 
The role of CaBP28K and the Ca2+-binding EF-hand motifs in CaBP28K was assessed on 
TRPV5-mediated 45Ca2+ uptake. To this end, stably transfected Madin-Darby Canine Kidney 
type-I epithelial (MDCK) cell lines were generated that express TRPV5 and CaBP28K or 
CaBP28KΔEF. Total expression of EGFP-TRPV5 remained constant in the MDCK-TRPV5, 
MDCK-TRPV5-CaBP28K and MDCK-TRPV5-CaBP28KΔEF cell lines (Fig. 5A). Furthermore, 
immunoblot analysis demonstrated the integrity of the EGFP-TRPV5 fusion-protein by the 
protein band of ~100 kDa. In addition, flow cytometry analysis of the EGFP-signal was 
employed to investigate the percentage of EGFP-TRPV5-positive cells. Importantly, >98% of 
the cells expressed EGFP-TRPV5, indicating that virtually all cells contribute to 45Ca2+ uptake 
in the MDCK-TRPV5, MDCK-TRPV5-CaBP28K and MDCK-TRPV5-CaBP28KΔEF cell lines 
(Fig. 5B). These results demonstrated that differences in 45Ca2+ uptake are not due to 
alterations in TRPV5 expression. Stable expression of EGFP-TRPV5 in MDCK cells 
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(MDCK-TRPV5) resulted in a ~6-fold increase of ruthenium red-sensitive 45Ca2+ uptake 
compared to empty vector-transfected cells (mock). Stable expression of CaBP28K in these 
cells (MDCK-TRPV5-CaBP28K) (Fig. 5C) further increased the ruthenium red-sensitive 
45Ca2+ uptake by ~2-fold as compared to EGFP-TRPV5 and empty vector-expressing 
(MDCK-TRPV5-mock) cells (Fig. 5D). Stable expression of CaBP28KΔEF in EGFP-TRPV5-
expressing cells (MDCK-TRPV5-CaBP28KΔEF) did not result in an increase of ruthenium 
red-sensitive 45Ca2+ uptake, indicating the importance of the Ca2+-binding EF-hand motifs in 
CaBP28K. 
Fig. 5.  Role of 
CaBP28K in TRPV5-
mediated 45Ca2+ uptake  
EGFP-TRPV5 and 
CaBP28K, CaBP28KΔEF or 
empty vector were stably 
expressed in MDCK cells. 
The expression level of 
EGFP-tagged TRPV5 as 
determined using rabbit 
anti-GFP antibody (A) or 
flow cytometry analysis 
(B; black peaks) reveal 
that the expression of 
TRPV5 in empty vector 
and CaBP28K expressing 
cells equal. The open peak 
in the three panels 
indicates background 
fluorescence in non-
transfected cells. The two 
TRPV5 immuno-positive 
bands correspond to the 
core (lower) and 
glycosylated forms of 
EGFP-TRPV5. (C) The stable expression of CaBP28K and CaBP28KΔEF in MDCK or MDCK EGFP-
TRPV5-expressing cells was verified using anti-CaBP28K antibodies. (D) Ruthenium red-sensitive 
45Ca2+ uptake of MDCK cells stably expressing both (black bars) TRPV5 and CaBP28K, CaBP28KΔEF or 
empty vector and MDCK cells stably expressing (open bars) CaBP28K, CaBP28KΔEF or empty vector. 
Significant differences in 45Ca2+ uptake are indicated by an asterisk (p<0.05). 
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CaBP28K has no effect on the current characteristics of TRPV5 
Since CaBP28K binds to TRPV5 and posses the ability to regulate downstream cellular 
processes, CaBP28K could directly affect channel activity. The effect of CaBP28K on the 
electrophysiological characteristics of TRPV5 was investigated by controlling [Ca2+]i in a 
spatially uniform manner using uncaging of Ca2+ from the photolysable Ca2+-chelator DMNP-
EDTA. TRPV5 activity in the presence and absence of CaBP28K and CaBP28K∆EF was 
correlated to [Ca2+]i (see supplementary data Fig. S1 for additional information). Regulating 
[Ca2+]i enabled us to study the effect of CaBP28K on the characteristics of TRPV5 without the 
influence of Ca2+ buffering by CaBP28K. Neither CaBP28K nor CaBP28KΔEF modulated the 
Ca2+ sensitivity of TRPV5 when [Ca2+]i was gradually increased from 100 to 600 nM (Fig. 6A 
and B).  
 
 
Fig. 6. Direct Influence of CaBP28K on the characteristics of TRPV5 
(A) Dose-response curves showing the effect of an increasing [Ca2+]i on the normalized Na+ 
inward current in divalent-free extracellular solution (DVF) of TRPV5 (O, n=9), TRPV5 and 
CaBP28K (+, n=11) or TRPV5 and CaBP28KΔEF (Δ, n=12) expressing cells. (B) Averaged IC50 for 
each of the transfections and recordings shown in panel A.    
 
CaBP28K∆EF dominant negatively inhibits transcellular Ca2+ transport in primary 
rabbit CNT/CCD cultures 
If the translocation of CaBP28K towards and subsequent interaction with TRPV5 is of any 
physiological relevance, disruption of the CaBP28K-TRPV5 association will result in a 
decreased Ca2+ buffering at the entry gate and coherent impairment of transcellular Ca2+ 
transport. This hypothesis was experimentally evaluated by using the lentiviral expression 
system to express EGFP-CaBP28K∆EF in primary rabbit CNT/CCD cultures and subsequent 
Ca2+ transport measurements across these infected confluent cell monolayers. Viral expression 
of EGFP-CaBP28K∆EF resulted in a dominant negative effect on transcellular Ca2+ transport 
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across primary CNT/CCD cultures (Fig. 7A). As compared to non-infected cultures, viral 
expression of only EGFP did not influence transcellular Ca2+ transport. Viral infection with 
efficiencies of ~ 50% (Fig. S2) did not affect the transepithelial resistance in any of the 
conditions tested, confirming the integrity of the CNT/CCD monolayer and (data not shown). 
Importantly, only half of the CNT/CCD cells expressed the CaBP28K∆EF mutant indicating 
that the observed inhibition is significantly underestimated. To investigate whether 
CaBP28K∆EF inhibited TRPV5-mediated transcellular Ca2+ transport in primary CNT/CCD 
cultures the potent TRPV5 channel blocker ruthenium red was included during the Ca2+ 
transport assay. Addition of 10 μM ruthenium red to the apical side of the cell monolayer 
abolished transcellular Ca2+ transport in the absence or presence of exogenous CaBP28KΔEF 
(Fig. 7A). 
Next, we measured expression of wild-type CaBP28K and EGFP-CaBP28K∆EF in these primary 
renal cell cultures (Fig. 7B). No differences in wild-type CaBP28K expression was detected 
between EGFP and EGFP-CaBP28K∆EF-infected cells as compared to the endogenously 
expressed Na,K-ATPase, indicating that the observed effects were not due to down-regulation 
of endogenous CaBP28K.  
Fig. 7. Effect of CaBP28K∆EF on 
transcellular Ca2+ transport 
(A) Effect of lentivirus-mediated 
overexpression of GFP and GFP-
CaBP28K∆EF on transcellular Ca2+ 
transport in primary rabbit CNT/CCD 
cells. Averaged transcellular Ca2+ 
transport for each infection, expressed 
as mean ± SEM. 10 μM ruthenium red 
was added to the apical side of the cell 
monolayer during the transport assay to 
estimate the TRPV5-mediated Ca2+ 
transport. Significant differences as 
compared to mock infected cells are 
indicated by an asterisk (p<0.05) (B) 
The expression of GFP and GFP-
CaBP28K∆EF (upper panel) was 
assessed with immunoblotting using 
rabbit anti-GFP antibody and the 
expression of endogenous CaBP28K was 
checked with monoclonal anti-CaBP28K 
antibody that does not recognize GFP-CaBP28K∆EF (lower panel). To check for equal loading the 
expression of the endogenously expressed Na,K-ATPase was measured (lower panel). 
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Discussion  
The present study identified CaBP28K as a dynamic Ca2+ buffer facilitating TRPV5-mediated 
Ca2+ transport by buffering [Ca2+] in close vicinity to the channel mouth. This conclusion is 
based on the following observations. First, CaBP28K translocates towards TRPV5-containing 
plasma membranes upon a decrease in [Ca2+]i. Second, CaBP28K directly associates with 
TRPV5 at a low [Ca2+]i. Third, expression of CaBP28K in TRPV5-expressing cells increases 
TRPV5-mediated Ca2+ influx, while inactivation of the EF-hand motifs in CaBP28K abolishes 
this stimulatory effect. Fourth, the Ca2+-insensitive CaBP28K mutant (CaBP28K∆EF) competes 
with wild-type CaBP28K for TRPV5 association resulting in a dominant negative inhibition of 
transepithelial Ca2+ transport in primary rabbit CNT/CCD cultures. 
In the past, CaBP28K was identified as a high capacity Ca2+ buffer with Ca2+ affinities fitting 
the classical properties of a Ca2+ buffer. However, sequential Ca2+ binding and conformational 
changes suggested that CaBP28K can act as a Ca2+ sensor controlling downstream cellular 
processes (24, 25, 39, 40). CaBP28K is highly expressed in Ca2+-transporting epithelia where it 
co-localizes with TRPV5. This study reveals that the expression of CaBP28K and TRPV5 are 
positively correlated, suggesting a fundamental role of CaBP28K in the regulation of TRPV5 
activity. In various studies exploring the regulatory role of the calciotropic hormones 
including vitamin D, estrogens, parathyroid hormone and dietary Ca2+, we observed the 
concomitant regulation of TRPV5 and CaBP28K in kidney (10). Likewise, genetic ablation of 
TRPV5 in mice resulted in a decreased expression of CaBP28K (41). Blockage of TRPV5 by 
ruthenium red eliminated parathyroid hormone-stimulated transepithelial Ca2+ transport in 
primary CNT/CCD cultures and simultaneously decreased the expression of CaBP28K. The 
magnitude of the Ca2+ influx through TRPV5 predominantly controlled the expression of 
CaBP28K (16). Interestingly, Arnold and Heintz identified a 40-bp element in the CaBP28K 
promoter which forms a cell-specific and Ca2+-sensitive transcriptional regulatory mechanism 
that may play a key role in setting the Ca2+ buffering capacity of Purkinje cells (42). Together, 
these data assure adequate CaBP28K expression to facilitate sufficient buffering of the TRPV5-
mediated Ca2+ influx.  
Here, we demonstrated that in Ca2+-transporting epithelia, CaBP28K also directly associates 
with TRPV5 in a Ca2+-dependent fashion. In line with this interaction, in kidney cells 
CaBP28K is found in the cytosol as well as along the apical membrane, where it co-localizes 
with TRPV5. This apical localization of CaBP28K is significantly disturbed in kidney cells of 
TRPV5-/- mice where CaBP28K is distributed evenly throughout the cytosol. In addition, both 
static and dynamic measurements using cells co-expressing CaBP28K and TRPV5 revealed 
that CaBP28K accumulates at the plasma membrane when [Ca2+]i is low. Importantly, this 
translocation only occurs in the presence of TRPV5. Taken together, these data suggest that 
CaBP28K possesses the ability to specifically target to TRPV5-expressing plasma membranes 
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at a low [Ca2+]i. CaBP28K translocation is supported by previous findings showing that a 
fraction of CaBP28K specifically associates with particular subcellular domains (39, 43) and 
that CaBP28K redistributes after Ca2+ sensing (44). Further evidence for targeted CaBP28K 
mobility has been provided by Schmidt and coworkers who demonstrated a specific 
association of CaBP28K with membrane associated inositol-1,4,5-triphosphate, but not with 
cytosolic inositol-1,4,5-triphosphate (22). 
In addition to CaBP28K other Ca2+-binding proteins were found to associate with and affect the 
activity of TRPV5 via distinct mechanisms. Functional expression of TRPV5 requires binding 
of the S100A10-annexin 2 complex, whereas 80K-H acts as a Ca2+ sensor regulating TRPV5 
activity (45, 46). Regulation by the ubiquitous calmodulin, however, seems to be restricted to 
the closely related family member TRPV6 (28). This multifaceted regulation of TRPV5 
enables a strict control of transcellular Ca2+ transport at the apical entry gate. It is, however, 
not clear yet how these Ca2+ binding proteins integrate in this complex regulatory network to 
balance TRPV5-mediated Ca2+ influx. 
Co-expression of CaBP28K in TRPV5-expressing HEK293 cells increased the Ca2+ uptake, 
while inactivation of the EF-hand motifs in CaBP28K blocked this stimulatory effect. 
CaBP28K∆EF was still capable to bind TRPV5, although the Ca2+-dependency of the 
association was abolished. This implies that binding of CaBP28K to TRPV5 does not directly 
affect the physiological properties of TRPV5, otherwise the presence of Ca2+-insensitive 
CaBP28K would also lead to an increase in TRPV5-mediated Ca2+ uptake. Furthermore, this 
emphasizes the importance of the EF-hand motifs in CaBP28K. The activity of TRPV5 is 
tightly regulated by [Ca2+]i in such a way that Ca2+ entering through TRPV5 exerts a negative 
feedback on channel activity (3). The present data showing Ca2+-dependent association of 
TRPV5 and CaBP28K and an elevated 45Ca2+ uptake in TRPV5 and CaBP28K co-expressing 
cells, suggests that the increase in 45Ca2+ uptake is due to CaBP28K Ca2+ buffering in close 
vicinity of the channel mouth. The activity of TRPV5 in the presence of CaBP28K or 
CaBP28K∆EF was measured at various, experimentally controlled, [Ca2+]i to further investigate 
whether CaBP28K directly affects TRPV5 current characteristics. In response to a gradual 
increase of [Ca2+]i by UV-induced uncaging of Ca2+, the activity of TRPV5 decreased, 
revealing the negative feedback of Ca2+ on channel activity. Co-expression of CaBP28K or 
CaBP28KΔEF did not change these observations indicating that CaBP28K does not directly 
affect channel inactivation characteristics at controlled [Ca2+]i. Thus, CaBP28K associates with 
TRPV5 and stimulates TRPV5-mediated Ca2+-influx by increasing the buffering of [Ca2+] in 
close proximity to the channel mouth. This dynamic buffering and association is a unique 
process in comparison to channel regulation by other Ca2+-binding proteins like calmodulin. 
Channel-associated calmodulin senses [Ca2+]i and regulates channel activity by directly 
affecting channel (in)activation (13, 14).  
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Association of CaBP28K with TRPV5 and the consequent local buffering of Ca2+ is essential to 
facilitate the process of transcellular Ca2+-transport, which is evident from the dominant 
negative effect of CaBP28K∆EF on transcellular Ca2+ transport in primary CNT/CCD cultures. 
CaBP28K∆EF lacks Ca2+-buffering capacity, but competes with endogenous CaBP28K for 
binding sites on TRPV5 as revealed by the reduction of CaBP28K and TRPV5 association in 
the presence of CaBP28KΔEF. This will reduce the local buffering of Ca2+ entering the 
epithelial cell via TRPV5, which subsequently results in inactivation of the channel and 
reduced transcellular transport rates. Note that addition of ruthenium red abolished 
transcellular Ca2+ transport in the absence or presence of exogenous CaBP28KΔEF. Thus, these 
findings demonstrate that CaBP28K regulates TRPV5-mediated Ca2+-transport.  
Our previous findings that during transcellular Ca2+ transport in renal epithelial cells no 
apparent changes in the overall [Ca2+]i could be detected (47) indicates that overall Ca2+ 
buffering is efficiently controlled in these cells. These measurements were, however, not 
performed on the subcellular level or in close proximity to the channel mouth where [Ca2+] 
fluctuates during transcellular Ca2+ transport. Opening of epithelial Ca2+ channels likely elicits 
Ca2+ influx of such a large magnitude that spatial distribution of Ca2+ is complicated by 
insufficient local Ca2+ buffers as suggested for voltage-operated Ca2+ channels (48). The 
dominant negative effect of CaBP28K∆EF on transcellular Ca2+ transport in primary 
CNT/CCD cultures, however, revealed that a channel-associated Ca2+ buffer is of utmost 
importance for buffering of the Ca2+ influx through TRPV5.  
Together these findings constitute the first direct evidence that CaBP28K is essential for 
transepithelial Ca2+ transport and elucidates the molecular role of CaBP28K as a dynamic Ca2+ 
buffer. At a low [Ca2+]i, CaBP28K translocates towards the plasma membrane and associates 
with TRPV5. Here, it buffers Ca2+ that enters the cell via TRPV5, thereby counteracting local 
accumulation of cytosolic free Ca2+ and coherent inactivation of the channel. Upon Ca2+-
binding, CaBP28K diffuses from TRPV5 and subsequently facilitates transport of Ca2+ to the 
basolateral membrane. Furthermore, this illustrates an intrinsic mechanism of targeted Ca2+ 
buffering by spatial interactions to subcellular domains where local Ca2+ levels become 
detrimental. Probably similar mechanisms occur in brain, bone, teeth, inner ear, placenta and 
intestine where CaBPs are abundantly expressed and where cells tolerate large fluctuations in 
[Ca2+]i 
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Summary  
The epithelial Ca2+ channel TRPV5 displays Ca2+-dependent negative feedback regulation of 
channel activity, which is essential during transcellular Ca2+ transport to prevent a cellular 
Ca2+ overload. Here, a model of transcellular Ca2+ transport in kidney was developed to 
provide insight in the contribution of calbindin-D28K to TRPV5 activity and transcellular Ca2+ 
transport. The recent finding that calbindin-D28K directly associates with TRPV5 in a Ca2+-
dependent fashion was incorporated to further evaluate our results. Renal Ca2+-transporting 
cells were modeled as a cylinder in which Ca2+ enters at the luminal side via TRPV5 from 
where Ca2+ spreads out evenly. The model indicated that at the luminal side a non-equilibrium 
zone resides were buffering is essential to prevent Ca2+ accumulation. Our model predicts that 
during transcellular Ca2+ transport at least ~100 active TRPV5 channels are present at the cell 
surface of a renal Ca2+-transporting cell. Two possibilities were considered: (i) Ca2+ enters the 
cell and subsequently binds to calbindin-D28K; (ii) Ca2+ passes TRPV5 and is immediately 
bound by TRPV5-associated calbindin-D28K such that no free Ca2+ enters the cell. Our model 
indicates that in Ca2+-transporting cells, calbindin-D28K efficiently regulates the intracellular 
Ca2+ concentration by providing spatial Ca2+-buffering in close proximity to the TRPV5 pore.  
 
Introduction 
Transcellular Ca2+ transport in kidney is of fundamental importance to balance the net amount 
of Ca2+ excretion from the body by reabsorbing Ca2+ from the pro-urine. In renal Ca2+-
transporting cells the Ca2+ influx is mediated by the epithelial Ca2+ channel TRPV5, which is 
a distinct member of the Transient Receptor Potential (TRP) family of ion channels (1). In 
these cells, TRPV5 operates as gate facilitating cellular Ca2+ entry due to a steep inward 
electrochemical gradient across the luminal membrane (2). The activity of this highly Ca2+-
selective channel is tightly regulated by the intracellular Ca2+ concentration ([Ca2+]i) in close 
vicinity to the channel mouth (3). Using electrophysiological recordings in inside-out patches 
a half-maximal inhibition of TRPV5 currents occurred at ~200 nM Ca2+ (4). Thus, adequate 
intracellular buffering of Ca2+ is essential for a continuous influx of Ca2+ through this channel. 
In addition, during high rates of transcellular Ca2+ transport strict regulation of [Ca2+]i is 
crucial in protecting the cell against cytotoxic high levels of Ca2+ (5). Buffering of Ca2+ by 
specialized Ca2+-binding proteins (CaBPs) is, therefore, required (6-8). Ca2+ entering at the 
luminal side of the cell will diffuse as Ca2+ bound to CaBP to the basolateral side, thereby not 
affecting other intracellular processes. Subsequently, the Na+/Ca2+-exchanger (NCX1) and/or 
the plasma membrane ATPase (PMCA1b) extrude Ca2+ into the extracellular compartment. 
CaBPs have been implicated in facilitated diffusion of Ca2+ from the luminal membrane to the 
basolateral surface by increasing the diffusional range of Ca2+ (9-11). In kidney, calbindin-
D28K (CaBP28K) is contributing to this process, while calbindin-D9K fulfills this role in the 
80
Chapter V 
 
intestine. In the latter organ a comparable mechanism of transcellular Ca2+ transport operates 
as in kidney. Likewise, the intestinal Ca2+ transport machinery consists of TRPV6 as the 
luminal entry channel, calbindin-D9K (CaBP9K) for intracellular Ca2+ handling and PMCA1b 
to extrude Ca2+ basolaterally.  
Negative feedback regulation of channel activity by [Ca2+]i is a common mechanism occurring 
in a diverse range of ion channels including voltage and non-voltage-operated ion channels 
(12, 13). In general, these channels inactivate upon a local rise in [Ca2+]i in close proximity to 
the channel pore. One could envisage that upon opening of Ca2+ channels a high concentration 
of Ca2+ will be generated. For voltage-operated Ca2+ channels, it has been demonstrated that 
opening of these channels elicits a large Ca2+ influx that generates a micro-domain of Ca2+ 
(14). By modifying the spatial and temporal aspects of [Ca2+]i, Ca2+-binding proteins might 
influence the Ca2+-dependent activity of these ion channels (15). Indeed, CaBP28K was found 
to affect the activity of L-type voltage-operated channels contributing to the Ca2+-dependent 
channel activity by increasing the Ca2+ sensitivity of the channel (16). Recently, we showed 
that CaBP28K dynamically controls TRPV5-mediated Ca2+ influx (17). At a low [Ca2+]i 
CaBP28K translocates from a cytosolic compartment to the plasma membrane and associates 
with TRPV5. Here, CaBP28K locally buffers the flux of Ca2+ entering the cell via TRPV5 
thereby preventing inactivation of the channel.  
Primary cultures of rabbit connecting tubule (CNT) and cortical collecting duct (CCD) are a 
well-defined model for TRPV5-mediated transcellular Ca2+ transport endogenously 
expressing the complete transport machinery (2). These cultures are a valid representation of 
transcellular Ca2+ transport in kidney displaying Ca2+ fluxes comparable to those in vivo and 
sensitive to regulation by calciotropic hormones and other factors that determine the Ca2+ 
balance (18). Previously, Ca2+ measurements in these cultures revealed that no apparent 
changes in [Ca2+]i occurred during transcellular Ca2+ transport suggesting that overall Ca2+ 
buffering is efficiently controlled in these cells (19). These measurements were, however, not 
performed at the subcellular level or in close proximity to the channel mouth where Ca2+ 
levels could strongly fluctuate because opening of TRPV5 might generate a micro domain of 
Ca2+ at the channel mouth. Thus, cellular buffering is essential and potentially well regulated 
during transcellular Ca2+ transport across primary cultures of CNT/CCD cells. 
The aim of the present study was to evaluate in detail the contribution of CaBP28K to 
transcellular Ca2+ transport in kidney, including the recent findings of CaBP28K-TRPV5 
association. To this end, mathematical modeling of transcellular Ca2+ transport in primary 
rabbit cultures of CNT/CCD, as a cell system for Ca2+ reabsorption in vivo, was employed. 
Our model predicts the physiological importance of CaBP28K as a localized Ca2+ buffer 
providing efficient intracellular Ca2+ handling to maintain high levels of transcellular Ca2+ 
transport.   
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Glossary 
A  Average apical cell surface area of primary CNT/CCD cells. 
CCaBP  Total CaBP28K concentration 
Ca·CaBP  Concentration of Ca2+ bound to CaBP28K 
B0, B1   Integration constants 
DCa   Diffusion constant of Ca2+ 
DCaBP  Diffusion constant of CaBP28K 
J  Average, experimentally determined, Ca2+ flux over primary 
CNT/CCD cultures 
J0(), J1(), J2() Zeroth, first and second Bessel functions of the first kind, 
respectively 
Kd  Equilibrium constant 
kon, koff  Ca2+ binding constants of CaBP28K 
L  Diffusion distance between apical and basolateral membrane 
N  Number of TRPV5 channels 
p(...)  Port function 
r   Cylindrical coordinate (radius) 
rp   TRPV5 pore size 
R   Radius of the pore supply area (modeled as cylinder) 
z   Cylindrical coordinate (length) 
ΔCapore   Local Ca2+ increase at the pore due to the small pore size 
ΔCa·CaBPpore  Local Ca·CaBP increase at the pore due to the small pore size 
λAΙ  Characteristic distance of non-equilibrium zone at the apical side for 
model  I 
λAΙΙ  Characteristic distance of non-equilibrium zone at the apical side for 
model  II 
λB  Characteristic distance of non-equilibrium zone at the basolateral side 
ξi  Zero points of the first Bessel function 
 
Theoretical model 
To determine mathematically intracellular Ca2+ handling during transcellular Ca2+ transport, a 
model was considered where Ca2+ enters the cell at the apical side through TRPV5 with a 
limited pore size rp. Ca2+ that enters the cell via TRPV5 spreads out evenly over a circular 
region of radius R towards the basolateral side where we considered Ca2+ excretion (i.e. via 
NCX1 and PMCA1b) to be unrestricted (Fig. 1). All these areas, πR2, together cover the total 
apical cell surface A. 
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Fig. 1. Model of transcellular Ca2+ transport 
During mathematical modeling of 
transcellular Ca2+ transport from the apical to 
the basolateral side, a situation was 
considered where Ca2+ enters the cell at the 
apical side (z=0) through TRPV5 with a 
limited pore size rp. Ca2+ that enters the cell 
via TRPV5 spreads out evenly over a 
circular region of radius R towards the 
basolateral side where at z=L we considered 
Ca2+ excretion (i.e., via NCX1 and 
PMCA1b) to be unrestricted. 
 
First, a situation disregarding any Ca2+ binding and facilitated diffusion by CaBP28K was 
considered, as a basic step for the later, more realistic, mathematical treatment incorporating 
Ca2+ binding to CaBP28K and localized CaBP28K buffering by TRPV5 association. In this case, 
there is only free Ca2+ diffusion in the cell, and the steady state diffusion equation for [Ca2+] 
can be analytically solved in terms of Bessel functions of the cylindrical coordinates r, z*): 
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Where B0 is a constant to be determined for the specific calculations (see results), J is the 
average Ca2+ flux, DCa is the diffusion coefficient of free Ca2+, J0(), J1() and J2() are the 
zeroth, first and second Bessel functions of the first kind respectively, and ξi are the zero 
points of the first Bessel function, J1(ξi)= 0. The solution is given in terms of a dimensionless 
'port function' p(...) expressing the influence of the small TRPV5 pore size rp against the 
‘supply range’ R. For the Ca2+ flux J we incorporated the average Ca2+ flux over primary 
rabbit CNT/CCD cultures as experimentally determined (100 nmol·h–1·cm–2) (Fig. 2A) and 
the diffusion constant of Ca2+ is 0.8*10-5 cm2/s (11). Although Bessel functions are 
mathematically well known, their values must be found from specialized programs or 
tabulated data impeding a direct insight in the result for the port influence p(...). However, an 
approximate solution can be found for the TRPV5 location r=z=0, which allows an estimation 
of the effect of the TRPV5 pore size rp on the local Ca2+ concentration: 
                                                 
*) See supplementary information for details of the mathematical solutions 
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Where ΔCapore is the increase due to the small pore size. To obtain insight in the pore 
architecture, a pore diameter of 5.4 Å was estimated from permeation studies for TRPV6 (20). 
Because the pore domains of TRPV5 and TRPV6 are highly homologous (2), we assumed the 
pore size of TRPV5 to be equal to that of TRPV6. If there are N TRPV5 channels over an 
area A, this implies an average spreading area πR2= A/N for each TRPV5 and the increase for 
the average TRPV5 is calculated as: 
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The average apical surface of primary cultures of rabbit CCD/CNT cells, indicative for renal 
Ca2+-transporting cells in vivo, was determined as ~20 μm2 using confocal imaging of GFP-
expressing cells as described previously (17) (Fig 2B).  
Next, the effect of Ca2+ binding to CaBP28K was considered. In this case, there is additional 
intracellular Ca2+ transport by a diffusing Ca·CaBP complex (facilitated diffusion) such that 
the solution for the summed concentrations reads: 
 [ ] [ ] ( )zrRrRpJJzBCaBPCaDCaD pCaBPCa ,;,+−=⋅++ 12  (4) 
Where again B1 is a constant to be determined for the specific calculations (see results), DCaBP 
is the diffusion coefficient of CaBP28K and p(...) is the same function p(...) of eq.(1). The 
diffusion coefficient of CaBP9K (9 kDa) is determined as 0.12*10-5 cm2/s (11). Based on the 
relation between mass and diffusion coefficient, the diffusion coefficient for CaBP28K (28 
kDa) is considered as 0.082*10-5 cm2/s. Following the approach of Hoofd and Kreuzer (21), 
the solution for this facilitated diffusion can be divided into three parts to solve the individual 
concentrations of Ca2+ and Ca·CaBP: 
• A luminal side where all Ca2+ enters the cell via TRPV5; 
• A middle part where both species concentrations (i.e., free Ca2+ and Ca2+ bound to 
CaBP28K) are close to chemical equilibrium both contributing to the total Ca2+ flux; 
• A basolateral part where all Ca2+ that enters the cell via TRPV5 is transported across the 
basolateral membrane by NCX1 and PMCA1b. 
 
At this point, we will discern between two possible mechanisms for Ca2+ entry: 
• Model I where Ca2+ enters the cell and later binds to CaBP28K for facilitated diffusion to 
the basolateral membrane; 
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• Model II where, upon entering the cell, Ca2+ directly binds to CaBP28K (i.e., no free Ca2+ 
enters at the apical side but is immediately bound by CaBP28K) before subsequent 
facilitated diffusion to the basolateral side. Direct binding of Ca2+ to CaBP28K rather then 
free Ca2+-diffusing before binding CaBP28K was included to further investigate the 
findings that CaBP28K directly associates with TRPV5 at decreased intracellular Ca2+ 
concentrations (17). 
For both models, in the middle part the equilibrium relation between Ca2+ and CaBP28K is: 
 [ ] [ ][ ]+
+
+
=⋅ 2
d
2
CaBP CaK
CaC4CaBPCa  (5) 
Where CCaBP is the total CaBP28K concentration. Each CaBP28K molecule contains 4 functional 
binding sites (22), and Kd is the average equilibrium constant. The concentration of CaBP28K 
in Ca2+-transporting cells in kidney and primary cultures of rabbit CNT/CCD is unknown and 
variable because of genomic regulation by the calciotropic hormones that determine the Ca2+ 
balance (23). However, Feher et al. estimated the concentration of CaBP28K in intestine based 
upon the concentration of CaBP28K in supernatants from chicken duodenal homogenates (11). 
According to the same authors, the Kd of CaBP28K is 200 nM. The concentration of CaBP28K in 
duodenal homogenates in chickens maintained on a normal diet is ~250 μg/ml which 
translates into ~60 μM, water by weight and given the mucosa is ~70% cytosol. This value is, 
however, a clear underestimate because CaBP28K is not expressed in all duodenal cells, but 
merely in enterocytes that results in an overestimation of the volume. Moreover, the 
expression of CaBP28K in kidney is much higher then the expression in duodenum (24). Since 
no other values for calbindin concentrations in Ca2+-transporting cells are available and 
primary cultures of rabbit CNT/CCD cells were maintained under non-stimulated conditions 
the data from this previous study was used 
 
Equation (5) is sufficient to solve for the individual concentrations in the middle region, 
however, in the other regions there is no such equilibrium. In the basolateral region where all 
Ca2+ is transported across the basolateral membrane the relation can be calculated as (21): 
 [ ] [ ][ ] ⎟⎟⎠
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Where L is the distance between the apical and basolateral membrane which we estimated to 
be ~20 μm based on confocal laser scanning microscopy of primary rabbit CNT/CCD 
cultures, indicative for renal Ca2+-transporting cells in vivo. The characteristic distance of the 
non-equilibrium zone at the basolateral side (λB) is given by: 
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Where kon and koff are the Ca2+ binding constants for CaBP28K. CaBP28K was found to bind 
Ca2+ in at least two distinct kinetic patterns, one arising from high Ca2+ affinity sites that bind 
Ca2+ with a kon of ~1*107 M-1s-1 and another with lower affinity of ~8*107 M-1s-1 (25). For 
simplification a single averaged kon (5*107 M-1s-1) was used for modeling. Since Kd= koff/kon, 
using the above Kd we find koff= 10 s-1. 
Equation (7) implies that there is a non-equilibrium zone characterized by the distance λB of 
the equation. The solution can be solved in this form because the flux at the basolateral side is 
considered uniform, independent of the radial coordinate r. 
For the apical side, we can follow the same approach of Hoofd and Kreuzer to calculate a 
characteristic distance λA. However, we have to discern between the two models I and II, 
leading to different characteristic distances λAΙ and λAΙΙ, respectively. For model I, the λAΙ is 
similar to that of equation (7):  
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Now for the [Ca·CaBP] at the luminal side: For model II, the approach has to be modified 
accordingly, which leads to a characteristic distance λAΙΙ: 
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However, the Ca2+ flux is non-uniform and highest at the TRPV5 pore, r < rp, so that no 
mathematical solution for the concentrations can be found for this region. Nonetheless, an 
estimate can be made using the characteristic distance formulas since: 
- Down to the apical zone, z≈λAΙ or λAΙΙ, the solution of the middle, equilibrium, zone can 
be followed allowing estimates of [Ca2+] and [Ca·CaBP] at z=λAΙ or λAΙΙ. 
- In the apical zone for model I, there are little changes in [Ca·CaBP] since the flux 
towards the apical membrane is zero (CaBP28K cannot pass through the membrane and 
does not associate with TRPV5). So, the [Ca·CaBP] at z=λAΙ can be assumed to be the 
[Ca·CaBP] in the apical zone. 
- In the apical zone for model II, there are little changes in [Ca2+] since the flux towards 
the apical membrane is zero and CaBP28K immediately buffers the Ca2+  (see above). So, 
the [Ca2+] at z=λAΙΙ can be assumed to be the [Ca2+] in the apical zone. 
- In turn, knowing either [Ca·CaBP] (model I) or [Ca2+] (model II), the other species 
concentration [Ca2+] or [Ca·CaBP] follows from equation (4). 
Consequently, for model I, the 'port function' p(…) is present only in [Ca2+] and its peak value 
can be calculated using equations (2) and (3) with an adapted value for B0: B0' = (B1–
 [Ca·CaBP](0,0))/DCaBP according to equation (4). For model II, there is no peak in [Ca2+] but 
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a peak in [Ca·CaBP] because CaBP28K binds TRPV5 determining that equations (2), (3) have 
to be modified accordingly: 
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Results 
 
Cell model for transcellular Ca2+ transport 
TRPV5 was originally cloned from primary cultures of rabbit CNT/CCD which is a well 
studied model for transcellular Ca2+ transport in kidney (26). These primary cultures were 
used to obtain experimentally derived Ca2+ transport rates from the apical towards the 
basolateral compartment as described previous (17). In addition, 10 μM ruthenium red, a 
potent TRPV5 blocker, was added during the transport assay to establish TRPV5-mediated 
transcellular Ca2+ transport. These cultures displayed a net ruthenium red-sensitive Ca2+ flux 
from apical to the basolateral side of ~100 nmol/h/cm2 (Fig. 2A) and consisted of ~1*106 
cells/cm2 as determined after transcellular Ca2+ transport measurements. By confocal imaging 
of GFP-expressing primary rabbit CNT/CCD cultures (Fig. 2A) the luminal surface of a 
single cell was estimated to be ~20 µm2 and the distance between apical and basolateral 
membrane ~20 µm (17).  
Fig. 2. Transcellular Ca2+ 
transport across primary 
cultures of rabbit CNT/CCD 
(A) Transcellular Ca2+ transport 
across primary cultures of rabbit 
CNT/CCD is expressed as mean 
± SEM (open bar). 10 µM 
ruthenium red was added to the 
apical side of the cell monolayer 
during the transport 
measurements to estimate TRPV5-mediated Ca2+ transport (closed bar). (B) Confocal microscopy 
image of these cultures expressing EGFP grown to confluence on filter supports. Based on these 
images an average apical cell surface of ~20 µm2 and apical to basolateral distance of ~20 µm was 
estimated.    
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Recently, we demonstrated a direct interaction between TRPV5 and CaBP28K (17). To further 
investigate the implication of these data and to establish the role of CaBP28K in intracellular 
Ca2+ handling, transcellular Ca2+ transport across primary cultures of rabbit CNT/CCD was 
modeled primarily focusing on intracellular Ca2+ handling. In our calculations [Ca2+] at the 
basolateral excretion site of the cell was assumed to be zero such that Ca2+ entering the cell is 
transported unrestrictedly across the basolateral membrane (i.e. extruded via NCX1 and 
PMCA1b). In this case the integration can be calculated by B0 = J.L/DCa according to 
equation (1) (since all the other terms are close to zero at z=L). Similarly, B1 can be 
calculated using equation (4). Using the experimentally determined Ca2+ flux and cell size 
[Ca2+] bound to CaBP28K ([Ca·CaBP]) and [Ca2+] not buffered by CaBP28K were calculated to 
obtain an overall estimate of the [Ca2+]i in primary cultures of rabbit CNT/CCD cells (Fig. 
3A). The characteristic size of the basolateral zone λB, as calculated using equation (7) is 0.32 
µm. This is rather small, but its influence is large as the local [Ca2+] rises to 0.15 µM in this 
small zone. This in turn implies that [Ca·CaBP] is ~91 µM (Fig. 3B). For the apical zone, the 
characteristic sizes are λAΙ= 0.43 µm for model I, and λAΙΙ= 0.43 µm for model II according to 
equations (8) and (9), respectively.  
 
Fig. 3.  Intracellular Ca2+ profile during transcellular Ca2+ transport  
Concentration profiles of free Ca2+ (A) and Ca2+ bound to CaBP28K (B) in the middle and 
basolateral zones for both models I and II. Basolateral Ca2+ transport (via NCX1 and PMCA1b) 
was considered to be unrestricted such that all Ca2+ entering the cell is excreted at the basolateral 
side at z=20 µm. 
 
Amount of active TRPV5 channels at the luminal plasma membrane 
Overall luminal Ca2+ influx is the net result of the amount of channels at the plasma 
membrane and their single channel activity. Single channel conductance in relation to the total 
membrane transport capacity is a reliable measurement for the number of channels at the cell 
surface. In vivo TRPV5 conductance is, however, unknown. This makes the estimation of the 
number of TRPV5 channels contributing to the overall Ca2+ transport in primary cultures of 
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rabbit CNT/CCD not possible via the above-described approach. Therefore, our model was 
employed to estimate the amount of TRPV5 channels during the process of transcellular Ca2+ 
transport. We postulate that with a given Ca2+ flux the local [Ca2+] in close vicinity to the 
TRPV5 pore is determined by the number of TRPV5 channels in the luminal plasma 
membrane. This relation is given for the apical domain (r=z=0) according to equations (1) to 
(3) for model I (Fig. 4). Thus, indicating that the more TRPV5 channels are active at the 
luminal membrane the lower the [Ca2+] in the TRPV5 pore will be since the flux is divided 
over the total number of channels. 
 
Fig. 4. Relation of apical [Ca2+] and number of channels at the cell surface 
Local Ca2+ increase ΔCapore (A) and [Ca2+]  at the TRPV5 location r=z=0 (B), according to 
equations (3) (approximation; points in panel A) and equation (2) (using Bessel functions; line in 
both panels) plotted against the number of TRPV5 channels in the apical plasma membrane, N.  
Difference between approximation of equation (3) and exact Bessel calculation via equations (1), 
(2) are negligible.  
 
CaBP28K associates with TRPV5 and thereby prevents channel inactivation because Ca2+ that 
enters the cell via TRPV5 is buffered by CaBP28K (17). To estimate a minimal number of 
TRPV5 channels contributing to the determined Ca2+ flux we assumed that CaBP28K binds all 
Ca2+ entering the cell and that all channels inactivate upon Ca2+ saturation of CaBP28K. Thus, 
the total CaBP28K concentration is a measure for the amount of active channels at the cell 
surface. To this end, the local Ca·CaBP increase (ΔCa·CaBPpore) and [Ca2+] bound to CaBP28K 
([Ca·CaBP]) at the apical membrane (r=z=0) were plotted against the number of TRPV5 
channels at the apical membrane (N) (Fig. 5). Importantly, since one CaBP28K molecule is 
capable of binding four Ca2+ ions (22), [Ca·CaBP] cannot exceed the maximum binding 
capacity of CaBP28K which is 4 times the total CaBP28K concentration CCaBP (indicated in both 
figures with broken lines). The point of intersection in the figures indicates the minimal 
number of TRPV5 channels at the plasma membrane (i.e. ~108). This in turn implies that 
each TRPV5 channel covers a ‘supply area’ (πR2) of 20/108 µm2 translating into R = 0.24 µm. 
Knowing the total Ca2+ flux per surface area and the size of the apical cell surface, the 
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estimation of the number of channels during renal transcellular Ca2+ transport further 
indicates that the single channel Ca2+ flux of TRPV5 is in the order of 5*10-11 nmol/s 
suggesting that ~3*104 Ca2+ ions pass TRPV5 per second (see supplemental data for a detailed 
description). Thus during renal Ca2+ reabsorption at least ~100 TRPV5 channels, with a single 
channel activity in the order of 3*104 Ca2+ ions per second, are in the plasma membrane of a 
single cell contributing to the Ca2+ reabsorption.  
 
Fig. 5. Determination of the number of TRPV5 channels at the apical membrane of primary 
cultures of rabbit CNT/CCD  
Local Ca·CaBP increase ΔCa·CaBPpore (A) and bound [Ca2+], [Ca·CaBP] at the TRPV5 location 
r=z=0 (B) plotted against the number of TRPV5 channels in the apical plasma membrane, N (point 
and closed lines). Open lines represent the maximum Ca2+ binding capacity of CaBP28K, which is 4 
times the CaBP28K concentration CCaBP. Point of intersection indicates the minimum amount of 
TRPV5 channels in the apical plasma membrane during transcellular Ca2+ transport across primary 
cultures of rabbit CNT/CCD (N≈108).  See text for details. 
 
Role of calbindin-D28K in local Ca2+ buffering 
To investigate the influence of CaBP28K on the Ca2+ buffering capacity within the TRPV5 
pore domain the local [Ca2+] was calculated in that area. First, Ca2+ influx without any Ca2+ 
binding and facilitated diffusion by CaBP28K (no Ca2+ buffering) was considered (equation 1, 
with R = 0.2 µm originating from the estimation described above, R = 0.24 µm) (Fig. 6A). 
This resulted in a maximal [Ca2+] in the TRPV5 pore domain and high basal [Ca2+]i of 7.5 
µM. Next, buffering by CaBP28K was considered without CaBP28K binding to TRPV5 (model 
I) (Fig. 6B). As anticipated, and in line with previous modeling studies (11), this resulted in a 
decrease of basal [Ca2+]i to ~0.39 µM. The local [Ca2+] in the TRPV5 pore domain, however, 
still revealed a maximal [Ca2+] as a result of Ca2+ accumulating without sufficient buffering. 
Subsequently, CaBP28K-TRPV5 association was included  (model II) which resulted in the 
disappearance of the local Ca2+ peak within the TRPV5 pore domain demonstrating the 
important contribution of CaBP28K to the local Ca2+-buffering (Fig. 6C).  
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Fig. 6. Role of CaBP28K in maintaining [Ca2+] in the TRPV5 pore  
Representation of the Ca2+ profile during transcellular Ca2+ transport across primary cultures of 
rabbit CNT/CCD in vicinity of the TRPV5 pore (field sizes of 0.03 µm) (A) [Ca2+] in the TRPV5 
pore domain for a supply radius R of 0.2 µm in the absence of CaBP28K (no Ca2+-buffering or 
facilitated diffusion). (B) Free [Ca2+] (upper panel) and [Ca2+] bound to CaBP28K (lower panel) in 
the vicinity of the TRPV5 pore for a supply radius R of 0.2 µm with Ca2+-buffering and facilitated 
diffusion by CaBP28K but without TRPV5-CaBP28K association (model I). (C) Free [Ca2+] (upper 
panel) and [Ca2+] bound to CaBP28K (lower panel) in the vicinity of the TRPV5 pore for a supply 
radius R of 0.2 µm with Ca2+-buffering and facilitated diffusion by CaBP28K and with TRPV5-
CaBP28K association (model II). 
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Discussion  
In the present study, a mathematical model was developed demonstrating the contribution of 
CaBP28K to the process of facilitated transcellular Ca2+ transport occurring in renal Ca2+-
transporting cells. Two versions of the model were developed which may or may not be active 
simultaneously. These models indicate that i) at the luminal side of the epithelial cell a non-
equilibrium zone resides where local buffering is essential to prevent accumulation of Ca2+; ii) 
with a given flux [Ca2+] within the TRPV5 pore domain is determined by the number of 
active TRPV5 channels present at the apical cell surface; iii) typically, a minimum of ~100 
TRPV5 channels are present at the luminal surface of the Ca2+-transporting epithelial cells; iv) 
association of CaBP28K with TRPV5 prevents a local accumulation of Ca2+ within the TRPV5 
pore domain, thereby delaying channel inactivation. 
 
Modeling of transcellular Ca2+ transport in primary cultures of rabbit CNT/CCD reveals that 
at the basolateral membrane the non-equilibrium zone is relatively small, however, its 
influence is high since [Ca2+] within this particular domain increases to ~150 nM (figure 3). 
Basolateral Ca2+ excretion is an interplay between NCX1 and PMCA1b that are both affected 
by [Ca2+] at the basolateral interior of the cell. At least for NCX1 it has been shown that Ca2+ 
directly binds to the exchanger with an apparent affinity of 140-400 nM which initiates the 
excretion of Ca2+ (27). The activity of PMCA1b is highly dependent on the Ca2+ sensor 
calmodulin which in its Ca2+ bound state occupies an auto-inhibitory side, thereby activating 
PMCA1b (28). The non-equilibrium zone at the basolateral membrane is thus of physiological 
importance for activation of NCX1 and PMCA1b to extrude Ca2+ across the basolateral 
membrane. Importantly, in our model the basolateral [Ca2+] is in the physiological range 
essential for NCX1 and PMCA1b activation, substantiating the reliability of our model.        
 
Unlike previous modeling studies that adapted the properties of CaBPs to determine the Ca2+ 
fluxes, our model focuses on the intrinsic mechanism of intracellular Ca2+ handling during 
experimentally derived Ca2+ fluxes. Taking into account the physiological Ca2+ fluxes and cell 
properties our model reveals that at the luminal entry side Ca2+ accumulates when no adequate 
Ca2+ buffering (and facilitated diffusion of Ca2+) is provided. In this case the determined 
[Ca2+]i is beyond the normal physiological range underlining the need for high capacity Ca2+ 
buffering in Ca2+-transporting cells. Importantly, when Ca2+ buffering by CaBP28K is included 
[Ca2+]i is within the physiological range. This is in line with previous models that suggested 
an important role for CaBPs in the facilitated diffusion of Ca2+ and protection against Ca2+ 
toxicity, thereby allowing high levels of transcellular Ca2+ transport (11, 15). The [Ca2+] in the 
TRPV5 pore domain under these conditions, however, will be high because Ca2+ that enters 
the cell via TRPV5 is not immediately buffered. This would result in preliminary TRPV5 
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inactivation and insufficient transport of Ca2+. However, when CaBP28K-TRPV5 association is 
included in the model the [Ca2+] peak within the TRPV5 pore domain is abolished, 
demonstrating the significant effect of localized buffering by CaBP28K. The association of 
TRPV5 and CaBP28K is thus of physiological importance to prevent local accumulation of 
Ca2+ and to facilitate high rates of transcellular Ca2+ transport. Importantly, this accumulation 
is visible in our model and in line with the predominant apical localization of CaBP28K in 
renal Ca2+-transporting cells, and accumulation at the cell surface upon a decrease in [Ca2+]i 
(17). Reflecting the previous results that no apparent changes in the overall [Ca2+]i are 
observed during transcellular Ca2+ transport this supports our findings that CaBP28K prevents 
local accumulation by association with TRPV5. In addition, the essential role of CaBP28K in 
these renal Ca2+-transporting epithelia is underlined by the coordinated expression of CaBP28K 
and TRPV5 (23). The expression of both proteins, along with the other components of 
transcellular Ca2+ transport, is coupled in such a way that whenever the expression of TRPV5 
changes the abundance of the other Ca2+ transport proteins follows accordingly. This 
coordinated control provides for efficient regulation of renal Ca2+ reabsorption (23).      
 
A valuable readout in determining ion channel regulation is the single channel conductance 
that discriminates between regulation of channel activity and cell surface expression. Single 
channel data of TRPV5-mediated Na+ currents is available, while no reliable measurements 
have been made in the presence of extracellular Ca2+ (2). The relation between the number of 
TRPV5 channels and [Ca2+] in the TRPV5 pore with a given influx, however, allows an 
estimate of the number of channels when the local luminal [Ca2+] is known. Our previous 
findings that CaBP28K associates with TRPV5 and acts as a dynamic Ca2+ buffer controlling 
TRPV5 activity allows for an alternative approach (17). In our mathematical model of 
transcellular Ca2+ transport, which is supported by experimental evidence (17), Ca2+ entering 
the cell via TRPV5 is directly bound by CaBP28K such that no free Ca2+ enters the cell (model 
II). Since TRPV5 is inhibited upon a rise in the local [Ca2+] this suggests that when CaBP28K 
is saturated with Ca2+ active channels are not present on the cell surface. Thus, with a given 
flux the total CaBP28K concentration is a measure of the minimal amount of active TRPV5 
channels at the plasma membrane. Because each CaBP28K molecule can bind 4 Ca2+ ions (22) 
the effective Ca2+ binding capacity reflects four times the CaBP28K concentration which 
translates in ~100 TRPV5 channels at the plasma membrane. Thus, during renal transcellular 
Ca2+ transport the minimal number of TRPV5 channels at the cell surface that contribute to 
Ca2+ flux is in the order of 100 channels per cell. Adapting this value and knowing the 
transcellular Ca2+ transport rate and the size of the cell surface we estimate that 3*104 Ca2+ 
ions pass each TRPV5 channel per second during renal transcellular Ca2+ transport in vivo 
(see supplemental data for calculation).  
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In conclusion, our mathematical model describes the essential role of CaBPs in preventing 
local accumulation of Ca2+ in micro-domains in close vicinity of TRPV5 during transcellular 
Ca2+ transport. Thus, spatial buffering reduces the apical [Ca2+] and tempers the region in 
which [Ca2+] exceeds to levels that would cause inactivation of TRPV5.  
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Supplemental information: Theory of the model  
 
The model layout 
Transepithelial Ca2+ transport is modeled in 
cylindrical coordinates, radial coordinate r and 
longitudinal coordinate z. Ca2+ enters at the 
apical side, z= 0, through a centrally located 
circular region of radius rP, the TRPV5 pore. 
Transported Ca2+ leaves the cell through the 
basolateral side, z= L, and there is no transport 
through the cell cylinder side, r= R. 
 
Glossary 
CCaBP Total CaBP28K concentration 
[Ca2+] Concentration of Ca2+  
[Ca·CaBP] Concentration of Ca2+ bound to CaBP28K 
B0 Integration constant 
DCa Diffusion constant of Ca2+ 
DCaBP Diffusion constant of CaBP28K 
exp() Exponential function 
fR,i(r), fZ,i(z) Function terms in the separation of variables analysis 
gI(z),gII(z) Function terms in the non-equilibrium models 
Hi Constants in the separation-of-variables solution 
J Total Ca2+ flux 
J0(), J1(), J2() Zeroth, first and second Bessel functions of the first kind, respectively 
Kd Equilibrium constant 
kon, koff Ca2+ binding constants of CaBP28K 
L Diffusion distance between apical and basolateral membrane 
p(...) Port function 
r Cylindrical coordinate (radius) 
rP TRPV5 pore size 
R Radius of the pore supply area (modelled as cylinder) 
t Integration variable 
Y0() Zeroth Bessel function of the second kind respectively 
z Cylindrical coordinate (length) 
λAI Characteristic distance of non-equilibrium zone at the apical side for model  I 
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λAII Characteristic distance of non-equilibrium zone at the apical side for model  II 
λB Characteristic distance of non-equilibrium zone at the basolateral side 
ρ Net reaction rate of Ca2+ binding to calbindin 
ξi Zero points of the first Bessel function 
 
Basic model: no Ca2+ binding to CaBP28K. 
In this case, there is only free Ca2+ diffusion, and the steady state concentration [Ca2+](r,z), 
follows from the diffusion equation: 
 [ ]( ) 0zrCaD 22Ca =∇ + ,  (10) 
where 
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 (11) 
The boundary conditions of this mathematical problem are: no flux through the cylinder side 
(r= R), since all Ca2+ leaves through the basolateral side: 
 [ ] ( ) zany   forzR
r
CaDCa 0
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⎞
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∂ + ,  (12) 
and only influx in the central region: 
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Note that the influx is assumed constant over the TRPV5 pore and that the total incoming flux 
is (πrp2)×(JR2/rp2) = πR2J, an average flux J over the whole cylinder area πR2. 
Away from the apical side, for increasing z, the Ca2+ will spread out evenly and the flux will 
become uniform, independent of r: 
 [ ] ( ) Jzr
z
CaDCa −=∞→⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂ + ,
2
 (14) 
with an obvious solution: 
 [ ]( )
CaD
JzBzrCa −=+ 0
2 ,  (15) 
where B0 is an integration constant. Then, the full solution can be derived as a deviation from 
this function: 
 [ ] ( ) ( )zrRrp
D
JR
D
JzBzrCa p
CaCa
,;,, +−=+ 0
2  (16) 
written here in terms of a dimensionless function p(…) which we shall call 'port function', and 
constructed by the standard method of separation of variables: 
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 ( ) ( ) ( )∑∞
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Z,iR,ip zfrfzrRrp ,;,  (17) 
where each term in the summation must obey equation (1): 
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This is rewritten in the form 
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The ξi has to be a constant since the first part is independent of z and the second part is 
independent of r so all parts have to be independent of both variables. Then, textbook 
mathematics learns that the first part solution is a zero-order Bessel function and the second 
part solution is an exponential function so that: 
 ( ) ( ) ( )∑∞
=
ξ−ξ=
1
0
i
iiip RzRrHzrRrp /exp/J,;,  (20) 
where the constants Hi and ξi yet have to be determined. Mathematically, also the Bessel 
function Y0(…) and the increasing exponential function exp(+ξiz/R) are possible as a solution, 
but the first one is not bounded for r= 0 (approaches infinity) and the second one violates the 
assumption of approaching equation (15) for large z. 
For the ξi, we use the boundary condition of no flux through the cylinder side at r=R, equation 
(12), worked out as: 
 ( ) 0
1
1 =ξξ∑∞
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i
Rz
i
i
i
i
R
HJR /eJ  (21) 
which has to be true for any z. This is only possible if 
 ( ) 01 =ξiJ  (22) 
so that the ξi are the intersection points of the first Bessel function with its horizontal axis. 
This solution has to obey boundary condition  (13), but that is easier worked out for the 
derivative of equation  (13): 
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where δ(…) is the Dirac delta function. This leads to: 
 ( ) ( )p
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12
2
/J  (24) 
Both sides of this identity can be multiplied by rJ1(ξkr/R)/(JR) and integrated over r from 
0→R: 
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where the left side can be rewritten as, defining t= r/R and rearranging: 
 ( ) ( ) ( ) ( )∫∑ ∫ −δξ⋅=ξξ⋅ξ∞
=
R
p
p
k
i
ikii rr
r
RRrrdrtttdtH
0
21
1
1
0
11
2 /JJJ  (26) 
so that the orthonormality relation for J1() can be used: 
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to yield, together with the integration over the Dirac delta function: 
 ( ){ } ( ) 2122212
p
PkPkkk
r
RRrrH /JJ ξ=ξξ  (28) 
from which the terms Hk can be solved as: 
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which fixes the solution for p(rP,R;r,z) as: 
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To appreciate the effect of TRPV5 on the intracellular Ca2+ concentration, it is important to 
see how this function behaves at the coordinates where the TRPV5 is located, i.e., r=z=0. In 
the case of a small port radius, rP/R«1, we can derive an approximate solution for p(rP,R;0,0) 
by replacing the sum over i by an integral over di: 
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Also using the following properties of the Bessel functions: 
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so that dξi≈ πdi, the summation of equation (30) becomes  
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and, defining t= ξirP/R: 
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Note, that in this derivation also an approximation is made for the starting point of the 
integral, which is kept as zero throughout. A better approximation would be to replace the 
sum i: 1→∞ by an integral di: ½→∞ i.e. ξi: ¾π→∞ i.e. t: ¾πrP/R→∞, so, the integral 
t: 0→¾πrP/R has to be subtracted. This is easily calculated since for small values of t J1(t)≈½t, 
and the above solution can be improved to: 
 ( )
8
300 π−≈
p
P r
RRrp ,;,  (34A) 
an approximation that turns out to be very close to the exact calculations. 
 
Non-equilibrium, general 
When Ca2+ is reversibly bound to calbindin, the diffusion rate has to be equal to the reaction 
rate. This leads to an adapted equation replacing equation (1): 
 [ ]( ) [ ]( ) ρ,, =⋅∇−=∇ + zrCaBPCaDzrCaD 2CaBP22Ca  (35) 
where ρ is the net reaction rate of Ca2+ binding to calbindin (the (r,z) after the species 
concentrations is neglected for simplification): 
 [ ] [ ]( ) [ ]CaBPCakCaBPCaCCak offCaBPon ⋅−⋅−= + 42ρ  (36) 
since the on reaction is between Ca2+ and the available binding sites, and the off reaction is 
from the Ca-calbindin complex only; the calbindin can bind 4 Ca2+ ions so that the amount of 
available binding sites equals (4CCaBP – [Ca·CaBP]). Note, that the chemical equilibrium 
follows from equating ρ= 0. 
The diffusion equation (35) can be rewritten to read: 
 [ ] [ ]
CaBP
2
Ca
22
D
CaBPCa
D
Ca ρ;ρ −=⋅∇=∇ +  (37) 
or summed to cancel out the reaction rate ρ: 
 [ ] [ ] 0CaBPCaDCaD 2CaBP22Ca =⋅∇+∇ +  (38) 
which allows for a 'far away' solution, large z, along the same line as with equation (15): 
 [ ] [ ] JzBCaBPCaDCaD 1CaBP2Ca −=⋅++  (39) 
where B1 is an integration constant. Again, the full solution can be derived as a deviation from 
this function: 
 [ ] [ ] ( )zrRrJRpJzBCaBPCaDCaD p1CaBP2Ca ,;,+−=⋅++  (40) 
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Non-equilibrium, model I 
The solution method of Hoofd and Kreuzer uses the fact, that one of the species cannot pass 
the boundary at z= 0 so that its gradient, the first derivative to z, approaches zero there. In 
model I, this is non-passing species the calbindin complex. The other species is expressed in 
terms of a deviation gI(z) from the chemical equilibrium - see equation (6) of the cited paper: 
 [ ] [ ][ ] ( )zgCaBPCaC CaBPCaKCa ICaBPd +⋅−
⋅
=
+
4
2  (41) 
where Kd= kon/koff. Note, that there is no coordinate r here since the method is set up as one-
dimensional. Then, the reaction rate ρ is, from equation (36): 
 [ ]( ) )(ρ zgCaBPCaCk ICaBPon ⋅−= 4  (42) 
Equation 32 can be differentiated twice, neglecting the first derivative in [Ca·CaBP] that 
approaches zero towards the boundary: 
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which, using equations (37) and (42), can be worked out as: 
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Assuming that in a 3-dimensional case the zone 0<z<λAI  can be described having a constant 
value of [Ca·CaBP], an approximate solution for the [Ca2+] follows from equation (40) as: 
 [ ] [ ] ( ) ( ){ }zzrRrRp
D
Jz0rCaCa AIp
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22
−λ++λ==≈ ++ ,;,,  (46) 
 
Non-equilibrium, model II 
Here, the species that does not pass the membrane is Ca2+ and consequently instead of 
equation 32 expressing [Ca2+] in terms of [Ca·CaBP], an equation has to be used expressing 
[Ca·CaBP] in terms of [Ca2+]: 
 [ ] [ ][ ] ( )zgCaK CaCCaBPCa IId
CaBP +
+
=⋅
+
+
2
24
 (47) 
leading to a reaction rate ρ: 
 [ ]( ) ( )zgCakk IIonoff ++−= 2ρ  (48) 
Again, differentiating equation (47) twice leads to: 
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which can be worked out again using equation (37) and inserting the ρ for this model II: 
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When assuming that in a 3-dimensional case the zone 0<z<λAII can be described having a 
constant value of [Ca2+], an approximate solution for the [Ca·CaBP] follows from equation 
(40) as: 
 [ ] [ ] ( ) ( ){ }zzrRrRp
D
Jz0rCaBPCaCaBPCa AIIp
CaBP
AII −λ++λ==⋅≈⋅ ,;,,  (52) 
 
Single channel Ca2+ flux 
Transcellular Ca2+ transport rate was experimentally determined as 1*10-15 mol·h–1·µm–2 (100 
nmol·h–1·cm–2) and the averaged luminal cell surface as 20 µm2. This implies that transcellular 
Ca2+ transport over a single cell is 2*10-14 mol/h. The estimation of the amount of active 
TRPV5 channels at the apical cell surface (i.e. ~100) then determines that the single channel 
Ca2+ flux is 2*10-16 mol/h. Applying Avagadro’s number (6.02214*1023) this thus suggests 
that the flux of Ca2+ through a single active TRPV5 channel complex is in the order of 3*104 
Ca2+ ions per second.         
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Summary  
The Transient Receptor Potential channel Vanilloid 5 (TRPV5) is the most Ca2+-selective 
channel within the TRP superfamily of ion channels. This distinct member is expressed in 
Ca2+-transporting epithelia were it acts as a luminal entry gate controlling Ca2+ entry. In 
kidney TRPV5 constitutes the apical influx mechanism during Ca2+ reabsorption from the 
pro-urine. Regulation of TRPV5 activity is thus of utmost importance for determining Ca2+ 
entry and to maintain a normal Ca2+ balance. However, little is known about intracellular 
associated protein partners that affect TRPV5 activity. By a comprehensive approach this 
study identified Nipsnap1 as a novel factor involved in the control of TRPV5 activity. A 
combination of GST pull-down and co-immunoprecipitation assays demonstrated that 
Nipsnap1 associates with TRPV5 in a Ca2+-independent fashion. The binding of Nipsnap1 
was apparent at both the amino-terminus (TRPV577-112) and carboxyl-terminus (TRPV5595-601) 
of TRPV5 suggesting a mechanism of regulation involving multiple interaction sides. 
Electrophysiological recordings and 45Ca2+ uptake assays revealed that Nipsnap1 significantly 
reduces TRPV5 activity. Subsequent biotinylation assays showed that TRPV5 plasma 
membrane expression did not changed in the presence of Nipsnap1 suggesting that TRPV5 
inhibition by Nipsnap1 is not caused by reduced channel cell surface expression. In 
conclusion, this study presents the first physiological function of Nipsnap1 as an associated 
inhibitory regulator of TRPV5 activity. 
 
Introduction 
The highly selective Ca2+ channel TRPV5 is a member of the large and functionally diverse 
family of Transient Receptor Potential (TRP) ion channels. TRPV5 is expressed in Ca2+-
transporting epithelia where it acts as gate controlling the entry of Ca2+. Active Ca2+ 
reabsorption in kidney from the luminal compartment (pro-urine) to the basolateral side 
(blood) comprises a sequence of processes. At the apical side Ca2+ enters the renal epithelial 
cell via TRPV5 due to the steep inward electrochemical gradient across the apical membrane 
(1). In the cell, Ca2+ is rapidly bound to calbindin-D28K that ferries Ca2+ from the apical to the 
basolateral side where the plasma membrane ATPase (PMCA1b) and the Na+/Ca2+-exchanger 
(NCX1) extrude Ca2+ into the blood compartment. This transcellular process is under tight 
and coordinated control of the calciotropic hormones that efficiently regulate the above 
mentioned process via distinct genomic and non-genomic pathways (2). Besides hormonal 
regulation, the activity of TRPV5 is efficiently controlled by Ca2+ itself such that Ca2+ entry 
induces a negative feedback regulation of channel activity which is essential during high 
levels of Ca2+ transport to prevent a Ca2+ overload (3). Since TRPV5 lacks conserved Ca2+ 
binding sites that could translate the ambient Ca2+ concentration into channel activity, 
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associated protein complexes are possibly involved in this particular form of TRPV5 
regulation. 
Basically alterations of TRPV5 activity can be explained by changes in the number of TRPV5 
channels at the plasma membrane or by modification of channel activity at the cell surface. 
The Ca2+-binding proteins calmodulin, calbindin-D28K and 80K-H were previously identified 
as modulators of the epithelial Ca2+ channels affecting the Ca2+-dependent activity of TRPV5 
or TRPV6 (4-6). Calbindin-D28K was shown to translocate towards the plasma membrane and 
associate with TRPV5 upon a decrease in the intracellular Ca2+ concentration. Here it locally 
buffers the flux of Ca2+ that enters the cell via TRPV5 thereby preventing channel 
inactivation. In addition, the Ca2+ sensor calmodulin was identified to associate with TRPV5 
and, its closely related family member, TRPV6 in a Ca2+-dependent manner although 
regulation appeared to be confined to TRPV6. Similarly, 80KH was suggested as an 
associated Ca2+ sensor controlling TRPV5 activity. Thus, Ca2+-dependent control of TRPV5 
and TRPV6 activity is mediated by a number of factors. The molecular mechanisms that 
control trafficking of these channels towards the plasma membrane and subsequent activity at 
the cell surface are, however, poorly understood. Recently, the S100A10-annexin 2 complex 
and Rab11a were identified to be essential for TRPV5 and TRPV6 cell surface expression (7, 
8). S100A10-annexin 2 appeared to be involved in constitutive non-stimulated trafficking of 
TRPV5, whereas Rab11a was identified as an essential factor of a GTP-dependent mechanism 
controlling TRPV5 recycling to the plasma membrane.  
The aim of the present study was to elucidate the function of a newly identified TRPV5-
associated protein Nipsnap1. To this end, GST pull-down and co-immunoprecipitation 
experiments were performed to investigate Nipsnap1 association and identify the binding 
domain in TRPV5. 45Ca2+ uptake assays and electrophysiological recordings of cells co-
expressing TRPV5 and Nipsnap1 were established to investigate the role Nipsnap1 in TRPV5 
activity. Furthermore, cell surface labeling of these Nipsnap1 and TRPV5 co-expressing cells 
was carried out to study the ability of Nipsnap1 to control TRPV5 plasma membrane 
expression.  
    
Materials and methods 
 
Molecular biology and cell culture 
TRPV5 N- and C-terminal truncates were inserted into the pGEX6p-2 vector (Amersham 
Pharmacia Biotech, Roosendaal, The Netherlands) as described (8). TRPV5-pCINeo/IRES-
GFP expression vector was constructed as described (9). Nipsnap1 was cloned into the 
Xenopus laevis oocyte expression vector pT7Ts, pCDNA3.1 and pCINeo/IRES-GFP 
expression vectors using PCR. All constructs were verified by sequence analysis. HEK293 
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and COS cells were grown and transfected as described (5). HEK293 cells stably expressing 
HA-TRPV5 were established as previously described for MDCK EGFP-TRPV5 (10) and 
maintained in medium containing 400 µg/ml G418 (Gibco Europe, Breda, The Netherlands). 
Expression of HA-TRPV5 was verified using anti-HA and five clones were pooled to 
eliminate differences between independent cell lines.  
 
Protein-binding analysis 
GST pull down assays with [35S]Methionine-labeled proteins in TBS-HCl pH 7.4 containing 
0.5% (v/v) NP40 and 1 mM Ca2+ or 5 mM EDTA, were performed as described (5). HEK293 
cells were transiently co-transfected with pCDNA-Nipsnap1 and pCINeo/IRES-GFP-TRPV5. 
For co-immunoprecipitations cells were lysed by incubation for 1 h on ice in 50 mM Tris-HCl 
pH 7.4 containing 0.2% (v/v) Triton-X100, 0.2% (v/v) NP40 and the protease inhibitors 
leupeptin (0.01 mg/ml), pepstatin (0.05 mg/ml), phenylmethylsulfonyl fluoride (1 mM) and 
aprotinine (5 mg/ml). The lysates were centrifuged for 30 min at 16,000 g and supernatants 
were incubated with anti-TRPV5 immobilized on protein A-agarose beads (Kem-En-Tec A/S, 
Copenhagen, Denmark) for 16 h at 4ºC. After extensive washing in lysis buffer co-
immunoprecipitation was investigated by immunoblot analysis using monoclonal anti-Xpress 
tag (Invitrogen, Breda, The Netherlands).  
 
Electrophysiology and 45Ca2+ uptake assays 
Electrophysiological methods have been described previously in detail (9, 11). Whole cell 
currents were measured using an EPC-9 amplifier (HEKA, Lambrecht, Germany) using 
ruptured patches. Electrode resistances were 3-6 MΩ, and capacitance and access resistance 
was monitored continuously. A ramp protocol, consisting of linear voltage-ramps from -100 
to +100 mV within 450 ms, was applied every 2 s from a holding potential of +20 mV. Ca2+-
dependent inactivation was studied using a 3 second voltage step to –100 mV from a holding 
potential of +70 mV. Current densities, expressed per unit of membrane capacitance, were 
calculated from the current at –80 mV during the ramp protocols (8). The standard 
extracellular solution (“Krebs”) contained 150 mM NaCl, 6 mM CsCl, 1 mM MgCl2, 10 mM 
HEPES/NaOH pH 7.4 and 10 mM glucose. The Ca2+ concentration was varied between 1 and 
10 mM. Divalent free solutions did not contain added divalent cations, while trace amounts of 
divalent cations were removed with 100 μM EDTA. To inhibit monovalent cation currents, 
150 mM NaCl was replaced with an equimolar amount of N-methyl-D-glucamine-Cl. The 
standard internal (pipette) solution contained 20 mM CsCl, 100 mM Cs-aspartate, 1 mM 
MgCl2, 4 mM Na2ATP, 10 mM BAPTA, 10 mM HEPES/CsOH pH 7.2. Cells were kept in 
nominal Ca2+-free medium to prevent Ca2+ overload and exposed for maximal 5 min to a 
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Krebs solution containing 1.5 mM Ca2+ before sealing the patch pipette to the cell. All 
experiments were performed at room temperature (RT). 45Ca2+ uptake was determined at 37 
°C using HEK293 cells as described (12). To block TRPV5-mediated 45Ca2+ uptake cells were 
incubated with 10 μM ruthenium red.  
 
Biotinylation  
HEK293 cells were transfected with pCINEO/IRES-GFP-HA-TRPV5 and pCINEO/IRES-
GFP or pCINEO/IRES-GFP-HA-TRPV5 and pCINEO/IRES-GFP-VSV-Nipsnap1. Proteins 
that were present on the cell surface were biotinylated at 4 ºC using NHS-LC-LC-biotin (0.5 
mg/ml; Pierce, Etten-leur, The Netherlands). Precipitated using neutravidin-coupled beads 
(Pierce), and analyzed by immunoblot analysis using anti-TRPV5 (1). 
 
Statistical analysis 
In all experiments, data are expressed as mean ± SEM. Overall statistical significance was 
determined by analysis of variance (ANOVA) followed by Bonferroni contrast analysis to 
investigate individual significance using Instat 3 software for Apple computers (San Diego, 
CA, USA). P values below 0.05 were considered significant. 
 
Results 
 
Nipsnap1 interaction with TRPV5 
To identify novel TRPV5-interacting proteins a GST pull-down assay in combination with 
proteomics to identify the precipitated proteins was performed. The TRPV5 carboxyl-
terminus fused to GST was used as bait and total mouse kidney lysate as substrate. One of the 
identified proteins was Nipsnap1 that specifically associated with TRPV5 (data not shown). 
To confirm this interaction, GST pull-down assays were performed using in vitro translated 
Nipsnap1. Nipsnap1 bound to both the amino- and carboxyl-termini of TRPV5, in the 
presence (1 mM CaCl2) and absence (5mM EDTA) of Ca2+ (Fig. 1A). Subsequently, the 
interaction of TRPV5 and Nipsnap1 was studied by co-immunoprecipitation from TRPV5 and 
Xpress-tag-Nipsnap1 co-transfected COS cells. To this end, cell lysates were incubated with 
anti-TRPV5 antibodies coupled to protein-A beads to precipitate the TRPV5 complexes. 
Immunoblots containing the precipitated proteins were analyzed for the presence of Xpress-
tag-Nipsnap1. Nipsnap1 co-precipitated with TRPV5 in cells expressing both TRPV5 and 
Nipsnap1 (Fig. 1B), whereas Nipsnap1 was not co-precipitated from cells expressing 
Nipsnap1 only, demonstrating the specificity of the co-immunoprecipitation.  
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Fig. 1. Nipsnap1 
binding to TRPV5 and 
TRPV6 
(A) [35S]Methionine 
labeled in vitro 
translated Nipsnap1 was 
incubated with GST or 
GST fused to the N- or 
C-terminus of TRPV5 
immobilized on 
glutathione-Sepharose 
4B beads either in the 
presence (1 mM CaCl2) 
or absence (5 mM 
EDTA) of Ca2+. Input 
control represents 10% of the total pull down input. (B) Cells were co-transfected with 
pCDNA3.1-Nipsnap1 and pCINeo/IRES-GFP-TRPV5 or pCDNA3.1-Nipsnap1 and pCNeo/IRES 
GFP (control). Co-precipitation was investigated by immunoblotting using the Xpress-tag 
antibody.                   
 
Elucidation of the Nipsnap1 binding motif in TRPV5 
To further identify the Nipsnap1 binding sites in TRPV5, a series of amino- and carboxyl-
terminal deletion mutants were constructed as depicted in Fig. 2. Truncated forms of TRPV5 
were fused to GST and Nipsnap1 binding was determined by GST pull-down assays as 
described above. The interaction between TRPV5 amino-terminus and Nipsnap1 was 
abolished when the amino-terminus was truncated at position 77, whereas truncations at 
position 112 up to 240 did not disrupt the interaction with Nipsnap1 (Fig. 2A). The 
association between the carboxyl-terminus of TRPV5 and Nipsnap1 was disrupted when the 
carboxyl-terminus was truncated at position 596, whereas truncations at position 601 up to 
647 did not affect the binding with Nipsnap1 (Fig. 2B).  
 
Tissue distribution of Nipsnap1 
TRPV5 is mainly expressed in Ca2+-transporting tissues and to investigate Nipsnap1 co-
expression in mice the distribution of this novel protein was assessed in a cDNA tissue panel. 
Nipsnap1 mRNA was detected in all tissues tested except in spleen (Fig. 3). β-actin 
expression was established in all tissues demonstrating the integrity of the cDNA. 
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Fig. 2. Nipsnap1 interaction domains in TRPV5 
 [35S]Methionine labeled in vitro translated Nipsnap1 was incubated with GST or GST fused to 
TRPV5 amino- (A) and carboxyl-terminal (B) truncations as indicated. Input control represents 
10% of the total pull down input.  
 
Effect of Nipsnap1 on TRPV5 activity 
To study the potential role of Nipsnap1 in controlling TRPV5, the activity of TRPV5 was 
determined by whole-cell electrophysiological analysis in HEK293 cells transiently co-
expressed with TRPV5 and Nipsnap1. Nipsnap1 significantly reduced the inward Ca2+ current 
in response to a hyperpolarizing voltage step in these HEK293 cells (Fig. 4A and C). 
Likewise, the Na+ current was reduced in these Nipsnap1- and TRPV5-coexpressing cells 
(Fig. 4B and D). Subsequently, the effect of Nipsnap1 on TRPV5 activity was assessed by 
45Ca2+ uptake assays using HEK293 cells stably expressing the channel. Stably TRPV5-
expressing HEK293 cells exhibited a ruthenium red sensitive 45Ca2+ uptake demonstrating the 
function of TRPV5 in this cell line (Fig. 4E). In line with the patch-clamp results, transient 
transfection of Nipsnap1 in these stably TRPV5-expressing HEK293 cells significantly 
reduced 45Ca2+ uptake as compared to mock transfected stably TRPV5-expressing cells (Fig. 
4E). Addition of 10 μM ruthenium red to the stably TRPV5-expressing cells during the assay 
resulted in a decrease of 45Ca2+ uptake in both mock and Nipsnap1 transfected cells, 
demonstrating that the 45Ca2+ uptake is mediated by TRPV5. 
 
Fig. 3. Tissue distribution of Nipsnap1  
mRNA was extracted from several 
mouse tissues and Nipsnap1 expression 
was determined by semi quantitative 
reverse transcriptase PCR. The 
Nipsnap1 specific band was amplified  in all tissues expect in spleen at the expected size of 628 bp. β-
actin reverse transcriptase was amplified to check the integrity of the cDNAs. 
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Fig. 4 Nipsnap1 inhibits TRPV5 
activity. 
(A) Whole cell current voltage relations 
measured from 400 ms voltage ramps 
(interval = 5 s) in nominally DVF 
solution in HEK293 cells transiently 
transfected with either TRPV5 and mock 
(solid) or TRPV5 and Nipsnap1 (dotted 
line). (B) Inward Ca2+ currents measured 
in HEK293 cells transiently transfected 
with either TRPV5 and mock (solid) or 
TRPV5  and Nipsnap1 (dotted line) with 
10 mM extracellular Ca2+ during a 3 s 
step to –100 mV from a holding potential 
of + 70 mV. Average peak current density 
during the voltage step in 10 mM Ca2+ 
(n=10) (C) or average current densities at 
–80 mV in 10 mM EDTA (n=10) (D) in 
HEK293 cells transiently transfected with 
either TRPV5 and mock (open bars) or TRPV5 and Nipsnap1 (closed bars). Significant 
differences in TRPV5 activity was indicated by an asterisk (p<0.05). (E) 45Ca2+ uptake of HEK293 
cells stably expressing TRPV5 and transiently transfected with empty vector or Nipsnap1 (open 
bars). 10 μM ruthenium red was included during the uptake to investigate ruthenium red 
sensitivity (closed bars). Significant differences in 45Ca2+ uptake compared to all conditions are 
indicated by an asterisk (p<0.05). 
 
Effect of Nipsnap1 on TRPV5 cell surface expression 
A decrease in the TRPV5 activity can in principal be explained by a reduced cell surface 
expression or altered activity of TRPV5 at the plasma membrane. Therefore, cell surface 
biotinylation was applied to quantify the number of TRPV5 channels present at the plasma 
membrane. Co-expression of Nipsnap1 did not change the plasma membrane expression of 
TRPV5 (Fig. 5A). Analysis of total TRPV5 expression revealed a non-glycosilated and a 
glycosilated form which is the accessible form to extracellular biotin. As control the 
expression of Nipsnap1 was confirmed in these cells (Fig. 5B).  
 
Discussion 
The present study identified the physiological role of Nipsnap1 as a negative modulator of 
TRPV5-mediated Ca2+ transport. This conclusion is based on the following observations. 
First, the specific association of Nipsnap1 and TRPV5 was demonstrated in a proteomic assay 
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to unravel the TRPV5 interactome and subsequently confirmed by GST pull-down analysis 
and co-immunoprecipitation experiments. Second, Nipsnap1 co-expresses with TRPV5 in 
Ca2+-transporting tissues like kidney, intestine and bone. Third, Nipsnap1 inhibits TRPV5 
activity without affecting the cell surface expression of the epithelial Ca2+ channel. 
 
Fig. 5. Nipsnap1 has no effect on cell surface expression of TRPV5 
(A) Cell surface expression of TRPV5 as measured by cell surface biotinylation of HEK293 cells 
transiently expressing TRPV5 and Nipsnap1 or TRPV5 and empty vector. Analysis of total 
TRPV5 expression revealed a non-glycosilated form (lower band, left panel) and a glycosilated 
form (upper) which is the band accessible to extracellular biotin (right panel). (B) Nipsnap1 
expression as assed by anti-Xpress-tag. A representative blot of three independent experiments is 
shown. 
 
TRPV5 forms the apical entry gate in Ca2+-transporting cells. Its activity is determined by 
both calciotropic hormones and associated protein partners. Several binding partners 
including calbindin-D28K and 80K-H directly affect the Ca2+-dependent activity of TRPV5, 
whereas others such as the S100A10-annexin 2 complex and Rab11a control the TRPV5 cell 
surface expression. This study demonstrates that Nipsnap1 is co-expressed with TRPV5 in the 
Ca2+-transporting tissues (i.e., kidney, bone and intestine) which is in line with a function in 
the regulation of the Ca2+ balance. Besides kidney, bone and intestine Nipsnap1 expression 
was detected in all tested tissues except in spleen. These findings are similar to previous 
results demonstrating that Nipsnap1 is ubiquitously expressed, although spleen was not 
included in this latter study (13). Nipsnap1 is a member of an evolutionary conserved gene 
family with a putative role in vesicular trafficking since NIPSNAP in C. elegans localizes in a 
gene operon encoding SNAP25-like proteins (13). At present only a few studies have 
provided information about Nipsnap1 and no robust experimental evidence is available 
indicating that the NIPSNAP family is involved in vesicular trafficking. In line with a role in 
vesicular trafficking, however, is the punctuate vesicular distribution of GFP-tagged TassC, a 
NIPSNAP homologue (originally annotated as Nipsnap4). Nipsnap4 was identified in a Yeast 
two-hybrid screen as a direct interacting partner of the Salmonella virulence protein Spic (14). 
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These authors have named Nipsnap4 as TassC (target for Salmonella secreted protein C) since 
the only established role for Nipsnap4 was its interaction with Spic. Indicated by the survival 
of a SpiC deficient Salmonella strain in Nipsnap4 knockdown macrophages, Nipsnap4 was 
suggested as a host cell factor in these cells. It was concluded that Nipsnap4 determines 
vesicular trafficking and postulated that Nipsnap4 is inactivated by Salmonella SpiC thereby 
enabling host cell infection. Thus, although the function of the NIPSNAP family remains 
elusive, they have been implicated in the process of vesicular trafficking. 
 
Both pull-down assays and co-immunoprecipitations confirmed the potential TRPV5 and 
Nipsnap1 interaction. Detailed analysis of the interaction domain revealed that Nipsnap1 
binds to the TRPV5 amino-terminus (TRPV577-112) and carboxyl-terminus (TRPV5596-601) 
suggesting that Nipsnap1 is part of a mechanism of regulation involving multiple interaction 
sides. Interestingly, the TRPV5 carboxyl-terminal residues responsible for Nipsnap1 
association have previously been demonstrated to be critical for TRPV5 activity,  binding of 
interacting partners 80KH, NHERF4 and Rab11a, and channel multimerization (6, 7, 15, 16). 
In addition, this domain is conserved throughout evolution underlining the importance of this 
particular stretch of amino acid residues. Thus, suggesting that this region is either a critical 
element for the general folding of the carboxyl-terminus of TRPV5 or that several of the 
associated proteins recognize motifs within this particular region. Nipsnap1-mediated 
regulation of TRPV5 activity might be an interplay of several associated proteins that affect 
TRPV5 activity by antagonizing or synergizing each other by competitive association with the 
channel. In this situation, the occupancy of the binding sites would depend on the relative 
concentration and affinity of the proteins that, during overexpression of Nipsnap1, is in favor 
for Nipsnap1. Such a mechanism of ion channel regulation by competitive association for 
target sites is well defined for G-protein beta gamma subunits (Gβγ) dependent regulation of 
voltage-operated Ca2+ channels. These channels consist of a pore forming α subunit and 
several associated subunits, such as the intracellularly located β subunit that contributes to the 
overall functional characteristics of the channel complex (17). Voltage-dependent inhibition 
of these Ca2+ channels is mediated by Gβγ inhibition (18, 19). The binding sites of the Ca2+ 
channel β and Gβγ subunits overlap on the channel α part and functional measurement 
revealed that these subunits antagonize each other, thereby affecting channel activity (20, 21).  
 
Direct inhibition of TRPV5 activity by Nipsnap1 can theoretically be explained by a reduced 
cell surface expression of TRPV5 or by a decreased activity at the plasma membrane. The 
initial characterization of TRPV5 revealed that this channel displays constitutive activity (22). 
Thus, changes in channel localization at the cells surface are an efficient means to regulate 
channel activity. The biotinylation experiments, however, demonstrated that TRPV5 cell 
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surface expression is not affected by Nipsnap1 since the abundance of TRPV5 in the purified 
plasma membrane fraction is not changed in the presence of co-expressed Nipsnap1. Thus, 
Nipsnap1 decreased TRPV5 activity of channels present at the cell surface, by a potential 
competition with other auxiliary proteins for TRPV5 association. 
  
In conclusion, this study demonstrates the first function of the recently identified protein 
Nipsnap1 in modulating TRPV5-mediated Ca2+ transport and thereby affecting the total Ca2+ 
balance of the organism. Nipsnap1 determines the activity of TRPV5 present at the cell 
surface, thereby providing evidence that the family of NIPSNAP proteins is able to affect 
physiological processes via mechanisms independent of vesicular trafficking.             
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Chapter VII 
Abstract 
Inner ear physiology is highly homologous to renal physiology since several common 
transporters and channels are shared by both tissues. A number of Transient Receptor 
Potential (TRP) ion channels are detected in the inner ear although their precise localization 
and physiological functions remain elusive. TRPV5 is a unique member of the TRP 
superfamily of ion channels facilitating apical Ca2+ influx in epithelia. Here, we demonstrate 
using immunohistochemistry, startle response measurements and Auditory Brainstem 
Response (ABR) recordings that TRPV5, besides its well established function in kidney, 
fulfills an important role in sound perception. By immunohistochemistry, TRPV5 was 
localized to the apical membrane of Deiter’s supporting cells that are connected to the 
sensory-motor outer hair cells. Mice lacking TRPV5 displayed a decreased startle pre-pulse 
inhibition and increased ABR thresholds providing evidence for a critical function of TRPV5 
in sound amplification near threshold. In summary, a novel function for the epithelia Ca2+ 
channel TRPV5 as an essential component in inner ear physiology was demonstrated, thereby 
providing evidence for a direct role of Deiter’s supporting cells in sound perception.          
 
Introduction 
The inner ear contains the cochlea in which the organ of Corti forms a highly ordered auditory 
sensory epithelium. This epithelium is composed of an array of sensory hair and non-sensory 
supporting cell types that are organized in a precise pattern. The mechano-sensitive hair cells 
are divided along the length of the cochlea from base to apex with a single row of inner hair 
cells and three evenly spaced rows of outer hair cells. Directly underneath the outer hair cells 
lay the Deiter’s supporting cells of which the function still largely remains elusive. Given the 
important function of the hair cells as mechanosensory receptors in auditory transduction, it is 
easily envisaged that hearing deficits could easily occur due to loss or malfunction of hair cell 
function. However, mutations causing disturbances in the architecture of the organ of corti as 
a result of defects in supporting cells have also been identified (1, 2). On their apical surface 
hair cells contain microscopically fine projections, the stereocilia. The displacement of the 
stereocilia by mechanical forces increases tension in the tip links that connect individual 
stereocilia leading to opening of mechanotransduction channels and depolarization of the hair 
cells.  
 
Since several ion transporters and channels that are expressed in transporting epithelia in 
kidney are localized in the inner ear as well, the characteristics of these epithelia are quite 
homologous. Genetic disturbance in one of the components may therefore result in both 
kidney and inner ear malfunction (3, 4). This overlap gained a profound interest since several 
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key players in inner ear transporting epithelia are unknown but are, however, identified in 
kidney. 
 
Transient Receptor Potential (TRP) channels constitute a large and functionally versatile 
superfamily of cation channels that are expressed in many cell types from yeast to mammals 
(5). Here they fulfill critical functions in processes ranging from sensory physiology, male 
fertility, vasorelaxation and epithelial Ca2+ and Mg2+ transport. Although numerous TRPs 
have been identified their precise physiological function still remains largely unknown. One 
distinct member of the TRP family, TRPA1 has been identified as part of the mechano-
sensitive pathway enabling rapid K+ and Ca2+ entry in hair cell stereocilia (6). However, mice 
lacking TRPA1 display normal hair cell function and no deficiency in sound detection (7, 8). 
On the other hand genetic disruption of TRPV4 was found to cause delayed-onset hearing loss 
and make the cochlea more vulnerable to acoustic trauma (9). Thus, two TRP channels have 
been detected in the mammalian inner ear although their precise function in hearing remains 
elusive. 
 
TRPV5 and TRPV6 form the luminal entry gate in Ca2+-transporting epithelia in kidney and 
intestine, respectively (10). At the cellular level, Ca2+ enters the epithelial cells via the highly 
Ca2+-selective channels TRPV5 and TRPV6 due to a steep inward electrochemical gradient 
across the luminal membrane. In the cell, Ca2+ is bound by calbindin-D28K and -D9K (CaBP28K 
and CaBP9K) that ferry Ca2+ from the luminal side to the basolateral side where the Na+/Ca2+-
exchanger (NCX1) and the plasma membrane ATPase (PMCA1b) extrude Ca2+ into the blood 
compartment. Similar as its suggested function in kidney CaBP28K is thought to prevent toxic 
Ca2+ overload of hair cells by increased cytosolic Ca2+ buffering and intracellular Ca2+ 
transport (11, 12). However, genetic ablation of CaBP28K in mice does not affect hearing or 
survival of hair cells in acoustic trauma (13). Compensation may occur by other Ca2+ buffer 
proteins in the outer hair cells such as oncomodulin (prevalbumin-β) and in the inner hair cell 
calretenin (14). Different PMCA isoforms have been localized to discrete subcellular regions 
in the hair cells providing for Ca2+ excretion and rapid buildup of Ca2+ gradients. In analogy 
with basolateral excretion of Ca2+ in kidney, Ca2+-ATPases extrude Ca2+ from stereocilia (15). 
PMCA2a is the predominant isoform present in hair cell bundles, whereas PMCA1b has been 
detected at the plasma membrane of hair cells and supporting cell somas (16). In addition, 
NCX1 has been detected in the inner ear epithelia, however, its function is not clear. A 
spliced isoform of NCX1 is expressed in the cochlear lateral wall and in the organ of Corti, 
whereas five NCX1 isoforms have been detected in the cochlear modiolus (17). Alternative 
splicing may therefore provide diverse functions for NCX in the inner ear. The ion-
transporting epithelium that is most homologous to the epithelia along the nephron in kidney 
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is the non-sensory transporting epithelium stria vascularis. In this particular cochlear cell type, 
ion transport pathways have been detected known from transcellular transport processes in 
kidney (3, 4). The third part of the cochlea, the spiral ganglion consists of neuronal cells that 
innervate the hair cells and transduce sound stimuli to the brain.  
 
Several components of transcellular Ca2+ transport in kidney are thus expressed in the inner 
ear where their function could be similar. The localization and function of the apical influx 
channel TRPV5 in the inner ear is, however, unknown. Recently, TRPV5 transcripts were 
detected in primary cultures of semicircular canal duct epithelial cells (18). In these cells a 
similar model for transcellular Ca2+ transport, as described in kidney, was suggested with 
TRPV5 and TRPV6 as apical influx channels, CaBP28K and CaBP9K as intracellular Ca2+ 
transport proteins and NCX and PMCA as extrusion mechanisms. The authors speculated that 
TRPV5-mediated transcellular Ca2+ transport could be essential for the low endolymph Ca2+ 
concentration in the vestibular labyrinth. Interestingly, vitamin D receptors were also detected 
in these cells and the expression of the Ca2+ transport machinery was positively affected by 
vitamin D as described in kidney cells (10, 18).   
 
The aim of the present study was to investigate the role of TRPV5 in inner ear physiology. By 
using immunohistochemistry, pre-pulse inhibition and Auditory Brainstem Response (ABR) 
measurements of TRPV5 knockout mice we provide evidence that TRPV5 fulfills a critical 
role in sound perception.  
 
Methods 
 
Generation of TRPV5 knockout mice (TRPV5-/-) 
TRPV5-/- mice were generated by targeted ablation of the TRPV5 gene and genotyped as 
described previously (19). Wild-type and TRPV5-/- littermates were kept in a light and 
temperature-controlled room with ad libitum access to deionized drinking water and standard 
pelleted chow (Sniff Spezialdiäten, Soest, the Netherlands). Eight week old TRPV5-/- and 
wild-type littermates were used for acoustic recordings and subsequently sacrificed for 
immunohistochemistry. 
 
Acoustic startle reflex 
Startle reactivity was measured using a startle response system (SR-LAB, San Diego 
Instruments, San Diego). The startle chamber consisted of a non-restrictive plexiglas cylinder 
(4 cm diameter), resting on a plexiglas platform inside the ventilated and sound attenuated 
chamber. A high-frequency loudspeaker inside the chamber produced both a continuous 
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background noise of 70 dB and the various acoustic stimuli. Vibrations of the platform, 
produced by the whole-body startle response of the mouse, were detected and transduced by a 
piezoelectric accelerometer mounted underneath the platform, connected to an automated 
system. Each mouse was placed inside the cylinder for 5 min with a background noise of 70 
dB to habituate before the first startle stimuli were given. The first block of the testing session 
consisted of 5 separate 120 dB startle pulse trials. The middle portion of the session consisted 
of 4 blocks with each block containing: (1) two startle pulse alone trials (120 dB burst), (2) 
four pre-pulse trials, in which 72, 74, 78, or 86 dB stimuli preceded the 120 dB burst, and (3) 
a no stimulus trial (only the 70 dB background noise). These 7 trials were presented in a 
pseudo-random order. The last part of the testing session consisted of a block with 5 separate 
120 dB startle pulse trials. Pre-pulse inhibition was calculated and expressed as percentage 
pre-pulse inhibition according to the following equation:  
 
pre-pulse inhibition (%) = 100 - [100 * (the startle amplitude following a 120 dB pulse 
preceded by a pre-pulse / the startle amplitude following a 120 dB pulse alone)]. 
 
Auditory brainstem response measurements 
Auditory Brainstem Response (ABR) measurements were performed in a sound-proof room 
with low reverberation. Needle electrodes were placed on M1 and M2 (left and right 
mastoids) and referred to Cz (vertex) to record the auditory-evoked potentials. A ground 
electrode was placed halfway on the tail of the mice. Interelectrode impedances were 
measured before and after each measurement (< 8 kOhm). Click stimuli of 100 μs and tone 
burst stimuli of 8 kHz (1ms rise/fall, 3ms plateau time) were presented in a sound field by 
placing the loudspeakers 5 cm in front of each ear. The loudness levels at the position of the 
ear were measured and calibrated with a Bruel and Kjaer 2203 sound pressure level (SPL) 
meter (Bruel & Kjaer, Nærum, Denmark). All thresholds were corrected afterward for the 
soundfield setup. Before the measurements were performed, the mice were i.p. injected with 
ketamine (200 mg/kg) anesthetic. A standard-evoked potential recording system (MedElec 
Synergy EP, Oxford Instruments Inc, Oxon, U.K.) was used to present 100 µs click stimuli 
with a fixed stimulation rate of 20 Hz. The analysis time was set at 15 ms from the onset of 
the click with a 1.5 ms pre-stimulus time to assess baseline levels. The recorded 
electroencephalography (EEG) signals were high-pass filtered at 100 Hz and low-pass filtered 
at 3 kHz; an automatic artifact rejection and a 60 Hz notch filter were used to avoid 
electromyography signals (EMG) or external noise. Auditory brainstem responses were 
obtained from both contra- and ipsilateral stimulation sites. The EEG signals were averaged 
for different stimulation levels according to standard audiometrical top-down procedures, 
starting at 90 dB (SPL), uncorrected for the soundfield. Peaks were identified according to the 
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Jewett and Williston nomenclature (20). The auditory hearing threshold was defined as the 
lowest level (in dBSPL) at which at least one reproducible peak was visually recognized in 
the responses obtained from the ipsilateral measured ear. Additionally, absolute peak and 
interpeak latencies were analyzed to assess possible conductive and/or retro-cochlear 
pathology. 
 
Immunohistochemistry  
Cochlea’s of wild-type and TRPV5-/- littermate mice (p4) were isolated and staining for 
TRPV5 was performed on cryosections of periodate-lysine-paraformaldehyde fixed cochlear 
samples using an affinity-purified anti-TRPV5 antibody as described previously (21). Images 
were taken using a Zeiss LSM510meta confocal laser scanning microscope equipped with a 
PlanApochromatic 63x 1.4 oil immersion DIC lens (Carl Zeiss GmbH, Jena, Germany). 
 
Statistical analysis 
In all experiments, data are expressed as mean ± SEM. Overall statistical significance was 
determined by analysis of variance (ANOVA) followed by Bonferroni contrast analysis to 
investigate individual significance using Instat 3 software for Apple computers (San Diego, 
CA, USA). P values below 0.05 were considered significant. 
 
Results 
 
Localization of TRPV5 in Deiter’s cells  
The localization of TRPV5 in cochlea of p4 wild-type mice was performed by 
immunohistochemistry and cochlea of TRPV5-/- littermates were used as a negative control. In 
wild-type mice TRPV5 immunopositive staining was present in Deiter’s supporting cells 
connecting the outer hair cells in the organ of Corti, whereas no TRPV5 immunopositive 
staining could be detected in corresponding cells of TRPV5-/- (Fig. 1B). Fig. 1A represents an 
overview of the organ of Corti cell types. Interestingly, TRPV5 immunopositive staining 
appeared directly at the interface of Dieter’s and outer hair cells suggesting apical localization 
of TRPV5. DIC images revealed that TRPV5-/- and wild-type littermates display normal 
morphology in the organ of Corti of TRPV5-/- as compared to their wild-type littermates.  
 
Acoustic pre-pulse inhibition startle response is reduced in TRPV5-/- mice 
To investigate the contribution of TRPV5 to sound perception, TRPV5-/- and wild-type 
littermates were analyzed in the acoustic startle reflex setup to asses their immediate reaction 
to sound stimuli. Both wild-type and TRPV5-/- mice demonstrated a continuous response 
amplitude of ~40 arbitrary units during the background (70 dB) trails (data not shown). This 
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response was defined as the basal activity of individual mice. Both groups showed maximal 
startle amplitude of ~1000 arbitrary units in reaction to the 120 dB startle pulses throughout 
the protocol (data not shown). Pre-pulse inhibition is defined as the suppression of the 120 dB 
pulse-induced startle response when this stimulus is preceded by a weak pre-pulse (+2, +4, +8 
or + 16 dB above background). The wild-type mice revealed typical pre-pulse inhibition, 
which was increased by application of elevating pre-pulse intensities (Fig. 2A). The strongest 
pre-pulse inhibition was shown after the +16 dB pre-pulse. Similarly, TRPV5-/- mice revealed 
an increased pre-pulse inhibition accompanying elevated pre-pulse intensities. The pre-pulse 
inhibition was, however, less pronounced as their wild-type littermates with significant 
differences (p<0.05) at +16 dB pre-pulse intensity above background. To investigate potential 
neuronal conductance alterations the latencies during the startle reflexes were assessed. 
Latency responses to the startle pulses were equal in both groups throughout the protocol 
demonstrating the absence of neuronal defects in the TRPV5-/- mice (Fig. 2B).   
 
Fig. 1. TRPV5 localizes to 
the cochlear spiral 
ganglion   
(A) Cartoon representing 
the sensory epithelium cell 
types in the organ of Corti. 
One inner hair cell (IHC) 
and three outer hair cells 
(OHC) are surrounded by 
different supporting cells: 
interphalangeal cells (I); 
pillar cells (P); Deiter’s cells 
(D); Hensen’s cells (H); and 
Claudius cells (C). (B) 
Immunohistological 
detection of TRPV5 in mice 
Deiter’s cells. Sections of 
cochlea isolated from 
TRPV5-/- mice were used as 
negative control in which 
immunopostive staining was 
virtually absent.   
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Fig. 2. Decreased acoustic 
pre-pulse inhibition startle 
reflexes in TRPV5-/- 
(A) Pre-pulse inhibition of the 
startle response was recorded 
by offering four successive 
protocols. Each protocol 
consisted of four pre-pulse 
trails, in which a 72, 74, 78, or 
86 dB stimulus preceded the 
120 dB startle pulse. Pre-pulse 
inhibition is expressed as 
percentage inhibition of the 
pulse response. Wild-type (open 
bars) mice reveal a clear pre-
pulse inhibition that is increased 
upon elevation of the intensity 
of the pre-pulse. TRPV5-/- mice 
(closed bars) reveal a lower pre-
pulse inhibition as compared to their wild-type littermates. (B) No differences were detected in the 
latency indicating that the observed decrease is independent from neuronal conductance. Significant 
differences (P<0.05) between wild-type (n=17) and TRPV5-/- (n=17) littermates are indicated by an 
asterisk.  
 
Increased auditory thresholds in TRPV5-/- mice  
Because TRPV5-/- mice displayed decreased acoustic pre-pulse inhibition startle responses, 
Acoustic Brainstem Response (ABR) recordings were measured to evaluate the exact hearing 
capacities of the TRPV5-/- mice. Besides a click ABR (2-3 kHz), a burst protocol (8 kHz) was 
applied to characterize the auditory thresholds at a higher frequency. In both, wild-type mice 
and TRPV5-/- littermates consistent and reproducible ABRs at 90 dBSPL were evoked using 
either click (Fig. 3A) or burst (Fig. 3B) stimuli. Peaks were subsequently identified according 
to the Jewett and Williston nomenclature (20) and auditory thresholds were determined by 
averaging of minimal 500 responses. Mean auditory thresholds were identified for wild-type 
mice and TRPV5-/- littermates in reaction to click and tone burst stimuli. TRPV5-/- 
consistently revealed higher thresholds (i.e. no reproducible responses at lower stimulation 
levels) compared to their wild-type littermates in reaction to both the click and burst stimuli 
(Fig. 3C) suggesting a critical role for TRPV5 in sound perception. 
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Fig. 3. Increased auditory 
thresholds in TRPV5-/- mice 
Representative auditory 
brainstem responses from a wild-
type mice (upper traces) and a 
TRPV5-/- littermate (lower traces) 
in response to click (A) or burst 
(B) stimuli at different stimulus 
intensity levels in dBSPL. Wild-
type mice (upper traces) reveal normal brainstem response obtained at different stimulation levels 
according to standard audiometrical descending top-down procedures until the level where no 
reproducible responses are recognized (i.e. 15 dBSPL for click and 20 dBSPL for burst stimuli). In 
contrast to the wild-type mice, the TRPV5-/- littermates (lower traces) show a lack of auditory 
brainstem responses at lower stimulation levels (i.e. higher hearing threshold at 40 dBSPL for both 
click and burst stimuli). Horizontal axes: time window of 15 ms (1.5 ms /division); vertical axes: 
amplitude in microvolt (μV). Stimulus onset at 1.5 ms. (C) Mean auditory brainstem thresholds of 
wild-type mice and TRPV5-/- littermates obtained with click and burst stimuli. Significant 
differences (p<0.05) between wild-type (n=16) mice and TRPV5-/- littermates (n=18) are indicated 
by an asterisk.  
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In order to investigate the neuronal conductivity in TRPV5-/- and wild-type littermate mice, 
latencies of the click and burst stimuli were analyzed. The mean absolute latencies of peak (JI 
to JV) and mean interwave intervals (JI-III, JI-IV, JI-V) of the ABR obtained from TRPV5-/- 
and wild-type mice at 90 dB for clicks (Fig. 4A) and tone bursts (Fig. 4B) revealed no 
significant differences between both animal groups suggesting normal neuronal conductivity 
in TRPV5-/- mice. To investigate neural behavior near threshold levels, input-output functions 
of latency growth were analyzed for both stimuli. Therefore, the latency of peak V was 
plotted as a function of the stimulus intensity. The latency shift as a function of stimulus 
intensity for click (Fig. 4C) and burst (Fig. 4D) showed the typical latency increase at lower 
intensities (22) revealing no overall differences between wild-type and TRPV5-/- (p > 0.05). 
 
Fig. 4. Normal latencies in TRPV5-/- mice 
Mean peak and interpeak latencies (ms) obtained with 90 dB click- (A) and tone burst- (B) ABR in 
wild-type (closed symbols) and TRPV5-/- (open symbols) littermates. No differences in latencies in 
response to either click or burst stimuli indicate a normal neuronal conductivity in TRPV5-/-. Input-
output curves of JV latency as a function of stimulus intensity for the click-ABR (C) and for tone 
burst-ABR (D). Mean latencies of peak V decreased with increasing stimulation level and no 
differences were observed between both groups indicating that neural synchronicity at the 
brainstem is normal in TRPV5-/- mice.  
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Discussion 
The present study identified TRPV5 as an essential component in Deiter’s supporting cells 
contributing significantly to overall sound perception thresholds. Our conclusion is based on 
the following experimental observations. First, in cochlea TRPV5 localizes to Deiter’s cells at 
the outer hair cell interface. Second, genetic ablation of TRPV5 decreases the acoustic pre-
pulse inhibition while the latencies remained normal. Third, mice lacking TRPV5 display 
increased thresholds with normal latencies during auditory brainstem recordings. 
Mice that lack TRPV5 display renal Ca2+ wasting, intestinal hyperabsorption and a reduced 
bone thickness underlying the important function of TRPV5 in maintaining a normal Ca2+ 
balance (19). Since the Ca2+ transport proteins described in transcellular Ca2+ reabsorption in 
kidney are also expressed in the cochlea where they potentially fulfill similar functions we 
explored the functional aspect of the apical influx channel TRPV5 in sound perception. 
Recently, TRPV5 transcripts have been detected in primary cultures of semicircular canal 
duct epithelial cells from neonatal rats (18). The authors speculated that TRPV5 is involved in 
maintaining the low Ca2+ concentration in vestibular endolymph. Here, we localized TRPV5 
to the outer hair cell interface of Deiter’s supporting cells using wild-type and TRPV5-/- mice. 
TRPV5 was, however, not detected in the stria vascularis. Like in kidney, TRPV5 localized 
apically in the Deiter’s cells suggesting that TRPV5 could account for apical Ca2+ influx. 
Acoustic startle responses are specially suited for the investigation of immediate responses to 
sudden acoustic stimuli resulting in a measurable startle response of the subject (23, 24). Both 
tested mice strains showed a similar acoustic startle response to the 120 dB startle pulse 
demonstrating normal detection of the high intensity startle pulses. Startle responses of wild-
type mice in reaction to the 120 dB startle pulse preceded by a low intensity pre-pulse 
revealed a typical reaction such that the startle response decreased when the pre-pulse 
increased (pre-pulse inhibition). The pre-pulse inhibition in TRPV5-/- littermates was 
decreased compared to the wild-type mice, suggesting defects in the detection of the pre-
pulse. Importantly, no adaptations to the 120 dB startle pulse were detected throughout the 
protocol indicating that the observed decrease in pre-pulse inhibition is not due to habituation. 
Furthermore, the time point of the maximal response (Tmax) was comparable demonstrating 
that the latency is equal in both mice. Besides broadband clicks, higher frequency tone bursts 
ABRs were recorded since the power spectrum of broadband clicks is merely focused at a 
relative low frequency range (around 3 kHz). Both click and burst recordings revealed 
increased thresholds for TRPV5-/- mice as compared to their wild-type littermates further 
indicating a critical function for TRPV5 in sound perception. 
Similar as during the startle response measurements the ABR recordings of TRPV5-/- showed 
comparable latencies. This suggests that there is no conductive hearing loss or high-frequency 
cochlear hearing loss, which is normally associated with a total wave delay of the ABR (25). 
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In addition, the response morphology of the ABR peak latencies does not differ from the 
control group further demonstrating that TRPV5-/- mice have normal neuronal conductivity. In 
addition, analysis of the interwave intervals showed that the JI-III and JI-V interwave 
intervals of the TRPV5-/- mice are similar to the interwave intervals obtained from wild-type 
littermates confirming the absence of any neuropathology. Tone burst-evoked ABR revealed 
similar latencies for both wild-type and TRPV5-/- demonstrating that cochlear generation of 
excitatory postsynaptic potentials are comparable to responses obtained with click stimuli. 
Moreover, these results reveal the absence of differences in neural conductivity which could 
potentially explain the higher threshold in the TRPV5-/- mice. Taken together, we found no 
differences in neural synchronicity at the brainstem or altered neural conductivity between 
wild-type and TRPV5-/- mice. 
Sound detection in TRPV5-/- mice is undisturbed at higher intensity as reflected by the normal 
startle response at 120 dB and normal ABRs at higher intensities. Since only at low sound 
intensities hearing of the TRPV5-/- mice is disturbed it is likely that cochlear amplification by 
the outer hair cells is malfunctioning. TRPV5 localizes to Dieters’s cells that are generally not 
assigned as sensory cells although they can, at least in vitro, divide and differentiate into 
functional hair cells (26). Deiter’s cells belong to the organ of Corti non-sensory supporting 
cells of which the function is not fully understood, while their role in cochlear homeostasis 
has gained general acceptance. Deiter’s cells are in close contact with the apical and basal 
pole of the outer hair cells. Mutations in both Fibroblast Growth Factor receptor 3 and 
Sprouty2 were found to cause perturbations in the cytoarchitecture of the organ of Corti 
leading to a disturbance in the overall sound perception indicating that the architecture of the 
supporting cells is essential for normal sound perception within the organ of Corti (1, 2). The 
organ of Corti in TRPV5-/-, however, has a normal morphology as compared to their wild-type 
littermates. Together these results suggest a direct effect, of the Deiter’s cells in sound 
perception, other than merely providing support to the outer hair cells.    
In summary, TRPV5 likely plays an essential role in sound perception. In cochlea TRPV5 
localizes to the Deiter’s cells where the channel contributes to amplification of lower sound 
intensities thereby determining hearing thresholds. At the outer hair cell interface TRPV5 
potentially accounts for apical Ca2+ influx in Deiter’s cells. Thus, our data provides evidence 
for a more direct role of Deiter’s cells in supporting sound perception near threshold 
intensities. 
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Chapter VIII 
Introduction 
To balance the total amount of Ca2+ in our body Ca2+ is absorbed in the intestine, exchanged 
from bone and reabsorbed in kidney. The specialized TRP family members TRPV5 and 
TRPV6 contribute significantly to this process by acting as luminal influx ports in these 
tissues (1-3). Transcellular Ca2+ transport in Ca2+-transporting epithelia constitutes a three-
step process (4). First, Ca2+ enters the cell at the luminal membrane via TRPV5 and TRPV6. 
Second, once in the cell Ca2+ is bound by calbindins that ferry Ca2+ from the luminal 
membrane towards the basolateral membrane. Finally, Ca2+ is excreted by the Na+/Ca2+ 
exchanger NCX1 and Ca2+ ATPase PMCA1b. A detailed insight into the molecular regulation 
of TRPV5 and TRPV6 is thus pivotal for the general understanding of Ca2+ homeostasis. 
Various mechanisms to regulate the activity of these channels have been identified operating 
both on the genomic and non-genomic level. The results described in this thesis focused on 
the intrinsic mechanisms controlling the activity of these channels thereby describing novel 
perspectives in TRPV5 and TRPV6 physiology. This chapter will summarize and discuss the 
data of these studies and will integrate the results in our current understanding of TRPV5- and 
TRPV6-mediated Ca2+ transport. Finally, new research questions will be formulated that can 
be addressed in future studies.    
 
Coordinated genomic control of the renal Ca2+ transport machinery 
Several studies exploring the regulatory role of 1,25(OH)2D3, PTH, estrogens and dietary Ca2+ 
revealed a concomitant regulation of the renal Ca2+ transport proteins. Additional evidence for 
1,25(OH)2D3- and PTH-independent regulation of the Ca2+ balance was obtained from 
TRPV5-/- mice. Down-regulation of the vitamin D-dependent Ca2+ transport proteins including 
calbindin-D28K (CaBP28K) and NCX1 in kidneys of these mice despite elevated levels of 
1,25(OH)2D3 suggests that TRPV5 is primarily involved in the regulation of the Ca2+ transport 
protein expression in kidney independent of 1,25(OH)2D3. An interesting question is how the 
expression of TRPV5 specifically coordinates the Ca2+ transport machinery. Because TRPV5 
is the gatekeeper controlling the apical Ca2+ influx it is feasible that the magnitude of Ca2+ 
influx through TRPV5 determines the expression of the Ca2+ transport proteins. This 
hypothesis was recently investigated using primary cultures of rabbit connecting tubule 
(CNT) and cortical collecting duct (CCD) cells (5). Long-term exposure to PTH stimulated 
transepithelial Ca2+ transport in these epithelial cells, and concomitantly elevated the 
expression of TRPV5, CaBP28K and NCX1. Blockage of TRPV5 channel activity by 
ruthenium red abolished PTH-stimulated transepithelial Ca2+ transport, which was 
accompanied by a reduction in NCX1 and CaBP28K expression. These findings support the 
hypothesis that the magnitude of the Ca2+ influx through TRPV5 controls the expression of 
the other Ca2+ transport proteins. This implicates an efficient regulation of Ca2+ reabsorption 
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in kidney where Ca2+ regulates its own transport activity. Thus, when the expression of 
TRPV5 changes the complete machinery including CaBP28K, NCX1 and PMCA1b follows 
accordingly. An important question that remains to be answered, however, is how the flux of 
Ca2+ through TRPV5 adjusts the expression of the Ca2+ transport proteins. Previous studies 
have indicated that Ca2+ is important for gene transcription (6). A Ca2+-responsive element has 
been identified in the promoter sequence of CaBP28K that underlies the purkinje cell specific 
expression of CaBP28K (7). However, It is not known whether this element is active in kidney 
and/or whether additional intracellular signaling molecules are involved. An established 
pathway for regulation of gene expression by Ca2+-signaling is via the ubiquitously expressed 
Ca2+ sensor calmodulin (CaM) that can stimulate gene expression via distinct mechanisms. 
Nuclear CaM-dependent kinase IV (CaMKIV) and the transcription factor CREB (cAMP-
response binding protein) are among the CaM-regulated proteins that affect gene expression 
(8). Besides CaM, the Ca2+-binding protein calcineurin / NFAT (nuclear factor of activated T 
cells) signaling cascade can also stimulate gene expression upon a rise of intracellular Ca2+. 
Recently this pathway has been shown to be essential for the expression of the sodium-
phosphate co-transporter (NaPi) in kidney underlying the Ca2+-dependent expression of NaPi 
(9). Currently, it is not known whether these mechanisms are involved in the TRPV5-
mediated control of the Ca2+ transport machinery transcription. However, recent cDNA micro 
array analysis, to further identify gene products in the kidney which are regulated by high 
dietary Ca2+ and/or 1,25(OH)2D3, performed on kidneys from high dietary Ca2+ or 
1,25(OH)2D3-treated 1α-OHase-/- mice provided novel insights in the Ca2+-dependent 
transcriptional regulation of the Ca2+ transport machinery. In this study, 1,25(OH)2D3 induced 
a significant regulation of ~1000 genes, whereas dietary Ca2+ supplementation of the 1α-
OHase-/- mice revealed ~2000 controlled genes (4). Importantly, Ca2+ transport proteins 
including NCX1 and CaBP28K were among the dietary Ca2+-regulated genes confirming that 
besides vitamin D, dietary Ca2+ determines the expression of the renal Ca2+ transporters. 
Furthermore, intracellular signaling molecules, including CaM, were identified that might be 
part of the signaling pathway that underlie the Ca2+-regulated expression of the complete Ca2+ 
transport machinery in kidney.   
Together these findings contribute to the concept that once the activity of the gatekeeper 
TRPV5 is altered, the complete Ca2+ transport machinery will be affected accordingly, since 
the magnitude of the Ca2+ flux that enters the cell via TRPV5 coordinates the expression of 
the other Ca2+ transport proteins. From a clinical point of view these findings reveal an 
efficient way to regulate overall renal Ca2+ handling by compounds that specifically stimulate 
or inhibit TRPV5 channel activity. The underlying molecular signaling pathway, however, 
remains to be identified. Future studies like promoter analysis in the Ca2+ transporter genes to 
identify functional Ca2+-responsive elements, and experiments focusing on the different Ca2+-
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dependent signaling pathways and transcription factors will bring further knowledge about the 
Ca2+-regulated coordinated genomic control of renal Ca2+ transporters.  
 
Factors and mechanisms controlling TRPV5 cell surface expression 
One of the mechanisms of ion channel regulation is the control of cell surface expression, 
thereby determining the ion permeability of the plasma membrane. Since TRPV5 and TRPV6 
are localized in vesicular structures and these channels display constitutive activity, cell 
surface expression of TRPV5 and TRPV6 largely controls the Ca2+ permeability of Ca2+-
transporting epithelia. Several TRPV5-associated proteins were previously identified in 
controlling channel plasma membrane expression. The S100A10-annexin 2 complex was 
identified as an essential component of the machinery employed to deliver TRPV5 to the 
plasma membrane whereas Rab11A is part of a GTP/GDP-dependent recycling mechanism of 
TRPV5 cell surface expression (10, 11). The key question that remains to be answered is 
whether both pathways integrate or operate in parallel. TRPV5 plasma membrane expression 
controlled by Rab11A recycling is clearly dependent on the processing of GTP as reflected by 
the different observations with Rab11A mutants that resemble constitutive GTP bound or 
GTP unbound states (10). No stimuli were identified that initiate plasma membrane 
expression of TRPV5 under the control of the S100A10-annexin 2 complex, suggesting that 
TRPV5 trafficking by the S100A10-annexin2 complex operates independently from the 
Rab11A pathway. However, the S100A10-annexin 2 complex has recently been identified to 
determine the distribution of Rab11-positive endosomes indicating that both pathways might 
intersect (12). Future experiments focusing on this overlap should elucidate this potential 
functional link. 
The project described in chapter 2 basically started with the fundamental question not 
answered thus far: “Which factors known to affect the Ca2+ balance control TRPV5 plasma 
membrane expression?”. Importantly, these factors most likely not directly activate or gate 
TRPV5 given the electrophysiological characteristics that the channel operates as a 
constitutively active ion channel but initiate Ca2+ transport by rapidly recruiting the channel 
towards the cell surface and visa versa. We demonstrated that extracellular pH dynamically 
determines TRPV5 cell surface expression and coherent channel activity enabling tight and 
spatial-temporal control of this channel. Upon extracellular alkalinization TRPV5 containing 
vesicles are recruited to the plasma membrane resulting in a significant increase in TRPV5 
activity, whereas extracellular acidification results in retrieval of TRPV5 from the plasma 
membrane accompanied by a decrease in channel activity. At the cell surface these TRPV5 
containing vesicles remain intact and do not completely fuse and collapse at the plasma 
membrane indicating that TRPV5 accesses the extracellular solution from inside these 
vesicles. This “kiss and linger” delivery process is unique as compared to previously 
132
Chapter VIII 
 
identified modes of vesicular trafficking (Fig. 1). The general concept of TRP channel 
delivery is that these channels are delivered via classical “fuse and collapse” modes of 
vesicular trafficking. “Fuse and collapse” exocytosis is a well studied process and many 
components have been identified that underly vesicle docking, fusion and collapsing at the 
plasma membrane (13). During “fuse and collapse” the vesicle forms a fusion pore at the cell 
surface that dilates until the membrane of the vesicle is completely collapsed into the plasma 
membrane (Fig. 1). “Fuse and collapse” delivery, however, operates on a time scale that 
might be insufficient for rapid regulation of constitutively active ion channels. Thus “kiss and 
linger” might be a more delicate mechanism underlying tight and spatial-temporal control of 
constitutively active ion channels. For exocytosis of soluble cargo three modes of vesicular 
movement have been identified. Besides the classical pathway “fuse and collapse” rapid 
stimulated exocytosis of soluble cargo is dependent on “kiss and run” which describes that 
exocytotic vesicles form a transient opening that does not dilate further. Upon release of its 
cargo, the vesicle rapidly reseals thereby retrieving the secretory vesicle intact from the cell 
surface (14-16). A third pathway termed, “fuse-pinch-and linger” or “kiss and coat” is sort of 
an intermediate between full fusion and transient openings. This latter mode of exocytosis 
entails prolonged maintenance of the transient opening followed by direct retrieval of the 
emptied vesicle. The latter two modes of exocytosis of soluble compound are thus comparable 
to “kiss and linger” delivery of TRP channels and potentially similar underlying machineries 
are employed. Recently “kiss and coat” vesicles were identified to be surrounded by an actin 
filament (F-actin) after reaching the cell surface followed by prolonged opening of the 
transient pore and subsequent direct retrieval (14). Thus, potentially the actin filament 
prevents the integration of recruited vesicles in the membrane which might be a general 
mechanism for generating local signals via direct membrane fusion. Detailed electron 
microscopy of TRPV5-expressing cells should provide further knowledge about potential 
actin based filaments around TRPV5-containing vesicles that form “kiss and linger” 
interactions with the plasma membrane.       
Kiss and linger delivery of TRP channels was previously investigated for TRPC5 although 
this study could not distinguish between actual vesicle fusion and subsequent diffusion of the 
channel into the plasma membrane or transient interaction of the vesicles with the plasma 
membrane (17). The results described in chapter 2, however, reveal that rapid recruitment of 
constitutively active TRP channels is dependent on vesicles that “kiss and linger” at the 
plasma membrane. A series of previous studies suggested that recruitment of TRPs to the 
plasma membrane is an alternative mechanism by which these channels are activated although 
the precise underlying mechanism remained unknown (18-20). Therefore, the elucidation of 
“kiss and linger“ opens new insights in ion channel regulation in general. Reflecting previous 
findings in TRPV5 regulation with the knowledge of this newly identified mechanism might 
133
Chapter VIII 
 
unravel other factors that rapidly increase overall TRPV5 activity via “kiss and linger” 
delivery. Intracellular Ca2+ is an important factor controlling TRPV5 activity although, recent 
data indicated that a decrease in [Ca2+]i does not result in the recruitment of TRPV5 to the cell 
surface as assed by TIRF microscopy (Lambers et al, unpublished results). Providing 
evidence that urinary Ca2+ can affect the trafficking of luminal transporters or channels is the 
mechanism underlying the coupling of hypercalciuria and polyuria (21). High levels of 
urinary Ca2+ were found to antagonize vasopressin-induced trafficking of the water permeable 
channel, aquaporin 2, suggesting that the urinary Ca2+ concentration controls aquaporin 2 cell 
surface expression on the luminal membrane (21). During hypercalciuria this mechanism 
might inhibit water reabsorption thereby preventing further concentration of Ca2+ and Ca2+ 
stone formation. Potentially, similar mechanisms exist for TRPV5 and TRPV6 where 
extracellular Ca2+ determines the cell surface expression via a “kiss and linger” pathway. In 
this case the Ca2+-sensing receptor which is expressed on the luminal surface of the distal 
conculte tubule (DCT) en CNT (22) senses potential changes in the local extracellar Ca2+ 
level which might result in rapid changes in TRPV5 cell surface expression via a “kiss and 
linger” mechanism.  
 
Fig. 1 Modes of 
vesicular 
trafficking 
Activation of 
constitutively 
active TRP 
channels likely 
depends on 
rapidly recruited 
TRP-containing 
vesicles that 
remain intact at 
the plasma membrane interface (process termed “kiss and linger”). Constitutively active TRP 
channels access the extracellular solutions from inside the vesicle via transient openings in the 
plasma membrane. Upon removal of the stimulus these vesicles are rapidly retrieved from the 
plasma membrane, enabling tight spatial-temporal control of the TRPV5 channels. Compared tot 
the classical vesicular pathway of membrane protein trafficking termed “fuse and collapse”, “kiss 
and linger” is thus a unique mechanism. “kiss and linger” resembles “kiss and run” exocytosis of 
soluble cargo. This specialized mode of vesicular cargo delivery describes that exocytotic vesicles 
form transient openings with the plasma membrane, which upon secretion of its cargo, relocate 
back to the cytosol for reloading.  
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Ca2+-dependent activity of TRPV5 and TRPV6 
Both TRPV5 and TRPV6 display a negative feedback regulation of channel activity by 
intracellular Ca2+. This is evident from the relation between [Ca2+]i and channel activity and 
the immediate decrease in channel activity after a hyperpolarizing pulse even in the presence 
of high affinity chemical Ca2+ buffers (23). TRPV5 inactivation is of physiological 
importance to prevent a Ca2+ overload in the situation where no adequate intracellular Ca2+ 
handling is provided. Both TRPV5 and TRPV6 are thus dependent on the amount and rate of 
Ca2+ they transport and amount of intracellular Ca2+-buffering present. Unlike several other 
ion channels that contain a functional Ca2+-binding EF-hand motif in their intracellular tail(s) 
(24-26), TRPV5 and TRPV6 do not have a Ca2+-binding domain. Thus, the stuctural 
properties of TRPV5 and TRPV6 cannot explain this phenomenon. A potential candidate that 
translates the local Ca2+ concentration in channel activity might be CaM given that a diverse 
range of both voltage and non-voltage dependent ion channels are regulated by this 
ubiquitously expressed Ca2+ sensor. The results described in chapter 3 reveal that CaM 
associates with both TRPV5 and TRPV6 although channel regulation appears to be restricted 
to TRPV6. CaM is constitutively bound to both TRPV5 and TRPV6 at physiological [Ca2+]i 
and acts as a Ca2+ sensor only controlling TRPV6 activity. The difference in TRPV5 and 
TRPV6 channel regulation by CaM is rather unique given the high homology of both 
channels and similar association characteristics with this Ca2+ sensor. Detailed 
electrophysiological analysis revealed that the Ca2+-dependent inactivation kinetics of TRPV5 
are, initially after a hyperpolarizing pulse, less pronounced than for TRPV6 although total 
inactivation is not significantly different. (27). Potentially, CaM is involved in the initial 
TRPV5 inactivation as suggested from the differences in this particular part of TRPV5 
kinetics in the presence of Ca2+ insensitive CaM. Since the differences in overall TRPV5 
kinetics are not significant, more sensitive measurements focusing on the initial Ca2+-
dependent inactivation are needed to establish a potential role of CaM in TRPV5 activity. 
Previously, CaM was shown to be consistently co-regulated with TRPV5, supporting a 
potential functional link between these two proteins (28). Taken together these results suggest 
that CaM only affects the activity of TRPV6. Crucial to the CaM function are the number of 
CaM molecules regulating each channel. To address this point the stochiometry of the 
interaction should be known which is in the generally applied in vitro binding assays difficult 
to establish. Recently this important question was answered for L-type voltage-operated 
channel by creating channel-CaM fusion proteins (29). Using chimeric molecules this study 
revealed that a single CaM directs channel regulation. Reflecting TRPV6 regulation these 
results would suggest that a single constitutively associated CaM molecule translates the local 
Ca2+ concentration in TRPV6 channel activity.  
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In chapter 4 and 5 the role of calbindins in transcellular Ca2+ transport is described. CaBP28K 
is part of the transcellular Ca2+ transport machinery in Ca2+-transporting cells and is 
consistently co-regulated with TRPV5 (30). Previous modeling studies suggested that 
calbindin-D9K stimulates intestinal Ca2+ absorption by increasing the diffusional range of 
Ca2+, thereby facilitating Ca2+ transport from the luminal influx side towards the basolateral 
membrane where Ca2+ is excreted (31, 32). Based on these models a similar role for CaBP28K 
in renal Ca2+-transporting cells was predicted. In chapter 4 we described CaBP28K as an 
interacting protein partner of TRPV5 and demonstrated that CaBP28K dynamically regulates 
TRPV5 channel activity. CaBP28K association does not directly affects the biophysical 
properties of TRPV5. However, by binding with TRPV5 CaBP28K provides for spatial Ca2+-
buffering at the side where Ca2+ levels can become detrimental. This prevents a local increase 
of [Ca2+]i and preliminary TRPV5 inactivation. Thus, besides facilitating intracellular Ca2+ 
diffusion, CaBP28K enables high levels of transcellular Ca2+ transport by preventing a local 
accumulation of Ca2+ in the TRPV5 pore. Probably, similar mechanisms of targeted Ca2+-
buffering occur in brain, bone, teeth, inner ear, placenta and intestine where calbindins are 
abundantly expressed and cells tolerate a large Ca2+ influx. In line with this suggestion is the 
study of Lee and co-workers who found that CaBP28K affects the activity of L-type voltage-
operated channels contributing to the Ca2+-dependent activity by increasing the Ca2+ 
sensitivity of the channel (33). Thus for these channels, CaBP28K acts as a Ca2+ sensor thereby 
substantiating previous results that CaBP28K may function not only as a Ca2+ buffer, but also 
as a Ca2+ sensor affecting downstream processes (34-36). 
Unlike the previous modelling studies that adapted the properties of CaBPs to determine Ca2+ 
fluxes, the model described in chapter 5 focuses on the intrinsic mechanism of intracellular 
Ca2+-handling during experimentally derived Ca2+ fluxes. This enabled us to study in detail 
the experimental findings described in chapter 4. Renal Ca2+-transporting cells were modelled 
as a cylinder in which Ca2+ enters the cell at the luminal side cell surface via TRPV5 from 
where Ca2+ spreads out evenly. This revealed that spatial buffering of Ca2+ by CaBP28K-
TRPV5 association reduces the apical [Ca2+] and tempers the region in which [Ca2+] exceeds 
to levels that would cause channel inactivation. During a previous study no changes in [Ca2+]i 
were detectable during high levels of transcellular Ca2+ transport (37). In line with these 
findings our model demonstrated that association of CaBP28K with TRPV5 results in the 
disappearance of the local increase in the TRPV5 pore domain [Ca2+] that originates from the 
transport of Ca2+ via the channel. Compared to other Ca2+ channels that generate a micro-
domain of high [Ca2+] around their pore to initiate a cascade of signaling processes, TRPV5 
possesses a targeted Ca2+ buffer that prevents accumulation of Ca2+. In Ca2+-transporting 
epithelia transcellular Ca2+ transport thus operates independently from Ca2+-signaling (37). 
The underlying mechanism of how CaBP28K discriminates between Ca2+-signaling and Ca2+ 
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transport is likely mediated by spatial buffering via interaction with the channel or plasma 
membrane. Moreover, the Ca2+-binding properties of CaBP28K are insufficient to prevent Ca2+-
signaling. At least for excitable cell it is known that opening of Ca2+-signaling channels 
generates a Ca2+ flux of such a large magnitude that the flux is out of range of any Ca2+ 
buffer. This in turn implicates that CaBP28K continuously binds all Ca2+ that enters the cell via 
TRPV5 and subsequently transports Ca2+ to the basolateral membrane. Although the single 
channel Ca2+ conductance of TRPV5 is unknown these findings basically suggest that opening 
of TRPV5 channels elicits a Ca2+ flux that is in range of Ca2+-buffering by CaBP28K. 
Interactions at the side of Ca2+ entry further stimulate direct buffering of Ca2+ such that no free 
Ca2+ enters the cell but is immediately buffered by CaBP28K. This is supported by our findings 
described in chapter 5 predicting that the single TRPV5 channel Ca2+ flux is in the order of 
104 Ca2+ ions per second. This is significantly lower compared to voltage-operated Ca2+ 
channels, contributing to Ca2+-signaling in excitable cells that generate single channel Ca2+ 
fluxes in the order of 106 Ca2+ ions per second. Thus, Ca2+ influx through TRPV5 and 
subsequent immediate Ca2+-buffering by CaBP28K are processes that are directly coupled and 
optimized for high levels of transcellular Ca2+ transport without initiation of and interference 
with signaling pathways.  
Integration of our current knowledge of Ca2+-dependent regulation of TRPV5 and TRPV6 
activity suggests a crucial role for CaBP28K and CaM. In this process, calbindins act as 
dynamic Ca2+ buffers providing adequate intracellular Ca2+-handling, whereas CaM operates 
as a Ca2+ sensor controlling channel activity. Compared to calbindins, the affinity of CaM for 
Ca2+ is relatively high which enables CaM to bind Ca2+ even in the presence of submillimolar 
concentrations of calbindin. This enables CaM to constitutively interact with TRPV5 and 
TRPV6 at a physiological [Ca2+]i since Ca2+-CaM associates with these channels under these 
conditions (35, 38). Thus most likely, both associated proteins operate independently from 
each other. In addition, the novel EF-hand containing protein 80K-H was identified as a Ca2+ 
sensor controlling TRPV5 activity whereas the role of 80K-H in determining TRPV6 activity 
is unknown (39). Although 80K-H was shown to bind Ca2+, the Ca2+ affinity of the two EF-
hand structures remains elusive which makes it difficult to integrate 80K-H in a model of 
overall Ca2+-dependent activity of these channels. Probably, the Ca2+-binding affinity of the 
EF-hand structures in 80K-H is comparable with those in the high affinity sites of CaM. 
Otherwise, 80K-H would not be able to control TRPV5 activity in the presence of the high 
levels of calbindins in Ca2+-transporting cells. One could envisage that 80K-H is involved in 
the inactivation of TRPV5 when CaBP28K is saturated with Ca2+. This implicates that 
inactivation of the EF-hand residues would result in an increased overall TRPV5 activity 
since the negative feedback inhibition by 80K-H is abolished in this case. The results, 
however, indicates that inactivation of the EF-hand structures in 80K-H decreases TRPV5 
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activity. This further substantiates that the affinity of 80K-H is comparable to that of CaM and 
80K-H controls TRPV5 activity independently from CaBP28K by acting as a Ca2+ sensor. In 
summary, the effect of CaM on TRPV6 and 80K-H on TRPV5 activity are comparable and 
implicates that at a physiological [Ca2+]i these proteins control TRPV5 and TRPV6 function, 
making them part of the complex regulatory network to balance Ca2+ influx in Ca2+-
transporting epithelia. 
Thus, our findings suggest a comprehensive model for Ca2+-dependent activity of TRPV5 and 
TRPV6 (Fig. 2). At a physiological [Ca2+]i these channels are normally transported to the cell 
surface and 80K-H and CaM associate with TRPV5 and TRPV6, respectively. Here, the 
channels are active and Ca2+ that enters the cell is immediately buffered by recruited 
calbindins. Subsequently, calbindines transport Ca2+ to the basolateral membrane where Ca2+ 
is excreted. Upon saturation of the calbindins the channels inactivate because of a local rise in 
[Ca2+]. The mechanism that translates this local increase in TRPV5 and TRPV6 inhibition, 
however, remains to be elucidated. 
 
Fig. 2 
Regulation of 
TRPV5 and 
TRPV6 by 
Ca2+-binding 
proteins  
Overall Ca2+-
dependent 
activity of 
TRPV5 and 
TRPV6 is 
determined by 
a set of Ca2+-
binding 
proteins. At 
normal 
physiological [Ca2+]i these channels reach the cell surface where 80K-H and CaM associate with 
TRPV5 and TRPV6, respectively. Here, the channels are active and Ca2+ that enters the cell is 
immediately buffered by recruited CaBP28K (TRPV5) and CaBP9K (TRPV6). Calbindins 
subsequently ferry Ca2+ to the basolateral membrane where Ca2+ is excreted by NCX1 and 
PMCA1b. Upon saturation of the calbindins the channels inactivate due to a local rise in [Ca2+]. 
The mechanism that translates this local increase into TRPV5 and TRPV6 inhibition is, however, 
still not identified.  
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TRPV5 regulation at the cell surface 
Although the electrophysiological characteristics of both TRPV5 and TRPV6 reveal 
constitutive activity, these channels appear to be affected by associated proteins via 
mechanisms other then plasma membrane trafficking (40, 41). The results shown in chapter 6 
contribute to this concept by revealing that the recently identified protein Nipsnap1 regulates 
TRPV5 activity without affecting cell surface expression. Co-expression of Nipsnap1 along 
with TRPV5 dramatically decreases channel activity. The interaction of Nipsnap1 is localized 
to the carboxyl-terminus MLERK sequence, previously identified to be essential for 80K-H 
and Rab11A association, and channel tetramerization (10, 39, 42). These findings suggest that 
Nipsnap1 competes with other TRPV5-associated proteins for binding to the channel. As 
evident from the cell surface biotinylation assays this competition does, however, not result in 
altered TRPV5 plasma membrane expression. Thus, associated proteins like S100A10-
annexin 2 and Rab11 are likely not involved in the Nipsnap1-mediated inhibition of TRPV5 
activity. Another option is that Nipsnap1 binding results in changes of the TRPV5 structure, 
which would decrease channel activity. Such a mechanism of structural changes was 
formulated, at least in part, to explain the pH-sensitivity of the channel (43). Both intra- and 
extracellular protons were found to affect the position of the TRPV5 pore helix structure such 
that upon acidification the helix rotates clockwise resulting in narrowing of the channel pore 
(43). The Nipsnap1-mediated inhibition of channel activity suggests that binding of Nipsnap1 
is dynamic, otherwise Nipsnap1 would consistently suppress TRPV5 activity. An obvious 
candidate factor controlling this dynamic behavior would be Ca2+ itself substantiating the 
negative feedback of Ca2+ on TRPV5 activity. However, Ca2+ does not affect the binding of 
Nipsnap1 and TRPV5 given the lack of Ca2+ dependence during the binding analysis 
suggesting that Ca2+ is not involved Nipsnap1 regulation. Thus, Nipsnap1 recruitment to 
TRPV5 at the cell surface might be part of TRPV5 regulation at the cell surface. Further 
experimental data should finally substantiate this hypothesis. 
  
TRPV5 in other tissues: a critical function in hearing  
Over the years TRPV5 research has focused on its regulation and functioning in the 
maintenance of the Ca2+ balance although this channel has also been identified in other tissues 
generally not implicated in Ca2+ homeostasis (4). The results presented in chapter 7 
substantiate our knowledge of TRPV5 function by highlighting its presence and physiological 
role in the inner ear. Besides malfunctioning of the Ca2+ balance (44), TRPV5-/- mice display 
decreased startle pre-pulse inhibition and increased acoustic brainstem response thresholds 
demonstrating deficits in sound perception. Although many cell types have been identified in 
the cochlea, the sound perceptive organ in the inner ear, their function still largely remains 
elusive. Research on hearing loss has traditionally focused on the hair cells, as they are the 
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first station in the conversion of sound into electrical signals that are conducted by the axons 
of the spiral ganglion neurons to the brain.  Directly underneath the hair cells lay the organ of 
Corti supporting cells of which the function is unknown. Recently, supporting cells have been 
suggested to fulfill an active role in the maintenance of the mechano-sensitive hair cell 
structure and function (45). Our results contribute to this concept by providing evidence for a 
TRPV5-based pathway in Deiters supporting cells involved in auditory threshold 
determination. Deiters cells contain a specialized system of endocellular protein filaments 
which provides them with internal strength important to support the outer hair cells (45). 
Because outer hair cells are involved in sound amplification near threshold intensities and 
TRPV5-/- mice display increased hearing thresholds the lack of TRPV5 most likely results in 
malfunctioning of the outer hair cells. How TRPV5 in Deiters cells contributes to outer hair 
cell function, however, is not clear. In addition to providing structural support, Deiters cells 
have been implicated as an ion reservoir salvaging K+ and avoiding its accumulation in the 
extracellular solution that might be cytotoxic to hair cells (46). Thus, potentially similar 
buffering mechanisms exist for the maintenance of [Ca2+]e such that Deiters cells absorb 
excess amount of extracellular Ca2+. In analogy to its function in Ca2+-transporting epithelia, 
TRPV5 accounts for luminal Ca2+ influx in these cells.  
 
Glimpse at the future 
The novel perspectives in TRPV5 and TRPV6 regulation have significantly contributed to our 
understanding of the overall control of luminal Ca2+ influx in Ca2+-transporting epithelia (see 
table 1 for an overview). While some of these newly identified concepts describe the cell 
surface expression of these channels, others unravel the Ca2+-dependent channel activity First, 
the identified pathway of rapid TRPV5 channel delivery to the plasma membrane opens a 
challenging field of research in TRP regulation. Channeling important questions, like which 
factors prevent collapsing and fusing during vesicular “kiss and linger” interactions with the 
plasma membrane, will provide a comprehensive view on the regulation of constitutively 
active ion channels. In this particular field, knowledge can be gained from research that 
focuses on “kiss and run” and “kiss and coat” exocytosis that are comparable to “kiss and 
linger”. Second, although several associated proteins are identified to control trafficking of 
these channels towards the cell surface, we still do not fully understand the mechanisms 
determining the functional restriction of TRPV5 and TRPV6 to the luminal plasma 
membrane. Questions like which factors determine apical sorting of TRPV5 and TRPV6 
remain unanswered. Since we identified extracellular alkalinization as a stimulus to initiate 
rapid plasma membrane trafficking of TRPV5 we now have a tool at hand to decipher the 
routes of apical sorting. Preliminary results adapting this control of TRPV5 cell surface 
expression, suggest a critical role for syntaxins in this process (Lambers et al, unpublished 
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results) highlighting potential factors controlling “kiss and linger” and apical sorting. Third, 
our model for transcellular Ca2+ transport allows the estimation of the number of TRPV5 
channels in the membrane. A more reliable estimation can be obtained when [Ca2+] in the 
TRPV5 pore has been determined. Future experiments that include fusion of fluorescent Ca2+ 
indicator proteins to the channel complex in combination with total internal reflection 
microscopy should provide this knowledge. In addition, this approach will provide 
alternatives to determine Ca2+ fluxes through single TRPV5 channels as recently described for 
other Ca2+ channels (47). Finally, besides TRPV5 and TRPV6 function in the tissues that 
contribute to the Ca2+ balance imminent research will spread out to other tissues, including 
inner ear, where these channels contribute to physiological processes other than the 
maintenance of the Ca2+ balance. In summary, the findings described in this thesis open new 
perspectives about the physiological function of TRPV5 and TRPV6 and pinpoint to novel 
associated protein partners controlling apical Ca2+ influx in Ca2+-transporting epithelia.  
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Samenvatting  
(Summary in Dutch) 
 
Summary in Dutch  
 
Inleiding                  
Vele vitale functies in ons lichaam zijn afhankelijk van een constante bloed 
calciumconcentratie. Dit blijkt onder andere uit ziektebeelden die samenhangen met een 
verstoorde calciumbalans, zoals osteoporose, idiopathische hypercalciurie,  nierstenen en 
rickets. Drie organen spelen een belangrijke rol bij de regulatie van de bloed 
calciumconcentratie, namelijk de botten, de darm en de nieren die gezamenlijk de 
calciumbalans handhaven. Het calciumtransport tussen deze organen en het bloed wordt 
gecontroleerd door de zogenaamde calciotrope hormonen zoals vitamine D en 
parathyroïdhormoon. Vitamine D stimuleert de actieve calciumabsorptie in de dunne darm en 
de nieren. Dit transcellulair calciumtransport vindt plaats in de gepolariseerde nier- en 
darmcellen in drie discrete stappen: (I) een calciuminflux via het luminale plasmamembraan, 
(II) cytosolische diffusie van calcium met behulp van calciumbindende eiwitten, (III) excretie 
van calcium over de basolaterale membraan door de natrium-calcium uitwisselaar en de 
calcium-ATPase. Influx via het luminale plasmamembraan wordt verzorgd door twee 
epitheliale calciumkanalen, namelijk TRPV5 en TRPV6. Deze eiwitten behoren tot de 
Transient Receptor Potential (TRP) superfamilie van kationkanalen. Het is uitvoerig bewezen 
dat TRPV5 en TRPV6 een poortwachtersfunctie vervullen in het calciumabsorptieproces en 
daarmee een essentiële rol spelen bij de regulatie van de calciumbalans. In diverse 
muismodellen is aangetoond dat een deficiëntie van TRPV5 of TRPV6 leidt tot ernstige 
verstoringen van de calciumbalans. Bijvoorbeeld, de TRPV5 knockout muis vertoont een 
hypercalciurie, hyperabsorptie en een verminderde botdichtheid. Ook muizen die door een 
genetisch defect geen vitamine D kunnen aanmaken hebben een ernstig fenotype mede 
doordat TRPV5 en TRPV6 sterk zijn verlaagd. Deze pathologische verschijnselen 
onderstrepen het fysiologisch belang van deze calciumkanalen. De lokalisatie van TRPV5 en 
TRPV6 in het luminale plasmamembraan van calciumtransporterende epitheelcellen in de 
dunne darm en de nieren is in overeenstemming met de gepostuleerde functie als 
poortwachter van de transcellulaire calciumabsorptie. Deze veronderstelling wordt verder 
ondersteund door de hormoon-afhankelijke regulatie van de epitheliale calciumkanalen. 
TRPV5 is met name van belang voor de calciumreabsorptie in de nier, terwijl TRPV6 een rol 
speelt bij de opname van calcium uit het voedsel. Om de calciumbalans beter te begrijpen 
dient een gedetailleerde kennis over het functioneren van TRPV5 en TRPV6 verkregen te 
worden. Het onderwerp van dit proefschrift is derhalve inzicht te verschaffen in de regulatie 
van deze epitheliale calciumkanalen. 
Er zijn diverse regulatiemechanismen die uiteindelijk influx van calcium via TRPV5 en 
TRPV6 in het apicale membraan bepalen. Ten eerste wordt de hoeveelheid beschikbare 
kanalen in de cel bepaald via genomische regulatie door de calciotrope hormonen, zoals 
vitamine D, die de calciumbalans controleren. Ten tweede reguleren gespecialiseerde 
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processen in de cel het transport van TRPV5 en TRPV6 naar het plasmamembraan. Ten derde 
wordt de activiteit van TRPV5 en TRPV6 beïnvloed in het plasmamembraan via 
structuurveranderingen of via geassocieerde eiwitten die door binding aan het kanaalcomplex 
de influx van calcium reguleren. Tenslotte wordt de recycling en afbraak van beide kanalen 
bepaald waardoor de influx van calcium via TRPV5 en TRPV6 efficiënt gereguleerd kan 
worden zonder aanmaak van nieuwe kanalen. Dit hoofdstuk geeft een korte samenvatting van 
de nieuwe inzichten en de rol van nieuw geïdentificeerde TRPV5 en TRPV6 bindingpartners 
in de regulatie van TRPV5 en TRPV6, zoals beschreven in dit proefschrift.       
 
Extracellulaire pH reguleert de plasmamembraan expressie van TRPV5 
Initiële elektrofysiologische karakterisatie van TRPV5 heeft aangetoond dat dit ionkanaal 
opereert als een constitutief actief calciumkanaal, wat inhoud dat TRPV5 volledig actief is 
wanneer het kanaal in het plasmamembraan aanwezig is. In hoofdstuk 2 wordt beschreven dat 
extracellulaire pH, naast regulatie van de poriestructuur, de expressie van TRPV5 in het 
plasmamembraan bepaalt via een uniek mechanisme. Gedetailleerde microscopische analyse 
toonde aan dat TRPV5 lokaliseert in intracellulaire vesicles die na extracellulaire alkalinisatie 
naar het plasmamembraan transporteren. Eenmaal aangekomen fuseren deze vesicles niet 
maar blijven intact. In combinatie met de samengaande toename van TRPV5 activiteit en 
toegankelijkheid voor extracellulaire labeling m.b.v. biotine, suggereren deze resultaten dat 
TRPV5 toegang verkrijgt tot extracellulair calcium vanuit vesicles via transiënte openingen in 
het plasmamembraan. Opeenvolgend, resulteerde extracellulaire acidificatie in een 
translocatie van de vesicles terug naar het cytosol. Dit mechanisme (genaamd “kiss en 
linger”) stelt de cel in staat om de plasmamembraan lokalisatie van TRPV5 snel en efficiënt te 
reguleren. Uit deze studie blijkt dat constitutieve ionkanalen, aanwezig in vesicles, in contact 
worden gebracht met het extracellulaire milieu via het “kiss en linger” mechanisme. 
   
 
Calcium-afhankelijke regulatie van TRPV5 en TRPV6 
Elektrofysiologische karakterisatie van TRPV5 en TRPV6 heeft tevens aangetoond dat de 
activiteit sterk gereguleerd wordt door calcium. Zo heeft calcium wat via TRPV5 en TRPV6 
de cel instroomt een sterk negatieve invloed op de activiteit van deze ionkanalen. Het 
achterliggende moleculaire mechanisme van de calcium-afhankelijke inactivatie is echter nog 
steeds niet bekend. De regulatie van de lokale calciumconcentratie bij beide kanalen bepaald 
dus mede de activiteit van de kanalen. Van een groot aantal andere ionkanalen is het bekend 
dat eiwit-eiwit associaties een belangrijke rol spelen bij de regulatie van de kanaalactiviteit. 
Uit onderzoek aan diverse ionkanalen is gebleken dat de calciumsensor calmoduline, wanneer 
geassocieerd met het ionkanaal, een belangrijke rol vervult in de regulatie van de activiteit. In 
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hoofdstuk 3 is de regulatie van TRPV5 en TRPV6 door calmoduline beschreven. Met behulp 
van calcium ongevoelige calmoduline mutanten, in verschillende binding en 
elektrofysiologische studies, is de rol van dit eiwit in de regulatie van TRPV5 en TRPV6 
vastgesteld. Dit toonde aan dat regulatie door  calmoduline beperkt is tot TRPV6 waar 
calmoduline functioneert als een calciumsensor die de activiteit van TRPV6 controleert.   
Hoofdstuk 4 en 5 beschrijven het belangrijke aspect van regulatie van de lokale 
calciumconcentratie in de TRPV5 porie. Door de snelle opname van calcium uit de 
extracellulaire matrix kan calcium accumuleren in het TRPV5 porie domein. Deze ophoping 
van calcium heeft een negatieve invloed op de activiteit van TRPV5 wat blijkt uit de calcium-
afhankelijke activiteit van dit kanaal. In een bindingsanalyse om nieuwe TRPV5-
geassocieerde eiwitten te ontdekken bleek dat calbindine-D28K aan TRPV5 bindt. Uit verdere 
analyses bleek dat, wanneer de intracellulaire calciumconcentratie verlaagt, calbindine-D28K 
naar de plasma membraan transloceert en associeert met TRPV5. Eerdere studies met 
primaire niercelkweken, die calcium transporteren vanuit het apicale compartiment naar het 
basolaterale compartiment, hebben aangetoond dat de verwerking van intracellulair calcium 
tijdens transcellulair calciumtransport efficiënt is gereguleerd aangezien er geen duidelijke 
veranderingen in de intracellulaire calciumconcentratie waarneembaar waren. Co-expressie 
van een calcium ongevoelige calbindin-D28K mutant, die nog wel met TRPV5 associeert, in 
deze primaire niercelkweken resulteerde in een dominant negatieve inhibitie van het 
transcellulaire calciumtransport over deze cellen. Deze resultaten tonen dus aan dat de 
TRPV5-calbindin-D28K associatie van fysiologisch belang is voor transcellulair 
calciumtransport. Hoofdstuk 5 integreert al deze resultaten in een model voor transcellulair 
calciumtransport en beschrijft dat calbindine-D28K door binding aan TRPV5 in staat is om 
lokaal de calciumconcentratie af te stemmen waardoor TRPV5 actief blijft. Wanneer het door 
TRPV5 instromende calcium aan calbindine-D28K bindt zal calbindine-D28K van TRPV5 
dissociëren waardoor er onvoldoende calcium gebufferd wordt, hetgeen resulteert in 
inactivatie van TRPV5. 
 
Nipsnap1 
Hoofdstuk 6 beschrijft de identificatie van Nipsnap1 als nieuw TRPV5-geassocieerd eiwit en 
zijn rol in de regulatie van TRPV5 kanaalactiviteit. Ook Nipsnap1 kwam naar voren als 
partner in de bindingsanalyse om nieuwe TRPV5-geassocieerde eiwitten te ontdekken. Uit 
verdere analyse bleek dat Nipsnap1 binding aan TRPV5 onafhankelijk is van calcium en 
lokaliseert in de TRPV5 amino- en carboxylterminus. Co-expressie van Nipsnap1 met TRPV5 
resulteerde in een drastische vermindering van TRPV5 activiteit. TRPV5-labeling 
experimenten aan het celoppervlak toonde aan dat NIPSNAP1 geen effect heeft op de 
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plasmamembraan lokalisatie van het kanaal. Deze studie beschrijft dus als eerste een 
fysiologische rol voor Nipsnap1 in de regulatie van TRPV5 kanaalactiviteit. 
 
Rol van TRPV5 in het binnenoor 
In de afgelopen jaren was het TRPV5 onderzoek met name gericht op de functie in nier en 
darm. Uit het in dit proefschrift beschreven onderzoek is gebleken dat TRPV5 ook voorkomt 
in het binnenoor. Iontransporterende cellen in ons lichaam hebben veel overeenkomsten in 
functie. Zo zijn iontransporterende cellen in nier en binnenoor vergelijkbaar, waardoor de 
hypothese ontstond dat TRPV5 mogelijk betrokken is in het gehoor. De resultaten in 
hoofdstuk 7 beschrijven dat TRPV5 inderdaad een rol vervult in het binnenoor. 
Lokalisatiestudies toonden aan dat TRPV5 tot expressie komt in Dieters cellen. Deiters cellen 
behoren tot de ondersteunende cellen in het binnenoor die bijdragen aan de structuur en het 
functioneren van het binnenoor. TRPV5 knockout muizen vertoonden tijdens diverse gehoor 
testen een verminderde gehoorfunctie vergeleken met muizen uit de controle groep. Deze 
studie beschrijft dus een nieuwe fysiologische functie voor het epitheliale calciumkanaal 
TRPV5 als onderdeel van het complexe mechanisme van geluidwaarneming. Welke functie 
TRPV5 nu vervult in Deiters ondersteunende cellen is nog echter nog niet duidelijk en zou 
door toekomstig onderzoek uitgezocht moeten worden. 
 
De resultaten beschreven in dit proefschrift dragen bij aan een beter inzicht in de handhaving 
van de calciumbalans. Naast verder onderzoek naar de calciumafhankelijkheid van TRPV5 en 
TRPV6 zou toekomstig onderzoek uitsluitsel moeten geven over de factoren die een rol 
spelen bij de snelle regulatie van beide kanalen via “kiss and linger” mechanismen. Tevens 
zijn beide kanalen, zoals de resultaten beschreven in dit proefschrift aangeven, naast 
handhaving van de calciumbalans waarschijnlijk betrokken bij meerdere vitale processen in 
ons lichaam. Een grote wetenschappelijke uitdaging ligt in het ontrafelen van de functie van 
TRPV5 en TRPV6 in deze processen.   
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